<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:oef="http://xbrl.sec.gov/oef/2025"
  xmlns:tsr="http://tsr/20260430"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tsr-20260430.xsd" xlink:type="simple"/>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_instant_FranklinBiotechnologyDiscoveryFund_ClassA_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7358_instant_FranklinBiotechnologyDiscoveryFund_ClassA_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7358_instant_FranklinBiotechnologyDiscoveryFund_ClassA_2026-04-30_4000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044000_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7358_instant_FranklinBiotechnologyDiscoveryFund_ClassA_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7358_instant_FranklinBiotechnologyDiscoveryFund_ClassA_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7358_instant_FranklinBiotechnologyDiscoveryFund_ClassA_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2021-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2016-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018631Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7358Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_instant_FranklinBiotechnologyDiscoveryFund_ClassC_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7359_instant_FranklinBiotechnologyDiscoveryFund_ClassC_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7359_instant_FranklinBiotechnologyDiscoveryFund_ClassC_2026-04-30_4000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044000_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7359_instant_FranklinBiotechnologyDiscoveryFund_ClassC_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7359_instant_FranklinBiotechnologyDiscoveryFund_ClassC_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7359_instant_FranklinBiotechnologyDiscoveryFund_ClassC_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000141458Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7359Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_instant_FranklinBiotechnologyDiscoveryFund_ClassR6_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7360_instant_FranklinBiotechnologyDiscoveryFund_ClassR6_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7360_instant_FranklinBiotechnologyDiscoveryFund_ClassR6_2026-04-30_4000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044000_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7360_instant_FranklinBiotechnologyDiscoveryFund_ClassR6_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7360_instant_FranklinBiotechnologyDiscoveryFund_ClassR6_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7360_instant_FranklinBiotechnologyDiscoveryFund_ClassR6_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128862Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7360Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_instant_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7357_instant_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7357_instant_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2026-04-30_4000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044000_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7357_instant_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7357_instant_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7357_instant_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000081539Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_5443Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2547_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7357Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7432Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_3987Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043987_7432Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4313Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054313_7432Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4342Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411074342_7432Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4316Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054316_7432Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4315Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054315_7432Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4317Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054317_7432Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4314Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054314_7432Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_3986Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043986_7432Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4922Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044922_7432Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4924Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044924_7432Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4923Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044923_7432Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_3989Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043989_7432Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4925Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044925_7432Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4975Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412194975_7432Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_3991Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043991_7432Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_ClassA_2021-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_ClassA_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_2021-05-01_2026-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7432Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_ClassA_2016-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_ClassA_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_2016-05-01_2026-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7432Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_ClassA_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_2016-04-30_2016-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7432Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_ClassA_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_2017-04-30_2017-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7432Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_ClassA_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_2018-04-30_2018-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7432Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_ClassA_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_2019-04-30_2019-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7432Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_ClassA_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_2020-04-30_2020-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7432Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_ClassA_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_2021-04-30_2021-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7432Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_ClassA_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_2022-04-30_2022-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7432Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_ClassA_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_2023-04-30_2023-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7432Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_ClassA_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_2024-04-30_2024-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7432Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018620Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7432_duration_FranklinCorePlusBondFund_2025-04-30_2025-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7432Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7440Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_3987Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043987_7440Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4313Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054313_7440Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4342Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411074342_7440Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4316Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054316_7440Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4315Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054315_7440Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4317Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054317_7440Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4314Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054314_7440Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_3986Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043986_7440Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4922Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044922_7440Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4924Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044924_7440Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4923Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044923_7440Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_3989Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043989_7440Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4925Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044925_7440Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4975Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412194975_7440Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_3991Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043991_7440Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_ClassC_2021-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_ClassC_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_2021-05-01_2026-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7440Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_ClassC_2016-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_ClassC_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_2016-05-01_2026-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7440Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_ClassC_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_2016-04-30_2016-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7440Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_ClassC_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_2017-04-30_2017-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7440Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_ClassC_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_2018-04-30_2018-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7440Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_ClassC_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_2019-04-30_2019-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7440Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_ClassC_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_2020-04-30_2020-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7440Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_ClassC_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_2021-04-30_2021-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7440Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_ClassC_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_2022-04-30_2022-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7440Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_ClassC_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_2023-04-30_2023-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7440Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_ClassC_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_2024-04-30_2024-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7440Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018622Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7440_duration_FranklinCorePlusBondFund_2025-04-30_2025-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7440Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7443Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_3987Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043987_7443Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4313Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054313_7443Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4342Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411074342_7443Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4316Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054316_7443Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4315Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054315_7443Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4317Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054317_7443Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4314Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054314_7443Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_3986Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043986_7443Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4922Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044922_7443Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4924Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044924_7443Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4923Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044923_7443Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_3989Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043989_7443Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4925Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044925_7443Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4975Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412194975_7443Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_3991Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043991_7443Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_ClassR_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_2021-05-01_2026-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7443Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_ClassR_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_2016-05-01_2026-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7443Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_ClassR_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_2016-04-30_2016-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7443Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_ClassR_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_2017-04-30_2017-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7443Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_ClassR_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_2018-04-30_2018-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7443Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_ClassR_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_2019-04-30_2019-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7443Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_ClassR_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_2020-04-30_2020-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7443Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_ClassR_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_2021-04-30_2021-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7443Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_ClassR_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_2022-04-30_2022-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7443Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_ClassR_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_2023-04-30_2023-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7443Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_ClassR_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_2024-04-30_2024-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7443Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018624Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7443_duration_FranklinCorePlusBondFund_2025-04-30_2025-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7443Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7441Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_3987Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043987_7441Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4313Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054313_7441Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4342Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411074342_7441Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4316Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054316_7441Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4315Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054315_7441Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4317Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054317_7441Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4314Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054314_7441Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_3986Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043986_7441Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4922Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044922_7441Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4924Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044924_7441Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4923Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044923_7441Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_3989Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043989_7441Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4925Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044925_7441Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4975Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412194975_7441Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_3991Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043991_7441Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_2021-05-01_2026-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7441Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_2016-05-01_2026-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7441Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_2016-04-30_2016-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7441Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_2017-04-30_2017-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7441Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_2018-04-30_2018-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7441Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_2019-04-30_2019-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7441Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_2020-04-30_2020-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7441Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_2021-04-30_2021-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7441Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_2022-04-30_2022-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7441Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_2023-04-30_2023-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7441Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_2024-04-30_2024-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7441Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128861Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7441_duration_FranklinCorePlusBondFund_2025-04-30_2025-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7441Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7431Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_3987Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043987_7431Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4313Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054313_7431Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4342Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411074342_7431Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4316Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054316_7431Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4315Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054315_7431Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4317Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054317_7431Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4314Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202411054314_7431Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_3986Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043986_7431Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4922Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044922_7431Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4924Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044924_7431Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4923Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044923_7431Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_3989Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043989_7431Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4925Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412044925_7431Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4975Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202412194975_7431Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_3991Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">tsr:bench202409043991_7431Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_2021-05-01_2026-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7431Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_2016-05-01_2026-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7431Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_2016-04-30_2016-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7431Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_2017-04-30_2017-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7431Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_2018-04-30_2018-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7431Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_2019-04-30_2019-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7431Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_2020-04-30_2020-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7431Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_2021-04-30_2021-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7431Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_2022-04-30_2022-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7431Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_2023-04-30_2023-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7431Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_2024-04-30_2024-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7431Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018623Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7431_duration_FranklinCorePlusBondFund_2025-04-30_2025-04-30_4434Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411144434_7431Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_3995Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043995_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_3996Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043996_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_4001Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044001_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_4002Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044002_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_4943Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202412104943_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2021-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2016-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018615Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7485Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_3995Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043995_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_3996Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043996_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_4001Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044001_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_4002Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044002_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_4943Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202412104943_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2021-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2016-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018617Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7484Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_3995Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043995_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_3996Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043996_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_4001Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044001_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_4002Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044002_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_4943Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202412104943_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018619Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7482Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_3995Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043995_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_3996Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043996_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_4001Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044001_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_4002Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044002_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_4943Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202412104943_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128860Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7483Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_3995Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043995_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_3996Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043996_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_4001Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044001_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_4002Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044002_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_4943Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202412104943_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018618Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_5438Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0792_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7486Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_instant_FranklinNaturalResourcesFund_ClassA_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7444_instant_FranklinNaturalResourcesFund_ClassA_2026-04-30_3999Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043999_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7444_instant_FranklinNaturalResourcesFund_ClassA_2026-04-30_4001Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044001_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7444_instant_FranklinNaturalResourcesFund_ClassA_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7444_instant_FranklinNaturalResourcesFund_ClassA_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7444_instant_FranklinNaturalResourcesFund_ClassA_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7444_instant_FranklinNaturalResourcesFund_ClassA_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2021-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2016-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018648Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7444_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7444Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_instant_FranklinNaturalResourcesFund_ClassC_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7445_instant_FranklinNaturalResourcesFund_ClassC_2026-04-30_3999Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043999_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7445_instant_FranklinNaturalResourcesFund_ClassC_2026-04-30_4001Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044001_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7445_instant_FranklinNaturalResourcesFund_ClassC_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7445_instant_FranklinNaturalResourcesFund_ClassC_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7445_instant_FranklinNaturalResourcesFund_ClassC_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7445_instant_FranklinNaturalResourcesFund_ClassC_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2021-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2016-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018647Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7445_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7445Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_instant_FranklinNaturalResourcesFund_ClassR6_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7446_instant_FranklinNaturalResourcesFund_ClassR6_2026-04-30_3999Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043999_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7446_instant_FranklinNaturalResourcesFund_ClassR6_2026-04-30_4001Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044001_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7446_instant_FranklinNaturalResourcesFund_ClassR6_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7446_instant_FranklinNaturalResourcesFund_ClassR6_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7446_instant_FranklinNaturalResourcesFund_ClassR6_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7446_instant_FranklinNaturalResourcesFund_ClassR6_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000132949Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7446_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7446Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_instant_FranklinNaturalResourcesFund_AdvisorClass_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7442_instant_FranklinNaturalResourcesFund_AdvisorClass_2026-04-30_3999Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043999_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7442_instant_FranklinNaturalResourcesFund_AdvisorClass_2026-04-30_4001Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044001_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7442_instant_FranklinNaturalResourcesFund_AdvisorClass_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7442_instant_FranklinNaturalResourcesFund_AdvisorClass_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7442_instant_FranklinNaturalResourcesFund_AdvisorClass_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7442_instant_FranklinNaturalResourcesFund_AdvisorClass_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018649Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_5440Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM2285_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7442_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_5441Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM10720_7442Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_3996Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043996_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_3999Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043999_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_3995Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043995_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_4000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044000_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_4001Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044001_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_4943Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202412104943_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2021-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2016-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018655Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7463_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7463Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_3996Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043996_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_3999Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043999_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_3995Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043995_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_4000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044000_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_4001Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044001_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_4943Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202412104943_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2021-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2016-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018657Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7464_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7464Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_3996Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043996_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_3999Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043999_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_3995Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043995_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_4000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044000_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_4001Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044001_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_4943Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202412104943_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018659Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7466_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7466Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_3996Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043996_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_3999Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043999_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_3995Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043995_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_4000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044000_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_4001Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044001_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_4943Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202412104943_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128865Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7462_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7462Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_3996Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043996_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_3999Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043999_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_3995Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043995_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_4000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044000_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_4001Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044001_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_4943Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202412104943_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018658Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_5442Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0619_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7465_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7465Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_3996Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043996_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_3995Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043995_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_3999Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043999_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_4002Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044002_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_4000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044000_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2021-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2016-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018650Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7453Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_3996Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043996_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_3995Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043995_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_3999Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043999_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_4002Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044002_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_4000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044000_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2021-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2016-05-01_2026-04-30_1400Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:SalesLoadAxis">oef:WithoutSalesLoadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018652Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7454Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_3996Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043996_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_3995Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043995_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_3999Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043999_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_4002Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044002_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_4000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044000_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018654Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7461Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_3996Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043996_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_3995Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043995_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_3999Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043999_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_4002Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044002_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_4000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044000_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000128864Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7455Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_3997Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043997_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_3996Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043996_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_3992Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043992_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_3993Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043993_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_3994Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043994_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_3995Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043995_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_3999Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043999_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_4002Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044002_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_3998Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409043998_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_4000Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044000_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_4003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="oef:IndustrySectorAxis">tsr:bench202409044003_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2021-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2016-05-01_2026-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2016-04-30_2016-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-30</startDate>
            <endDate>2016-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2017-04-30_2017-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-30</startDate>
            <endDate>2017-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2018-04-30_2018-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2019-04-30_2019-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2020-04-30_2020-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-30</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2021-04-30_2021-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2022-04-30_2022-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2023-04-30_2023-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2024-04-30_2024-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-04-30_2025-04-30Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:ClassAxis">tsr:C000018653Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_4435Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:BroadBasedIndexAxis">tsr:bench202411154435_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_5108Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkBM0824_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_3882Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="oef:AdditionalIndexAxis">tsr:benchmarkHB0331_7460Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="RATIO">
        <measure>pure</measure>
    </unit>
    <unit id="UNIT">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-88971">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-88972">0000872625</dei:EntityCentralIndexKey>
    <dei:EntityInvCompanyType
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-88973">N-1A</dei:EntityInvCompanyType>
    <dei:DocumentType
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-102481">N-CSR</dei:DocumentType>
    <dei:EntityRegistrantName
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-102482">Franklin Strategic Series</dei:EntityRegistrantName>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-102483"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:FundName
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-74"
      xml:lang="en-US">Franklin Biotechnology Discovery Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-83"
      xml:lang="en-US">Class A</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-86"
      xml:lang="en-US">FBDIX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-93"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-100"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Biotechnology Discovery Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-102"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-109"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-111"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-115"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:ExpensesTextBlock
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="foot-7358_798434-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class A&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$134&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.01%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102484"
      unitRef="USD">134</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7358_798434-1021"
      unitRef="RATIO">0.0101</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-178"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class A shares of Franklin Biotechnology Discovery Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;65.03%. The Fund &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;compares its performance to the&#160;&#x2009;NASDAQ Biotechnology Index and the S&amp;amp;P 500 Index, which returned 37.61% and 31.05%, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;respectively, for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Overweighted portfolio exposure to mid-, small-, and micro-cap biotechnology stocks, which generally performed well. &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Performance also benefited from a focus on companies with proven drug delivery platforms, favorable clinical trial catalysts, and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;strong balance sheets. In addition, an emphasis on identifying clinically or commercially &#x201c;de-risked&#x201d; assets appears to have &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;supported relative returns.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Successful stock selection in the biotech industry, where numerous overweighted or off-benchmark holdings more than doubled &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;in value, including key contributors Abivax, Ascendis Pharma, Praxis Precision Medicines, Merus, Spyre Therapeutics, Oruka &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Therapeutics, Centessa Pharmaceuticals, Dianthus Therapeutics and uniQure.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Stock selection and overweighting in the pharmaceuticals industry, where much larger-than-index positions in Terns &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Pharmaceuticals and Jazz Pharmaceuticals topped a fairly long list of contributors. To a lesser extent, additional relative-return &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;gains were achieved in three other industries: health care services (due to overweighting), managed health care (not an index &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;component), and health care equipment (lack of exposure).&#160;&#x2009;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Detrimental stock selection created a wide total-return gap in the life sciences tools and services industry; the combined value of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the Fund&#x2019;s related holdings declined, while those tracked by the benchmark index increased sharply.&#160;&#x2009;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Several overweighted or off-benchmark biotech and pharma holdings either sold off amid company-specific setbacks or posted &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;muted one-year gains. The key detractors in this regard were LENZ Therapeutics (purchased during the period), Benitec &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Biopharma, Soleno Therapeutics, ARS Pharmaceuticals, Ionis Pharmaceuticals (purchased during the period), Eli Lilly, MoonLake &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Immunotherapeutics (bought and sold during the period), Zealand Pharma, Ultragenyx Pharmaceuticals and Day One &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Biopharmaceuticals. Several of these positions were liquidated by year-end.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund lacked exposure to several index component companies&#x2014;such as Roivant Sciences, Arrowhead Pharmaceuticals, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;United Therapeutics, Viatris, and Axsome Therapeutics&#x2014;that significantly outperformed the benchmark. In addition, the &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;portfolio&#x2019;s cash allocation (averaging about 2.1% of total net assets) diluted relative performance during a time of robust and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;broad-based gains across the biotech and pharma industries.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-304"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-307"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-328"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7358img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-332"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class A&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;65.03&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;8.13&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.09&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class A (with sales charge)&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;55.94&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;6.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;9.47&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;NASDAQ Biotechnology Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;37.61&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;3.80&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;7.65&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-368"
      xml:lang="en-US">Class A</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-102486"
      unitRef="RATIO">0.6503</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2021-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-102487"
      unitRef="RATIO">0.0813</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2016-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-102488"
      unitRef="RATIO">0.1009</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30_1400Member"
      id="ixv-383"
      xml:lang="en-US">Class A (with sales charge)</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102489"
      unitRef="RATIO">0.5594</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102490"
      unitRef="RATIO">0.0691</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102491"
      unitRef="RATIO">0.0947</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-398"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-102492"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-102493"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-102494"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_5443Member"
      id="ixv-413"
      xml:lang="en-US">NASDAQ Biotechnology Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_5443Member"
      decimals="INF"
      id="ixv-102495"
      unitRef="RATIO">0.3761</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_5443Member"
      decimals="INF"
      id="ixv-102496"
      unitRef="RATIO">0.0380</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_5443Member"
      decimals="INF"
      id="ixv-102497"
      unitRef="RATIO">0.0765</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-428"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-102498"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-102499"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-102500"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-452"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-468"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$1,037,360,270&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;110&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$5,300,115&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;37.62%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7358_instant_FranklinBiotechnologyDiscoveryFund_ClassA_2026-04-30Member"
      decimals="INF"
      id="ixv-102501"
      unitRef="USD">1037360270</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7358_instant_FranklinBiotechnologyDiscoveryFund_ClassA_2026-04-30Member"
      decimals="INF"
      id="ixv-102502"
      unitRef="UNIT">110</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102503"
      unitRef="USD">5300115</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102504"
      unitRef="RATIO">0.3762</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="foot-7358_798455-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7358img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:UpdProspectusWebAddress
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-580"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-102505"
      unitRef="USD">9450</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-102506"
      unitRef="USD">11342</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-102507"
      unitRef="USD">11534</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-102508"
      unitRef="USD">11349</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-102509"
      unitRef="USD">13450</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-102510"
      unitRef="USD">16712</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-102511"
      unitRef="USD">11939</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-102512"
      unitRef="USD">13202</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-102513"
      unitRef="USD">15535</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-102514"
      unitRef="USD">14970</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102515"
      unitRef="USD">24703</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-102516"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-102517"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-102518"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-102519"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-102520"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-102521"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-102522"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-102523"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-102524"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-102525"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-102526"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_5443Member"
      decimals="INF"
      id="ixv-102527"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_5443Member"
      decimals="INF"
      id="ixv-102528"
      unitRef="USD">11103</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_5443Member"
      decimals="INF"
      id="ixv-102529"
      unitRef="USD">11602</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_5443Member"
      decimals="INF"
      id="ixv-102530"
      unitRef="USD">11917</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_5443Member"
      decimals="INF"
      id="ixv-102531"
      unitRef="USD">13902</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_5443Member"
      decimals="INF"
      id="ixv-102532"
      unitRef="USD">17344</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_5443Member"
      decimals="INF"
      id="ixv-102533"
      unitRef="USD">13405</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_5443Member"
      decimals="INF"
      id="ixv-102534"
      unitRef="USD">14926</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_5443Member"
      decimals="INF"
      id="ixv-102535"
      unitRef="USD">14837</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_5443Member"
      decimals="INF"
      id="ixv-102536"
      unitRef="USD">15187</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_5443Member"
      decimals="INF"
      id="ixv-102537"
      unitRef="USD">20899</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-102538"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-102539"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-102540"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-102541"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-102542"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-102543"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-102544"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-102545"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-102546"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-102547"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-102548"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7358_instant_FranklinBiotechnologyDiscoveryFund_ClassA_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-102549"
      unitRef="RATIO">0.940</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7358_instant_FranklinBiotechnologyDiscoveryFund_ClassA_2026-04-30_4000Member"
      decimals="INF"
      id="ixv-102550"
      unitRef="RATIO">0.003</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7358_instant_FranklinBiotechnologyDiscoveryFund_ClassA_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-102551"
      unitRef="RATIO">0.002</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7358_instant_FranklinBiotechnologyDiscoveryFund_ClassA_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-102552"
      unitRef="RATIO">0.001</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7358_instant_FranklinBiotechnologyDiscoveryFund_ClassA_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-102553"
      unitRef="RATIO">0.054</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-626"
      xml:lang="en-US">Franklin Biotechnology Discovery Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-635"
      xml:lang="en-US">Class C</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-638"
      xml:lang="en-US">FBTDX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-645"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-652"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Biotechnology Discovery Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-654"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-661"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-663"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-667"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:ExpensesTextBlock
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="foot-7359_798557-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class C&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$232&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.76%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102554"
      unitRef="USD">232</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7359_798557-1021"
      unitRef="RATIO">0.0176</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-730"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class C shares of Franklin Biotechnology Discovery Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;63.82%. The Fund &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;compares its performance to the&#160;&#x2009;NASDAQ Biotechnology Index and the S&amp;amp;P 500 Index, which returned 37.61% and 31.05%, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;respectively, for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Overweighted portfolio exposure to mid-, small-, and micro-cap biotechnology stocks, which generally performed well. &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Performance also benefited from a focus on companies with proven drug delivery platforms, favorable clinical trial catalysts, and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;strong balance sheets. In addition, an emphasis on identifying clinically or commercially &#x201c;de-risked&#x201d; assets appears to have &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;supported relative returns.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Successful stock selection in the biotech industry, where numerous overweighted or off-benchmark holdings more than doubled &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;in value, including key contributors Abivax, Ascendis Pharma, Praxis Precision Medicines, Merus, Spyre Therapeutics, Oruka &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Therapeutics, Centessa Pharmaceuticals, Dianthus Therapeutics and uniQure.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Stock selection and overweighting in the pharmaceuticals industry, where much larger-than-index positions in Terns &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Pharmaceuticals and Jazz Pharmaceuticals topped a fairly long list of contributors. To a lesser extent, additional relative-return &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;gains were achieved in three other industries: health care services (due to overweighting), managed health care (not an index &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;component), and health care equipment (lack of exposure).&#160;&#x2009;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Detrimental stock selection created a wide total-return gap in the life sciences tools and services industry; the combined value of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the Fund&#x2019;s related holdings declined, while those tracked by the benchmark index increased sharply.&#160;&#x2009;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Several overweighted or off-benchmark biotech and pharma holdings either sold off amid company-specific setbacks or posted &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;muted one-year gains. The key detractors in this regard were LENZ Therapeutics (purchased during the period), Benitec &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Biopharma, Soleno Therapeutics, ARS Pharmaceuticals, Ionis Pharmaceuticals (purchased during the period), Eli Lilly, MoonLake &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Immunotherapeutics (bought and sold during the period), Zealand Pharma, Ultragenyx Pharmaceuticals and Day One &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Biopharmaceuticals. Several of these positions were liquidated by year-end.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund lacked exposure to several index component companies&#x2014;such as Roivant Sciences, Arrowhead Pharmaceuticals, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;United Therapeutics, Viatris, and Axsome Therapeutics&#x2014;that significantly outperformed the benchmark. In addition, the &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;portfolio&#x2019;s cash allocation (averaging about 2.1% of total net assets) diluted relative performance during a time of robust and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;broad-based gains across the biotech and pharma industries.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-856"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-859"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-876"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7359img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-880"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class C&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;63.82&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;7.35&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;9.28&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;NASDAQ Biotechnology Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;37.61&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;3.80&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;7.65&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-916"
      xml:lang="en-US">Class C</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102556"
      unitRef="RATIO">0.6382</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102557"
      unitRef="RATIO">0.0735</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102558"
      unitRef="RATIO">0.0928</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-931"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-102559"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-102560"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-102561"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_5443Member"
      id="ixv-946"
      xml:lang="en-US">NASDAQ Biotechnology Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_5443Member"
      decimals="INF"
      id="ixv-102562"
      unitRef="RATIO">0.3761</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_5443Member"
      decimals="INF"
      id="ixv-102563"
      unitRef="RATIO">0.0380</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_5443Member"
      decimals="INF"
      id="ixv-102564"
      unitRef="RATIO">0.0765</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-961"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-102565"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-102566"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-102567"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-981"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-997"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$1,037,360,270&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;110&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$5,300,115&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;37.62%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7359_instant_FranklinBiotechnologyDiscoveryFund_ClassC_2026-04-30Member"
      decimals="INF"
      id="ixv-102568"
      unitRef="USD">1037360270</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7359_instant_FranklinBiotechnologyDiscoveryFund_ClassC_2026-04-30Member"
      decimals="INF"
      id="ixv-102569"
      unitRef="UNIT">110</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102570"
      unitRef="USD">5300115</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102571"
      unitRef="RATIO">0.3762</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="foot-7359_798577-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7359img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:UpdProspectusWebAddress
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-1109"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-102572"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-102573"
      unitRef="USD">11914</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-102574"
      unitRef="USD">12024</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-102575"
      unitRef="USD">11744</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-102576"
      unitRef="USD">13813</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-102577"
      unitRef="USD">17036</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-102578"
      unitRef="USD">12096</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-102579"
      unitRef="USD">13276</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-102580"
      unitRef="USD">15506</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-102581"
      unitRef="USD">14829</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102582"
      unitRef="USD">24293</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-102583"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-102584"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-102585"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-102586"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-102587"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-102588"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-102589"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-102590"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-102591"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-102592"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-102593"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_5443Member"
      decimals="INF"
      id="ixv-102594"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_5443Member"
      decimals="INF"
      id="ixv-102595"
      unitRef="USD">11103</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_5443Member"
      decimals="INF"
      id="ixv-102596"
      unitRef="USD">11602</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_5443Member"
      decimals="INF"
      id="ixv-102597"
      unitRef="USD">11917</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_5443Member"
      decimals="INF"
      id="ixv-102598"
      unitRef="USD">13902</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_5443Member"
      decimals="INF"
      id="ixv-102599"
      unitRef="USD">17344</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_5443Member"
      decimals="INF"
      id="ixv-102600"
      unitRef="USD">13405</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_5443Member"
      decimals="INF"
      id="ixv-102601"
      unitRef="USD">14926</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_5443Member"
      decimals="INF"
      id="ixv-102602"
      unitRef="USD">14837</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_5443Member"
      decimals="INF"
      id="ixv-102603"
      unitRef="USD">15187</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_5443Member"
      decimals="INF"
      id="ixv-102604"
      unitRef="USD">20899</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-102605"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-102606"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-102607"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-102608"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-102609"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-102610"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-102611"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-102612"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-102613"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-102614"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7359_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-102615"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7359_instant_FranklinBiotechnologyDiscoveryFund_ClassC_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-102616"
      unitRef="RATIO">0.940</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7359_instant_FranklinBiotechnologyDiscoveryFund_ClassC_2026-04-30_4000Member"
      decimals="INF"
      id="ixv-102617"
      unitRef="RATIO">0.003</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7359_instant_FranklinBiotechnologyDiscoveryFund_ClassC_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-102618"
      unitRef="RATIO">0.002</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7359_instant_FranklinBiotechnologyDiscoveryFund_ClassC_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-102619"
      unitRef="RATIO">0.001</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7359_instant_FranklinBiotechnologyDiscoveryFund_ClassC_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-102620"
      unitRef="RATIO">0.054</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-1155"
      xml:lang="en-US">Franklin Biotechnology Discovery Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-1164"
      xml:lang="en-US">Class R6</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-1167"
      xml:lang="en-US">FRBRX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-1174"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-1181"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Biotechnology Discovery Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-1183"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-1190"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-1192"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-1196"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:ExpensesTextBlock
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="foot-7360_798679-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class R6&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$89&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.67%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102621"
      unitRef="USD">89</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7360_798679-1021"
      unitRef="RATIO">0.0067</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-1259"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R6 shares of Franklin Biotechnology Discovery Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;65.61%. The Fund &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;compares its performance to the&#160;&#x2009;NASDAQ Biotechnology Index and the S&amp;amp;P 500 Index, which returned 37.61% and 31.05%, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;respectively, for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Overweighted portfolio exposure to mid-, small-, and micro-cap biotechnology stocks, which generally performed well. &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Performance also benefited from a focus on companies with proven drug delivery platforms, favorable clinical trial catalysts, and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;strong balance sheets. In addition, an emphasis on identifying clinically or commercially &#x201c;de-risked&#x201d; assets appears to have &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;supported relative returns.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Successful stock selection in the biotech industry, where numerous overweighted or off-benchmark holdings more than doubled &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;in value, including key contributors Abivax, Ascendis Pharma, Praxis Precision Medicines, Merus, Spyre Therapeutics, Oruka &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Therapeutics, Centessa Pharmaceuticals, Dianthus Therapeutics and uniQure.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Stock selection and overweighting in the pharmaceuticals industry, where much larger-than-index positions in Terns &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Pharmaceuticals and Jazz Pharmaceuticals topped a fairly long list of contributors. To a lesser extent, additional relative-return &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;gains were achieved in three other industries: health care services (due to overweighting), managed health care (not an index &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;component), and health care equipment (lack of exposure).&#160;&#x2009;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Detrimental stock selection created a wide total-return gap in the life sciences tools and services industry; the combined value of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the Fund&#x2019;s related holdings declined, while those tracked by the benchmark index increased sharply.&#160;&#x2009;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Several overweighted or off-benchmark biotech and pharma holdings either sold off amid company-specific setbacks or posted &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;muted one-year gains. The key detractors in this regard were LENZ Therapeutics (purchased during the period), Benitec &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Biopharma, Soleno Therapeutics, ARS Pharmaceuticals, Ionis Pharmaceuticals (purchased during the period), Eli Lilly, MoonLake &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Immunotherapeutics (bought and sold during the period), Zealand Pharma, Ultragenyx Pharmaceuticals and Day One &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Biopharmaceuticals. Several of these positions were liquidated by year-end.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund lacked exposure to several index component companies&#x2014;such as Roivant Sciences, Arrowhead Pharmaceuticals, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;United Therapeutics, Viatris, and Axsome Therapeutics&#x2014;that significantly outperformed the benchmark. In addition, the &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;portfolio&#x2019;s cash allocation (averaging about 2.1% of total net assets) diluted relative performance during a time of robust and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;broad-based gains across the biotech and pharma industries.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-1385"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-1388"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-1405"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7360img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-1409"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class R6&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;65.61&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;8.53&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.50&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;NASDAQ Biotechnology Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;37.61&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;3.80&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;7.65&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-1445"
      xml:lang="en-US">Class R6</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102623"
      unitRef="RATIO">0.6561</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102624"
      unitRef="RATIO">0.0853</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102625"
      unitRef="RATIO">0.1050</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-1460"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-102626"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-102627"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-102628"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_5443Member"
      id="ixv-1475"
      xml:lang="en-US">NASDAQ Biotechnology Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_5443Member"
      decimals="INF"
      id="ixv-102629"
      unitRef="RATIO">0.3761</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_5443Member"
      decimals="INF"
      id="ixv-102630"
      unitRef="RATIO">0.0380</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_5443Member"
      decimals="INF"
      id="ixv-102631"
      unitRef="RATIO">0.0765</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-1490"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-102632"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-102633"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-102634"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-1510"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-1526"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$1,037,360,270&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;110&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$5,300,115&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;37.62%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7360_instant_FranklinBiotechnologyDiscoveryFund_ClassR6_2026-04-30Member"
      decimals="INF"
      id="ixv-102635"
      unitRef="USD">1037360270</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7360_instant_FranklinBiotechnologyDiscoveryFund_ClassR6_2026-04-30Member"
      decimals="INF"
      id="ixv-102636"
      unitRef="UNIT">110</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102637"
      unitRef="USD">5300115</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102638"
      unitRef="RATIO">0.3762</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="foot-7360_798699-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7360img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:UpdProspectusWebAddress
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-1638"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-102639"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-102640"
      unitRef="USD">12050</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-102641"
      unitRef="USD">12305</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-102642"
      unitRef="USD">12153</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-102643"
      unitRef="USD">14456</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-102644"
      unitRef="USD">18023</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-102645"
      unitRef="USD">12923</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-102646"
      unitRef="USD">14349</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-102647"
      unitRef="USD">16946</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-102648"
      unitRef="USD">16386</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102649"
      unitRef="USD">27135</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-102650"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-102651"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-102652"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-102653"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-102654"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-102655"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-102656"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-102657"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-102658"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-102659"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-102660"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_5443Member"
      decimals="INF"
      id="ixv-102661"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_5443Member"
      decimals="INF"
      id="ixv-102662"
      unitRef="USD">11103</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_5443Member"
      decimals="INF"
      id="ixv-102663"
      unitRef="USD">11602</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_5443Member"
      decimals="INF"
      id="ixv-102664"
      unitRef="USD">11917</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_5443Member"
      decimals="INF"
      id="ixv-102665"
      unitRef="USD">13902</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_5443Member"
      decimals="INF"
      id="ixv-102666"
      unitRef="USD">17344</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_5443Member"
      decimals="INF"
      id="ixv-102667"
      unitRef="USD">13405</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_5443Member"
      decimals="INF"
      id="ixv-102668"
      unitRef="USD">14926</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_5443Member"
      decimals="INF"
      id="ixv-102669"
      unitRef="USD">14837</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_5443Member"
      decimals="INF"
      id="ixv-102670"
      unitRef="USD">15187</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_5443Member"
      decimals="INF"
      id="ixv-102671"
      unitRef="USD">20899</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-102672"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-102673"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-102674"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-102675"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-102676"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-102677"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-102678"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-102679"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-102680"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-102681"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7360_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-102682"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7360_instant_FranklinBiotechnologyDiscoveryFund_ClassR6_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-102683"
      unitRef="RATIO">0.940</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7360_instant_FranklinBiotechnologyDiscoveryFund_ClassR6_2026-04-30_4000Member"
      decimals="INF"
      id="ixv-102684"
      unitRef="RATIO">0.003</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7360_instant_FranklinBiotechnologyDiscoveryFund_ClassR6_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-102685"
      unitRef="RATIO">0.002</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7360_instant_FranklinBiotechnologyDiscoveryFund_ClassR6_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-102686"
      unitRef="RATIO">0.001</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7360_instant_FranklinBiotechnologyDiscoveryFund_ClassR6_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-102687"
      unitRef="RATIO">0.054</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-1684"
      xml:lang="en-US">Franklin Biotechnology Discovery Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-1693"
      xml:lang="en-US">Advisor Class</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-1696"
      xml:lang="en-US">FTDZX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-1703"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-1710"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Biotechnology Discovery Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-1712"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-1719"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-1721"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-1725"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:ExpensesTextBlock
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="foot-7357_798312-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Advisor Class&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$101&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.76%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102688"
      unitRef="USD">101</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7357_798312-1021"
      unitRef="RATIO">0.0076</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-1788"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Advisor Class shares of Franklin Biotechnology Discovery Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;65.45%. The &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Fund compares its performance to the&#160;&#x2009;NASDAQ Biotechnology Index and the S&amp;amp;P 500 Index, which returned 37.61% and 31.05%, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;respectively, for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Overweighted portfolio exposure to mid-, small-, and micro-cap biotechnology stocks, which generally performed well. &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Performance also benefited from a focus on companies with proven drug delivery platforms, favorable clinical trial catalysts, and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;strong balance sheets. In addition, an emphasis on identifying clinically or commercially &#x201c;de-risked&#x201d; assets appears to have &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;supported relative returns.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Successful stock selection in the biotech industry, where numerous overweighted or off-benchmark holdings more than doubled &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;in value, including key contributors Abivax, Ascendis Pharma, Praxis Precision Medicines, Merus, Spyre Therapeutics, Oruka &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Therapeutics, Centessa Pharmaceuticals, Dianthus Therapeutics and uniQure.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Stock selection and overweighting in the pharmaceuticals industry, where much larger-than-index positions in Terns &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Pharmaceuticals and Jazz Pharmaceuticals topped a fairly long list of contributors. To a lesser extent, additional relative-return &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;gains were achieved in three other industries: health care services (due to overweighting), managed health care (not an index &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;component), and health care equipment (lack of exposure).&#160;&#x2009;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Detrimental stock selection created a wide total-return gap in the life sciences tools and services industry; the combined value of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the Fund&#x2019;s related holdings declined, while those tracked by the benchmark index increased sharply.&#160;&#x2009;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Several overweighted or off-benchmark biotech and pharma holdings either sold off amid company-specific setbacks or posted &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;muted one-year gains. The key detractors in this regard were LENZ Therapeutics (purchased during the period), Benitec &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Biopharma, Soleno Therapeutics, ARS Pharmaceuticals, Ionis Pharmaceuticals (purchased during the period), Eli Lilly, MoonLake &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Immunotherapeutics (bought and sold during the period), Zealand Pharma, Ultragenyx Pharmaceuticals and Day One &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Biopharmaceuticals. Several of these positions were liquidated by year-end.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund lacked exposure to several index component companies&#x2014;such as Roivant Sciences, Arrowhead Pharmaceuticals, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;United Therapeutics, Viatris, and Axsome Therapeutics&#x2014;that significantly outperformed the benchmark. In addition, the &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;portfolio&#x2019;s cash allocation (averaging about 2.1% of total net assets) diluted relative performance during a time of robust and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;broad-based gains across the biotech and pharma industries.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-1914"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-1917"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-1934"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7357img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-1938"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Advisor Class&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;65.45&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;8.40&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.36&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;NASDAQ Biotechnology Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;37.61&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;3.80&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;7.65&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-1974"
      xml:lang="en-US">Advisor Class</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102690"
      unitRef="RATIO">0.6545</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102691"
      unitRef="RATIO">0.0840</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102692"
      unitRef="RATIO">0.1036</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-1989"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-102693"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-102694"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-102695"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_5443Member"
      id="ixv-2004"
      xml:lang="en-US">NASDAQ Biotechnology Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_5443Member"
      decimals="INF"
      id="ixv-102696"
      unitRef="RATIO">0.3761</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_5443Member"
      decimals="INF"
      id="ixv-102697"
      unitRef="RATIO">0.0380</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_5443Member"
      decimals="INF"
      id="ixv-102698"
      unitRef="RATIO">0.0765</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-2019"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-102699"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-102700"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-102701"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-2039"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-2055"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$1,037,360,270&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;110&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$5,300,115&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;37.62%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7357_instant_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2026-04-30Member"
      decimals="INF"
      id="ixv-102702"
      unitRef="USD">1037360270</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7357_instant_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2026-04-30Member"
      decimals="INF"
      id="ixv-102703"
      unitRef="UNIT">110</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102704"
      unitRef="USD">5300115</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102705"
      unitRef="RATIO">0.3762</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="foot-7357_798332-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7357img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:UpdProspectusWebAddress
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-2167"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-102706"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-102707"
      unitRef="USD">12032</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-102708"
      unitRef="USD">12266</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-102709"
      unitRef="USD">12099</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-102710"
      unitRef="USD">14376</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-102711"
      unitRef="USD">17907</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-102712"
      unitRef="USD">12824</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-102713"
      unitRef="USD">14217</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-102714"
      unitRef="USD">16772</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-102715"
      unitRef="USD">16201</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102716"
      unitRef="USD">26804</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-102717"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-102718"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-102719"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-102720"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-102721"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-102722"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-102723"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-102724"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-102725"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-102726"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-102727"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_5443Member"
      decimals="INF"
      id="ixv-102728"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_5443Member"
      decimals="INF"
      id="ixv-102729"
      unitRef="USD">11103</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_5443Member"
      decimals="INF"
      id="ixv-102730"
      unitRef="USD">11602</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_5443Member"
      decimals="INF"
      id="ixv-102731"
      unitRef="USD">11917</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_5443Member"
      decimals="INF"
      id="ixv-102732"
      unitRef="USD">13902</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_5443Member"
      decimals="INF"
      id="ixv-102733"
      unitRef="USD">17344</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_5443Member"
      decimals="INF"
      id="ixv-102734"
      unitRef="USD">13405</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_5443Member"
      decimals="INF"
      id="ixv-102735"
      unitRef="USD">14926</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_5443Member"
      decimals="INF"
      id="ixv-102736"
      unitRef="USD">14837</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_5443Member"
      decimals="INF"
      id="ixv-102737"
      unitRef="USD">15187</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_5443Member"
      decimals="INF"
      id="ixv-102738"
      unitRef="USD">20899</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-102739"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-102740"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-102741"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-102742"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-102743"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-102744"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-102745"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-102746"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-102747"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-102748"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7357_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-102749"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7357_instant_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-102750"
      unitRef="RATIO">0.940</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7357_instant_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2026-04-30_4000Member"
      decimals="INF"
      id="ixv-102751"
      unitRef="RATIO">0.003</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7357_instant_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-102752"
      unitRef="RATIO">0.002</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7357_instant_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-102753"
      unitRef="RATIO">0.001</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7357_instant_FranklinBiotechnologyDiscoveryFund_AdvisorClass_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-102754"
      unitRef="RATIO">0.054</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2213"
      xml:lang="en-US">Franklin Core Plus Bond Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2222"
      xml:lang="en-US">Class A</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2225"
      xml:lang="en-US">FRSTX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-2232"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2239"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Core Plus Bond Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-2241"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2249"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2251"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2255"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:MaterialFundChngNoticeTextBlock
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2260"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;"&gt;&lt;b&gt;&lt;i&gt;This report describes changes to the Fund that occurred during the reporting period.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngNoticeTextBlock>
    <oef:ExpensesTextBlock
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="foot-7432_805514-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class A&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$73&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.71%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102755"
      unitRef="USD">73</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7432_805514-1021"
      unitRef="RATIO">0.0071</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2324"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class A shares of Franklin Core Plus Bond Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;4.78%. The Fund compares its &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;performance to the&#160;&#x2009;Bloomberg U.S. Aggregate Index, which returned 4.06% for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Overweight allocation to high-yield (HY) and investment-grade (IG) corporate bonds, agency mortgage-backed securities (MBS), &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;commercial MBS and sovereign emerging market debt.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Out-of-index exposure to residential MBS and collateralized loan obligations (CLOs).&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Exposure to the five-, 20- and 30-year portions of the yield curve.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Security selection in HY corporate bonds, senior secured floating-rate bank loans and IG corporate bonds.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Exposure to the 10-year segment of the yield curve.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Use of derivatives and the impact on performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund utilized bond futures to manage duration exposure and high-yield credit default swap (CDS) to manage the Fund&#x2019;s credit &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;exposure. In aggregate, these instruments detracted slightly from performance.&lt;/span&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2436"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2439"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2460"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7432img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2464"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class A&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;4.78&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.81&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;2.80&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class A (with sales charge)&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.87&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.03&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;2.41&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Bloomberg U.S. Aggregate Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;4.06&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.18&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.67&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30_1400Member"
      id="ixv-2500"
      xml:lang="en-US">Class A</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-102757"
      unitRef="RATIO">0.0478</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2021-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-102758"
      unitRef="RATIO">0.0181</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2016-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-102759"
      unitRef="RATIO">0.0280</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2515"
      xml:lang="en-US">Class A (with sales charge)</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102760"
      unitRef="RATIO">0.0087</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102761"
      unitRef="RATIO">0.0103</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102762"
      unitRef="RATIO">0.0241</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7432_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member"
      id="ixv-2530"
      xml:lang="en-US">Bloomberg U.S. Aggregate Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7432_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102763"
      unitRef="RATIO">0.0406</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7432_duration_FranklinCorePlusBondFund_2021-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102764"
      unitRef="RATIO">0.0018</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7432_duration_FranklinCorePlusBondFund_2016-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102765"
      unitRef="RATIO">0.0167</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2554"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2570"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$2,747,319,270&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings (excludes derivatives, except purchased options, if any)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;866&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$6,862,755&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;349.54%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30Member"
      decimals="INF"
      id="ixv-102766"
      unitRef="USD">2747319270</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30Member"
      decimals="INF"
      id="ixv-102767"
      unitRef="UNIT">866</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102768"
      unitRef="USD">6862755</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102769"
      unitRef="RATIO">3.4954</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="foot-7432_805539-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9pt;color:#161616;;"&gt;&lt;sup&gt;,&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;&#x2020;&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7432img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:MaterialFundChngTextBlock
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2677"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW HAS THE FUND CHANGED?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective September 1, 2025, the Fund&#x2019;s principal investment strategies were changed to reflect the Fund&#x2019;s increased investments in &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;collateralized mortgage obligations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Related risk disclosure was added to the prospectus.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective September 30, 2025, Benjamin Cryer and Thomas Runkel no longer serve as portfolio managers of the Fund and Albert Chan &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;was added as a portfolio manager of the Fund.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective May 8, 2025, the investment manager contractually agreed to waive fees and/or reimburse operating expenses (excluding &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the Rule 12b-1 fees and certain non-routine expenses or costs, such as those relating to litigation, indemnification, reorganizations and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;liquidations) for the Fund so that the ratio of total annual fund operating expenses will not exceed 0.47% for each share class except &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R6 and 0.37% for Class R6 until August 31, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Additionally, effective May 8, 2025, the Fund&#x2019;s contractual management fee schedule was reduced to a fee equal to an annual rate &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;based on the value of the Fund&#x2019;s average daily net assets, as follows: 0.350% up to and including $5 billion; 0.330% over $5 billion up to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and including $10 billion; 0.310% over $10 billion up to and including $20 billion; and 0.290% over $20 billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes and planned changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;review the Fund&#x2019;s current prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngTextBlock>
    <oef:MaterialFundChngStrategiesTextBlock
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2685"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective September 1, 2025, the Fund&#x2019;s principal investment strategies were changed to reflect the Fund&#x2019;s increased investments in &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;collateralized mortgage obligations.&lt;/span&gt;</oef:MaterialFundChngStrategiesTextBlock>
    <oef:MaterialFundChngExpensesTextBlock
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2700"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective May 8, 2025, the investment manager contractually agreed to waive fees and/or reimburse operating expenses (excluding &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the Rule 12b-1 fees and certain non-routine expenses or costs, such as those relating to litigation, indemnification, reorganizations and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;liquidations) for the Fund so that the ratio of total annual fund operating expenses will not exceed 0.47% for each share class except &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R6 and 0.37% for Class R6 until August 31, 2026.&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Additionally, effective May 8, 2025, the Fund&#x2019;s contractual management fee schedule was reduced to a fee equal to an annual rate &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;based on the value of the Fund&#x2019;s average daily net assets, as follows: 0.350% up to and including $5 billion; 0.330% over $5 billion up to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and including $10 billion; 0.310% over $10 billion up to and including $20 billion; and 0.290% over $20 billion.&lt;/span&gt;</oef:MaterialFundChngExpensesTextBlock>
    <oef:SummaryOfChngLegendTextBlock
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2715"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes and planned changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;review the Fund&#x2019;s current prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;</oef:SummaryOfChngLegendTextBlock>
    <oef:MaterialChngDate
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2717"
      xml:lang="en-US">2025-05-01</oef:MaterialChngDate>
    <oef:UpdProspectusWebAddress
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2723"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:UpdProspectusPhoneNumber
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2726"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:UpdProspectusPhoneNumber>
    <oef:UpdProspectusEmailAddress
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-2730"
      xml:lang="en-US">prospectus.us.franklintempleton@fisglobal.com</oef:UpdProspectusEmailAddress>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-102770"
      unitRef="USD">9625</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-102771"
      unitRef="USD">10347</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-102772"
      unitRef="USD">10414</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-102773"
      unitRef="USD">10885</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-102774"
      unitRef="USD">10262</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-102775"
      unitRef="USD">11601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-102776"
      unitRef="USD">10897</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-102777"
      unitRef="USD">10977</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-102778"
      unitRef="USD">11319</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-102779"
      unitRef="USD">12109</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102780"
      unitRef="USD">12688</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_2016-04-30_2016-04-30_4434Member"
      decimals="INF"
      id="ixv-102781"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_2017-04-30_2017-04-30_4434Member"
      decimals="INF"
      id="ixv-102782"
      unitRef="USD">10083</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_2018-04-30_2018-04-30_4434Member"
      decimals="INF"
      id="ixv-102783"
      unitRef="USD">10051</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_2019-04-30_2019-04-30_4434Member"
      decimals="INF"
      id="ixv-102784"
      unitRef="USD">10582</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_2020-04-30_2020-04-30_4434Member"
      decimals="INF"
      id="ixv-102785"
      unitRef="USD">11730</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_2021-04-30_2021-04-30_4434Member"
      decimals="INF"
      id="ixv-102786"
      unitRef="USD">11698</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_2022-04-30_2022-04-30_4434Member"
      decimals="INF"
      id="ixv-102787"
      unitRef="USD">10703</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_2023-04-30_2023-04-30_4434Member"
      decimals="INF"
      id="ixv-102788"
      unitRef="USD">10657</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_2024-04-30_2024-04-30_4434Member"
      decimals="INF"
      id="ixv-102789"
      unitRef="USD">10500</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_2025-04-30_2025-04-30_4434Member"
      decimals="INF"
      id="ixv-102790"
      unitRef="USD">11343</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7432_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102791"
      unitRef="USD">11803</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_3987Member"
      decimals="INF"
      id="ixv-102792"
      unitRef="RATIO">0.318</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4313Member"
      decimals="INF"
      id="ixv-102793"
      unitRef="RATIO">0.246</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4342Member"
      decimals="INF"
      id="ixv-102794"
      unitRef="RATIO">0.120</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4316Member"
      decimals="INF"
      id="ixv-102795"
      unitRef="RATIO">0.076</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4315Member"
      decimals="INF"
      id="ixv-102796"
      unitRef="RATIO">0.052</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4317Member"
      decimals="INF"
      id="ixv-102797"
      unitRef="RATIO">0.037</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4314Member"
      decimals="INF"
      id="ixv-102798"
      unitRef="RATIO">0.025</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_3986Member"
      decimals="INF"
      id="ixv-102799"
      unitRef="RATIO">0.025</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4922Member"
      decimals="INF"
      id="ixv-102800"
      unitRef="RATIO">0.022</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4924Member"
      decimals="INF"
      id="ixv-102801"
      unitRef="RATIO">0.008</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4923Member"
      decimals="INF"
      id="ixv-102802"
      unitRef="RATIO">0.001</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_3989Member"
      decimals="INF"
      id="ixv-102803"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4925Member"
      decimals="INF"
      id="ixv-102804"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_4975Member"
      decimals="INF"
      id="ixv-102805"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7432_instant_FranklinCorePlusBondFund_ClassA_2026-04-30_3991Member"
      decimals="INF"
      id="ixv-102806"
      unitRef="RATIO">0.070</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-2796"
      xml:lang="en-US">Franklin Core Plus Bond Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-2805"
      xml:lang="en-US">Class C</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-2808"
      xml:lang="en-US">FSGCX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-2815"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-2822"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Core Plus Bond Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-2824"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-2832"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-2834"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-2838"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:MaterialFundChngNoticeTextBlock
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-2843"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;"&gt;&lt;b&gt;&lt;i&gt;This report describes changes to the Fund that occurred during the reporting period.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngNoticeTextBlock>
    <oef:ExpensesTextBlock
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="foot-7440_806227-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class C&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$113&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.11%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102807"
      unitRef="USD">113</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7440_806227-1021"
      unitRef="RATIO">0.0111</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-2907"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class C shares of Franklin Core Plus Bond Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;4.35%. The Fund compares its &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;performance to the&#160;&#x2009;Bloomberg U.S. Aggregate Index, which returned 4.06% for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Overweight allocation to high-yield (HY) and investment-grade (IG) corporate bonds, agency mortgage-backed securities (MBS), &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;commercial MBS and sovereign emerging market debt.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Out-of-index exposure to residential MBS and collateralized loan obligations (CLOs).&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Exposure to the five-, 20- and 30-year portions of the yield curve.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Security selection in HY corporate bonds, senior secured floating-rate bank loans and IG corporate bonds.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Exposure to the 10-year segment of the yield curve.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Use of derivatives and the impact on performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund utilized bond futures to manage duration exposure and high-yield credit default swap (CDS) to manage the Fund&#x2019;s credit &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;exposure. In aggregate, these instruments detracted slightly from performance.&lt;/span&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-3019"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-3022"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-3039"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7440img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-3043"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class C&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;4.35&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.40&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;2.40&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class C (with sales charge)&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;3.35&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.40&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;2.40&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Bloomberg U.S. Aggregate Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;4.06&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.18&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.67&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30_1400Member"
      id="ixv-3079"
      xml:lang="en-US">Class C</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-102809"
      unitRef="RATIO">0.0435</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2021-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-102810"
      unitRef="RATIO">0.0140</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2016-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-102811"
      unitRef="RATIO">0.0240</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-3094"
      xml:lang="en-US">Class C (with sales charge)</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102812"
      unitRef="RATIO">0.0335</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102813"
      unitRef="RATIO">0.0140</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102814"
      unitRef="RATIO">0.0240</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7440_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member"
      id="ixv-3109"
      xml:lang="en-US">Bloomberg U.S. Aggregate Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7440_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102815"
      unitRef="RATIO">0.0406</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7440_duration_FranklinCorePlusBondFund_2021-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102816"
      unitRef="RATIO">0.0018</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7440_duration_FranklinCorePlusBondFund_2016-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102817"
      unitRef="RATIO">0.0167</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-3130"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-3146"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$2,747,319,270&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings (excludes derivatives, except purchased options, if any)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;866&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$6,862,755&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;349.54%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30Member"
      decimals="INF"
      id="ixv-102818"
      unitRef="USD">2747319270</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30Member"
      decimals="INF"
      id="ixv-102819"
      unitRef="UNIT">866</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102820"
      unitRef="USD">6862755</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102821"
      unitRef="RATIO">3.4954</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="foot-7440_806251-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9pt;color:#161616;;"&gt;&lt;sup&gt;,&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;&#x2020;&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7440img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:MaterialFundChngTextBlock
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-3253"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW HAS THE FUND CHANGED?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective September 1, 2025, the Fund&#x2019;s principal investment strategies were changed to reflect the Fund&#x2019;s increased investments in &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;collateralized mortgage obligations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Related risk disclosure was added to the prospectus.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective September 30, 2025, Benjamin Cryer and Thomas Runkel no longer serve as portfolio managers of the Fund and Albert Chan &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;was added as a portfolio manager of the Fund.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective May 8, 2025, the investment manager contractually agreed to waive fees and/or reimburse operating expenses (excluding &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the Rule 12b-1 fees and certain non-routine expenses or costs, such as those relating to litigation, indemnification, reorganizations and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;liquidations) for the Fund so that the ratio of total annual fund operating expenses will not exceed 0.47% for each share class except &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R6 and 0.37% for Class R6 until August 31, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Additionally, effective May 8, 2025, the Fund&#x2019;s contractual management fee schedule was reduced to a fee equal to an annual rate &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;based on the value of the Fund&#x2019;s average daily net assets, as follows: 0.350% up to and including $5 billion; 0.330% over $5 billion up to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and including $10 billion; 0.310% over $10 billion up to and including $20 billion; and 0.290% over $20 billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes and planned changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;review the Fund&#x2019;s current prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngTextBlock>
    <oef:MaterialFundChngStrategiesTextBlock
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-3261"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective September 1, 2025, the Fund&#x2019;s principal investment strategies were changed to reflect the Fund&#x2019;s increased investments in &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;collateralized mortgage obligations.&lt;/span&gt;</oef:MaterialFundChngStrategiesTextBlock>
    <oef:MaterialFundChngExpensesTextBlock
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-3276"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective May 8, 2025, the investment manager contractually agreed to waive fees and/or reimburse operating expenses (excluding &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the Rule 12b-1 fees and certain non-routine expenses or costs, such as those relating to litigation, indemnification, reorganizations and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;liquidations) for the Fund so that the ratio of total annual fund operating expenses will not exceed 0.47% for each share class except &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R6 and 0.37% for Class R6 until August 31, 2026.&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Additionally, effective May 8, 2025, the Fund&#x2019;s contractual management fee schedule was reduced to a fee equal to an annual rate &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;based on the value of the Fund&#x2019;s average daily net assets, as follows: 0.350% up to and including $5 billion; 0.330% over $5 billion up to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and including $10 billion; 0.310% over $10 billion up to and including $20 billion; and 0.290% over $20 billion.&lt;/span&gt;</oef:MaterialFundChngExpensesTextBlock>
    <oef:SummaryOfChngLegendTextBlock
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-3291"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes and planned changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;review the Fund&#x2019;s current prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;</oef:SummaryOfChngLegendTextBlock>
    <oef:MaterialChngDate
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-3293"
      xml:lang="en-US">2025-05-01</oef:MaterialChngDate>
    <oef:UpdProspectusWebAddress
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-3299"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:UpdProspectusPhoneNumber
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-3302"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:UpdProspectusPhoneNumber>
    <oef:UpdProspectusEmailAddress
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-3306"
      xml:lang="en-US">prospectus.us.franklintempleton@fisglobal.com</oef:UpdProspectusEmailAddress>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-102822"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-102823"
      unitRef="USD">10719</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-102824"
      unitRef="USD">10734</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-102825"
      unitRef="USD">11184</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-102826"
      unitRef="USD">10501</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-102827"
      unitRef="USD">11822</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-102828"
      unitRef="USD">11056</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-102829"
      unitRef="USD">11089</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-102830"
      unitRef="USD">11400</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-102831"
      unitRef="USD">12144</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102832"
      unitRef="USD">12672</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_2016-04-30_2016-04-30_4434Member"
      decimals="INF"
      id="ixv-102833"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_2017-04-30_2017-04-30_4434Member"
      decimals="INF"
      id="ixv-102834"
      unitRef="USD">10083</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_2018-04-30_2018-04-30_4434Member"
      decimals="INF"
      id="ixv-102835"
      unitRef="USD">10051</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_2019-04-30_2019-04-30_4434Member"
      decimals="INF"
      id="ixv-102836"
      unitRef="USD">10582</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_2020-04-30_2020-04-30_4434Member"
      decimals="INF"
      id="ixv-102837"
      unitRef="USD">11730</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_2021-04-30_2021-04-30_4434Member"
      decimals="INF"
      id="ixv-102838"
      unitRef="USD">11698</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_2022-04-30_2022-04-30_4434Member"
      decimals="INF"
      id="ixv-102839"
      unitRef="USD">10703</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_2023-04-30_2023-04-30_4434Member"
      decimals="INF"
      id="ixv-102840"
      unitRef="USD">10657</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_2024-04-30_2024-04-30_4434Member"
      decimals="INF"
      id="ixv-102841"
      unitRef="USD">10500</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_2025-04-30_2025-04-30_4434Member"
      decimals="INF"
      id="ixv-102842"
      unitRef="USD">11343</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7440_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102843"
      unitRef="USD">11803</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_3987Member"
      decimals="INF"
      id="ixv-102844"
      unitRef="RATIO">0.318</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4313Member"
      decimals="INF"
      id="ixv-102845"
      unitRef="RATIO">0.246</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4342Member"
      decimals="INF"
      id="ixv-102846"
      unitRef="RATIO">0.120</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4316Member"
      decimals="INF"
      id="ixv-102847"
      unitRef="RATIO">0.076</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4315Member"
      decimals="INF"
      id="ixv-102848"
      unitRef="RATIO">0.052</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4317Member"
      decimals="INF"
      id="ixv-102849"
      unitRef="RATIO">0.037</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4314Member"
      decimals="INF"
      id="ixv-102850"
      unitRef="RATIO">0.025</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_3986Member"
      decimals="INF"
      id="ixv-102851"
      unitRef="RATIO">0.025</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4922Member"
      decimals="INF"
      id="ixv-102852"
      unitRef="RATIO">0.022</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4924Member"
      decimals="INF"
      id="ixv-102853"
      unitRef="RATIO">0.008</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4923Member"
      decimals="INF"
      id="ixv-102854"
      unitRef="RATIO">0.001</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_3989Member"
      decimals="INF"
      id="ixv-102855"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4925Member"
      decimals="INF"
      id="ixv-102856"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_4975Member"
      decimals="INF"
      id="ixv-102857"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7440_instant_FranklinCorePlusBondFund_ClassC_2026-04-30_3991Member"
      decimals="INF"
      id="ixv-102858"
      unitRef="RATIO">0.070</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3372"
      xml:lang="en-US">Franklin Core Plus Bond Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3381"
      xml:lang="en-US">Class R</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3384"
      xml:lang="en-US">FKSRX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-3391"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3398"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Core Plus Bond Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-3400"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3408"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3410"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3414"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:MaterialFundChngNoticeTextBlock
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3419"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;"&gt;&lt;b&gt;&lt;i&gt;This report describes changes to the Fund that occurred during the reporting period.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngNoticeTextBlock>
    <oef:ExpensesTextBlock
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="foot-7443_806629-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class R&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$98&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.96%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102859"
      unitRef="USD">98</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7443_806629-1021"
      unitRef="RATIO">0.0096</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3483"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R shares of Franklin Core Plus Bond Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;4.67%. The Fund compares its &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;performance to the&#160;&#x2009;Bloomberg U.S. Aggregate Index, which returned 4.06% for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Overweight allocation to high-yield (HY) and investment-grade (IG) corporate bonds, agency mortgage-backed securities (MBS), &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;commercial MBS and sovereign emerging market debt.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Out-of-index exposure to residential MBS and collateralized loan obligations (CLOs).&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Exposure to the five-, 20- and 30-year portions of the yield curve.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Security selection in HY corporate bonds, senior secured floating-rate bank loans and IG corporate bonds.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Exposure to the 10-year segment of the yield curve.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Use of derivatives and the impact on performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund utilized bond futures to manage duration exposure and high-yield credit default swap (CDS) to manage the Fund&#x2019;s credit &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;exposure. In aggregate, these instruments detracted slightly from performance.&lt;/span&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3595"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3598"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3615"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7443img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3619"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class R&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;4.67&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.56&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;2.56&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Bloomberg U.S. Aggregate Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;4.06&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.18&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.67&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3655"
      xml:lang="en-US">Class R</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102861"
      unitRef="RATIO">0.0467</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102862"
      unitRef="RATIO">0.0156</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102863"
      unitRef="RATIO">0.0256</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7443_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member"
      id="ixv-3670"
      xml:lang="en-US">Bloomberg U.S. Aggregate Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7443_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102864"
      unitRef="RATIO">0.0406</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7443_duration_FranklinCorePlusBondFund_2021-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102865"
      unitRef="RATIO">0.0018</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7443_duration_FranklinCorePlusBondFund_2016-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102866"
      unitRef="RATIO">0.0167</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3691"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3707"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$2,747,319,270&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings (excludes derivatives, except purchased options, if any)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;866&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$6,862,755&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;349.54%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30Member"
      decimals="INF"
      id="ixv-102867"
      unitRef="USD">2747319270</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30Member"
      decimals="INF"
      id="ixv-102868"
      unitRef="UNIT">866</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102869"
      unitRef="USD">6862755</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102870"
      unitRef="RATIO">3.4954</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="foot-7443_806705-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9pt;color:#161616;;"&gt;&lt;sup&gt;,&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;&#x2020;&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7443img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:MaterialFundChngTextBlock
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3813"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW HAS THE FUND CHANGED?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective September 1, 2025, the Fund&#x2019;s principal investment strategies were changed to reflect the Fund&#x2019;s increased investments in &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;collateralized mortgage obligations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Related risk disclosure was added to the prospectus.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective September 30, 2025, Benjamin Cryer and Thomas Runkel no longer serve as portfolio managers of the Fund and Albert Chan &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;was added as a portfolio manager of the Fund.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective May 8, 2025, the investment manager contractually agreed to waive fees and/or reimburse operating expenses (excluding &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the Rule 12b-1 fees and certain non-routine expenses or costs, such as those relating to litigation, indemnification, reorganizations and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;liquidations) for the Fund so that the ratio of total annual fund operating expenses will not exceed 0.47% for each share class except &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R6 and 0.37% for Class R6 until August 31, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Additionally, effective May 8, 2025, the Fund&#x2019;s contractual management fee schedule was reduced to a fee equal to an annual rate &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;based on the value of the Fund&#x2019;s average daily net assets, as follows: 0.350% up to and including $5 billion; 0.330% over $5 billion up to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and including $10 billion; 0.310% over $10 billion up to and including $20 billion; and 0.290% over $20 billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes and planned changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;review the Fund&#x2019;s current prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngTextBlock>
    <oef:MaterialFundChngStrategiesTextBlock
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3821"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective September 1, 2025, the Fund&#x2019;s principal investment strategies were changed to reflect the Fund&#x2019;s increased investments in &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;collateralized mortgage obligations.&lt;/span&gt;</oef:MaterialFundChngStrategiesTextBlock>
    <oef:MaterialFundChngExpensesTextBlock
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3836"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective May 8, 2025, the investment manager contractually agreed to waive fees and/or reimburse operating expenses (excluding &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the Rule 12b-1 fees and certain non-routine expenses or costs, such as those relating to litigation, indemnification, reorganizations and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;liquidations) for the Fund so that the ratio of total annual fund operating expenses will not exceed 0.47% for each share class except &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R6 and 0.37% for Class R6 until August 31, 2026.&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Additionally, effective May 8, 2025, the Fund&#x2019;s contractual management fee schedule was reduced to a fee equal to an annual rate &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;based on the value of the Fund&#x2019;s average daily net assets, as follows: 0.350% up to and including $5 billion; 0.330% over $5 billion up to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and including $10 billion; 0.310% over $10 billion up to and including $20 billion; and 0.290% over $20 billion.&lt;/span&gt;</oef:MaterialFundChngExpensesTextBlock>
    <oef:SummaryOfChngLegendTextBlock
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3851"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes and planned changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;review the Fund&#x2019;s current prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;</oef:SummaryOfChngLegendTextBlock>
    <oef:MaterialChngDate
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3853"
      xml:lang="en-US">2025-05-01</oef:MaterialChngDate>
    <oef:UpdProspectusWebAddress
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3859"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:UpdProspectusPhoneNumber
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3862"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:UpdProspectusPhoneNumber>
    <oef:UpdProspectusEmailAddress
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-3866"
      xml:lang="en-US">prospectus.us.franklintempleton@fisglobal.com</oef:UpdProspectusEmailAddress>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-102871"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-102872"
      unitRef="USD">10738</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-102873"
      unitRef="USD">10769</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-102874"
      unitRef="USD">11230</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-102875"
      unitRef="USD">10558</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-102876"
      unitRef="USD">11912</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-102877"
      unitRef="USD">11158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-102878"
      unitRef="USD">11211</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-102879"
      unitRef="USD">11533</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-102880"
      unitRef="USD">12297</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102881"
      unitRef="USD">12872</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_2016-04-30_2016-04-30_4434Member"
      decimals="INF"
      id="ixv-102882"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_2017-04-30_2017-04-30_4434Member"
      decimals="INF"
      id="ixv-102883"
      unitRef="USD">10083</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_2018-04-30_2018-04-30_4434Member"
      decimals="INF"
      id="ixv-102884"
      unitRef="USD">10051</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_2019-04-30_2019-04-30_4434Member"
      decimals="INF"
      id="ixv-102885"
      unitRef="USD">10582</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_2020-04-30_2020-04-30_4434Member"
      decimals="INF"
      id="ixv-102886"
      unitRef="USD">11730</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_2021-04-30_2021-04-30_4434Member"
      decimals="INF"
      id="ixv-102887"
      unitRef="USD">11698</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_2022-04-30_2022-04-30_4434Member"
      decimals="INF"
      id="ixv-102888"
      unitRef="USD">10703</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_2023-04-30_2023-04-30_4434Member"
      decimals="INF"
      id="ixv-102889"
      unitRef="USD">10657</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_2024-04-30_2024-04-30_4434Member"
      decimals="INF"
      id="ixv-102890"
      unitRef="USD">10500</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_2025-04-30_2025-04-30_4434Member"
      decimals="INF"
      id="ixv-102891"
      unitRef="USD">11343</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7443_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102892"
      unitRef="USD">11803</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_3987Member"
      decimals="INF"
      id="ixv-102893"
      unitRef="RATIO">0.318</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4313Member"
      decimals="INF"
      id="ixv-102894"
      unitRef="RATIO">0.246</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4342Member"
      decimals="INF"
      id="ixv-102895"
      unitRef="RATIO">0.120</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4316Member"
      decimals="INF"
      id="ixv-102896"
      unitRef="RATIO">0.076</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4315Member"
      decimals="INF"
      id="ixv-102897"
      unitRef="RATIO">0.052</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4317Member"
      decimals="INF"
      id="ixv-102898"
      unitRef="RATIO">0.037</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4314Member"
      decimals="INF"
      id="ixv-102899"
      unitRef="RATIO">0.025</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_3986Member"
      decimals="INF"
      id="ixv-102900"
      unitRef="RATIO">0.025</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4922Member"
      decimals="INF"
      id="ixv-102901"
      unitRef="RATIO">0.022</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4924Member"
      decimals="INF"
      id="ixv-102902"
      unitRef="RATIO">0.008</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4923Member"
      decimals="INF"
      id="ixv-102903"
      unitRef="RATIO">0.001</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_3989Member"
      decimals="INF"
      id="ixv-102904"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4925Member"
      decimals="INF"
      id="ixv-102905"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_4975Member"
      decimals="INF"
      id="ixv-102906"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7443_instant_FranklinCorePlusBondFund_ClassR_2026-04-30_3991Member"
      decimals="INF"
      id="ixv-102907"
      unitRef="RATIO">0.070</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-3932"
      xml:lang="en-US">Franklin Core Plus Bond Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-3941"
      xml:lang="en-US">Class R6</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-3944"
      xml:lang="en-US">FGKNX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-3951"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-3958"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Core Plus Bond Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-3960"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-3968"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-3970"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-3974"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:MaterialFundChngNoticeTextBlock
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-3979"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;"&gt;&lt;b&gt;&lt;i&gt;This report describes changes to the Fund that occurred during the reporting period.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngNoticeTextBlock>
    <oef:ExpensesTextBlock
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="foot-7441_806357-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class R6&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$37&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.36%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102908"
      unitRef="USD">37</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7441_806357-1021"
      unitRef="RATIO">0.0036</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-4043"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R6 shares of Franklin Core Plus Bond Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;5.27%. The Fund compares its &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;performance to the&#160;&#x2009;Bloomberg U.S. Aggregate Index, which returned 4.06% for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Overweight allocation to high-yield (HY) and investment-grade (IG) corporate bonds, agency mortgage-backed securities (MBS), &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;commercial MBS and sovereign emerging market debt.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Out-of-index exposure to residential MBS and collateralized loan obligations (CLOs).&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Exposure to the five-, 20- and 30-year portions of the yield curve.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Security selection in HY corporate bonds, senior secured floating-rate bank loans and IG corporate bonds.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Exposure to the 10-year segment of the yield curve.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Use of derivatives and the impact on performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund utilized bond futures to manage duration exposure and high-yield credit default swap (CDS) to manage the Fund&#x2019;s credit &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;exposure. In aggregate, these instruments detracted slightly from performance.&lt;/span&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-4155"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-4158"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-4175"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7441img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-4179"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class R6&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;5.27&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;2.20&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;3.19&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Bloomberg U.S. Aggregate Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;4.06&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.18&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.67&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-4215"
      xml:lang="en-US">Class R6</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102910"
      unitRef="RATIO">0.0527</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102911"
      unitRef="RATIO">0.0220</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102912"
      unitRef="RATIO">0.0319</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7441_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member"
      id="ixv-4230"
      xml:lang="en-US">Bloomberg U.S. Aggregate Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7441_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102913"
      unitRef="RATIO">0.0406</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7441_duration_FranklinCorePlusBondFund_2021-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102914"
      unitRef="RATIO">0.0018</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7441_duration_FranklinCorePlusBondFund_2016-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102915"
      unitRef="RATIO">0.0167</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-4251"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-4267"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$2,747,319,270&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings (excludes derivatives, except purchased options, if any)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;866&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$6,862,755&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;349.54%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30Member"
      decimals="INF"
      id="ixv-102916"
      unitRef="USD">2747319270</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30Member"
      decimals="INF"
      id="ixv-102917"
      unitRef="UNIT">866</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102918"
      unitRef="USD">6862755</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102919"
      unitRef="RATIO">3.4954</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="foot-7441_806381-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9pt;color:#161616;;"&gt;&lt;sup&gt;,&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;&#x2020;&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7441img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:MaterialFundChngTextBlock
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-4373"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW HAS THE FUND CHANGED?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective September 1, 2025, the Fund&#x2019;s principal investment strategies were changed to reflect the Fund&#x2019;s increased investments in &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;collateralized mortgage obligations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Related risk disclosure was added to the prospectus.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective September 30, 2025, Benjamin Cryer and Thomas Runkel no longer serve as portfolio managers of the Fund and Albert Chan &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;was added as a portfolio manager of the Fund.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective May 8, 2025, the investment manager contractually agreed to waive fees and/or reimburse operating expenses (excluding &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the Rule 12b-1 fees and certain non-routine expenses or costs, such as those relating to litigation, indemnification, reorganizations and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;liquidations) for the Fund so that the ratio of total annual fund operating expenses will not exceed 0.47% for each share class except &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R6 and 0.37% for Class R6 until August 31, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Additionally, effective May 8, 2025, the Fund&#x2019;s contractual management fee schedule was reduced to a fee equal to an annual rate &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;based on the value of the Fund&#x2019;s average daily net assets, as follows: 0.350% up to and including $5 billion; 0.330% over $5 billion up to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and including $10 billion; 0.310% over $10 billion up to and including $20 billion; and 0.290% over $20 billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes and planned changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;review the Fund&#x2019;s current prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngTextBlock>
    <oef:MaterialFundChngStrategiesTextBlock
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-4381"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective September 1, 2025, the Fund&#x2019;s principal investment strategies were changed to reflect the Fund&#x2019;s increased investments in &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;collateralized mortgage obligations.&lt;/span&gt;</oef:MaterialFundChngStrategiesTextBlock>
    <oef:MaterialFundChngExpensesTextBlock
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-4396"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective May 8, 2025, the investment manager contractually agreed to waive fees and/or reimburse operating expenses (excluding &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the Rule 12b-1 fees and certain non-routine expenses or costs, such as those relating to litigation, indemnification, reorganizations and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;liquidations) for the Fund so that the ratio of total annual fund operating expenses will not exceed 0.47% for each share class except &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R6 and 0.37% for Class R6 until August 31, 2026.&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Additionally, effective May 8, 2025, the Fund&#x2019;s contractual management fee schedule was reduced to a fee equal to an annual rate &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;based on the value of the Fund&#x2019;s average daily net assets, as follows: 0.350% up to and including $5 billion; 0.330% over $5 billion up to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and including $10 billion; 0.310% over $10 billion up to and including $20 billion; and 0.290% over $20 billion.&lt;/span&gt;</oef:MaterialFundChngExpensesTextBlock>
    <oef:SummaryOfChngLegendTextBlock
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-4411"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes and planned changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;review the Fund&#x2019;s current prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;</oef:SummaryOfChngLegendTextBlock>
    <oef:MaterialChngDate
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-4413"
      xml:lang="en-US">2025-05-01</oef:MaterialChngDate>
    <oef:UpdProspectusWebAddress
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-4419"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:UpdProspectusPhoneNumber
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-4422"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:UpdProspectusPhoneNumber>
    <oef:UpdProspectusEmailAddress
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-4426"
      xml:lang="en-US">prospectus.us.franklintempleton@fisglobal.com</oef:UpdProspectusEmailAddress>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-102920"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-102921"
      unitRef="USD">10803</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-102922"
      unitRef="USD">10905</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-102923"
      unitRef="USD">11454</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-102924"
      unitRef="USD">10828</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-102925"
      unitRef="USD">12284</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-102926"
      unitRef="USD">11581</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-102927"
      unitRef="USD">11711</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-102928"
      unitRef="USD">12119</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-102929"
      unitRef="USD">13010</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102930"
      unitRef="USD">13696</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_2016-04-30_2016-04-30_4434Member"
      decimals="INF"
      id="ixv-102931"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_2017-04-30_2017-04-30_4434Member"
      decimals="INF"
      id="ixv-102932"
      unitRef="USD">10083</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_2018-04-30_2018-04-30_4434Member"
      decimals="INF"
      id="ixv-102933"
      unitRef="USD">10051</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_2019-04-30_2019-04-30_4434Member"
      decimals="INF"
      id="ixv-102934"
      unitRef="USD">10582</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_2020-04-30_2020-04-30_4434Member"
      decimals="INF"
      id="ixv-102935"
      unitRef="USD">11730</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_2021-04-30_2021-04-30_4434Member"
      decimals="INF"
      id="ixv-102936"
      unitRef="USD">11698</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_2022-04-30_2022-04-30_4434Member"
      decimals="INF"
      id="ixv-102937"
      unitRef="USD">10703</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_2023-04-30_2023-04-30_4434Member"
      decimals="INF"
      id="ixv-102938"
      unitRef="USD">10657</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_2024-04-30_2024-04-30_4434Member"
      decimals="INF"
      id="ixv-102939"
      unitRef="USD">10500</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_2025-04-30_2025-04-30_4434Member"
      decimals="INF"
      id="ixv-102940"
      unitRef="USD">11343</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7441_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102941"
      unitRef="USD">11803</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_3987Member"
      decimals="INF"
      id="ixv-102942"
      unitRef="RATIO">0.318</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4313Member"
      decimals="INF"
      id="ixv-102943"
      unitRef="RATIO">0.246</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4342Member"
      decimals="INF"
      id="ixv-102944"
      unitRef="RATIO">0.120</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4316Member"
      decimals="INF"
      id="ixv-102945"
      unitRef="RATIO">0.076</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4315Member"
      decimals="INF"
      id="ixv-102946"
      unitRef="RATIO">0.052</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4317Member"
      decimals="INF"
      id="ixv-102947"
      unitRef="RATIO">0.037</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4314Member"
      decimals="INF"
      id="ixv-102948"
      unitRef="RATIO">0.025</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_3986Member"
      decimals="INF"
      id="ixv-102949"
      unitRef="RATIO">0.025</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4922Member"
      decimals="INF"
      id="ixv-102950"
      unitRef="RATIO">0.022</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4924Member"
      decimals="INF"
      id="ixv-102951"
      unitRef="RATIO">0.008</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4923Member"
      decimals="INF"
      id="ixv-102952"
      unitRef="RATIO">0.001</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_3989Member"
      decimals="INF"
      id="ixv-102953"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4925Member"
      decimals="INF"
      id="ixv-102954"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_4975Member"
      decimals="INF"
      id="ixv-102955"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7441_instant_FranklinCorePlusBondFund_ClassR6_2026-04-30_3991Member"
      decimals="INF"
      id="ixv-102956"
      unitRef="RATIO">0.070</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4492"
      xml:lang="en-US">Franklin Core Plus Bond Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4501"
      xml:lang="en-US">Advisor Class</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4504"
      xml:lang="en-US">FKSAX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-4511"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4518"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Core Plus Bond Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-4520"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4528"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4530"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4534"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:MaterialFundChngNoticeTextBlock
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4539"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;"&gt;&lt;b&gt;&lt;i&gt;This report describes changes to the Fund that occurred during the reporting period.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngNoticeTextBlock>
    <oef:ExpensesTextBlock
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="foot-7431_805384-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Advisor Class&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$47&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.46%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102957"
      unitRef="USD">47</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7431_805384-1021"
      unitRef="RATIO">0.0046</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4603"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Advisor Class shares of Franklin Core Plus Bond Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;5.04%. The Fund &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;compares its performance to the&#160;&#x2009;Bloomberg U.S. Aggregate Index, which returned 4.06% for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Overweight allocation to high-yield (HY) and investment-grade (IG) corporate bonds, agency mortgage-backed securities (MBS), &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;commercial MBS and sovereign emerging market debt.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Out-of-index exposure to residential MBS and collateralized loan obligations (CLOs).&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Exposure to the five-, 20- and 30-year portions of the yield curve.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Security selection in HY corporate bonds, senior secured floating-rate bank loans and IG corporate bonds.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Exposure to the 10-year segment of the yield curve.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Use of derivatives and the impact on performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund utilized bond futures to manage duration exposure and high-yield credit default swap (CDS) to manage the Fund&#x2019;s credit &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;exposure. In aggregate, these instruments detracted slightly from performance.&lt;/span&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4715"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4718"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4735"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7431img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4739"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Advisor Class&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;5.04&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;2.06&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;3.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Bloomberg U.S. Aggregate Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;4.06&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.18&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.67&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4775"
      xml:lang="en-US">Advisor Class</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102959"
      unitRef="RATIO">0.0504</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102960"
      unitRef="RATIO">0.0206</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102961"
      unitRef="RATIO">0.0305</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7431_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member"
      id="ixv-4790"
      xml:lang="en-US">Bloomberg U.S. Aggregate Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7431_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102962"
      unitRef="RATIO">0.0406</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7431_duration_FranklinCorePlusBondFund_2021-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102963"
      unitRef="RATIO">0.0018</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7431_duration_FranklinCorePlusBondFund_2016-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102964"
      unitRef="RATIO">0.0167</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4811"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4827"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$2,747,319,270&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings (excludes derivatives, except purchased options, if any)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;866&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$6,862,755&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;349.54%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30Member"
      decimals="INF"
      id="ixv-102965"
      unitRef="USD">2747319270</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30Member"
      decimals="INF"
      id="ixv-102966"
      unitRef="UNIT">866</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102967"
      unitRef="USD">6862755</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102968"
      unitRef="RATIO">3.4954</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="foot-7431_805408-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9pt;color:#161616;;"&gt;&lt;sup&gt;,&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;&#x2020;&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7431img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:MaterialFundChngTextBlock
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4933"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW HAS THE FUND CHANGED?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective September 1, 2025, the Fund&#x2019;s principal investment strategies were changed to reflect the Fund&#x2019;s increased investments in &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;collateralized mortgage obligations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Related risk disclosure was added to the prospectus.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective September 30, 2025, Benjamin Cryer and Thomas Runkel no longer serve as portfolio managers of the Fund and Albert Chan &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;was added as a portfolio manager of the Fund.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective May 8, 2025, the investment manager contractually agreed to waive fees and/or reimburse operating expenses (excluding &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the Rule 12b-1 fees and certain non-routine expenses or costs, such as those relating to litigation, indemnification, reorganizations and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;liquidations) for the Fund so that the ratio of total annual fund operating expenses will not exceed 0.47% for each share class except &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R6 and 0.37% for Class R6 until August 31, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Additionally, effective May 8, 2025, the Fund&#x2019;s contractual management fee schedule was reduced to a fee equal to an annual rate &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;based on the value of the Fund&#x2019;s average daily net assets, as follows: 0.350% up to and including $5 billion; 0.330% over $5 billion up to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and including $10 billion; 0.310% over $10 billion up to and including $20 billion; and 0.290% over $20 billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes and planned changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;review the Fund&#x2019;s current prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngTextBlock>
    <oef:MaterialFundChngStrategiesTextBlock
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4941"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective September 1, 2025, the Fund&#x2019;s principal investment strategies were changed to reflect the Fund&#x2019;s increased investments in &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;collateralized mortgage obligations.&lt;/span&gt;</oef:MaterialFundChngStrategiesTextBlock>
    <oef:MaterialFundChngExpensesTextBlock
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4956"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective May 8, 2025, the investment manager contractually agreed to waive fees and/or reimburse operating expenses (excluding &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the Rule 12b-1 fees and certain non-routine expenses or costs, such as those relating to litigation, indemnification, reorganizations and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;liquidations) for the Fund so that the ratio of total annual fund operating expenses will not exceed 0.47% for each share class except &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R6 and 0.37% for Class R6 until August 31, 2026.&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Additionally, effective May 8, 2025, the Fund&#x2019;s contractual management fee schedule was reduced to a fee equal to an annual rate &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;based on the value of the Fund&#x2019;s average daily net assets, as follows: 0.350% up to and including $5 billion; 0.330% over $5 billion up to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and including $10 billion; 0.310% over $10 billion up to and including $20 billion; and 0.290% over $20 billion.&lt;/span&gt;</oef:MaterialFundChngExpensesTextBlock>
    <oef:SummaryOfChngLegendTextBlock
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4971"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes and planned changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;review the Fund&#x2019;s current prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;</oef:SummaryOfChngLegendTextBlock>
    <oef:MaterialChngDate
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4973"
      xml:lang="en-US">2025-05-01</oef:MaterialChngDate>
    <oef:UpdProspectusWebAddress
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4979"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:UpdProspectusPhoneNumber
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4982"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:UpdProspectusPhoneNumber>
    <oef:UpdProspectusEmailAddress
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-4986"
      xml:lang="en-US">prospectus.us.franklintempleton@fisglobal.com</oef:UpdProspectusEmailAddress>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-102969"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-102970"
      unitRef="USD">10776</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-102971"
      unitRef="USD">10861</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-102972"
      unitRef="USD">11392</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-102973"
      unitRef="USD">10768</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-102974"
      unitRef="USD">12202</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-102975"
      unitRef="USD">11490</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-102976"
      unitRef="USD">11603</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-102977"
      unitRef="USD">11994</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-102978"
      unitRef="USD">12863</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-102979"
      unitRef="USD">13510</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_2016-04-30_2016-04-30_4434Member"
      decimals="INF"
      id="ixv-102980"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_2017-04-30_2017-04-30_4434Member"
      decimals="INF"
      id="ixv-102981"
      unitRef="USD">10083</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_2018-04-30_2018-04-30_4434Member"
      decimals="INF"
      id="ixv-102982"
      unitRef="USD">10051</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_2019-04-30_2019-04-30_4434Member"
      decimals="INF"
      id="ixv-102983"
      unitRef="USD">10582</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_2020-04-30_2020-04-30_4434Member"
      decimals="INF"
      id="ixv-102984"
      unitRef="USD">11730</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_2021-04-30_2021-04-30_4434Member"
      decimals="INF"
      id="ixv-102985"
      unitRef="USD">11698</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_2022-04-30_2022-04-30_4434Member"
      decimals="INF"
      id="ixv-102986"
      unitRef="USD">10703</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_2023-04-30_2023-04-30_4434Member"
      decimals="INF"
      id="ixv-102987"
      unitRef="USD">10657</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_2024-04-30_2024-04-30_4434Member"
      decimals="INF"
      id="ixv-102988"
      unitRef="USD">10500</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_2025-04-30_2025-04-30_4434Member"
      decimals="INF"
      id="ixv-102989"
      unitRef="USD">11343</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7431_duration_FranklinCorePlusBondFund_2025-05-01_2026-04-30_4434Member"
      decimals="INF"
      id="ixv-102990"
      unitRef="USD">11803</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_3987Member"
      decimals="INF"
      id="ixv-102991"
      unitRef="RATIO">0.318</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4313Member"
      decimals="INF"
      id="ixv-102992"
      unitRef="RATIO">0.246</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4342Member"
      decimals="INF"
      id="ixv-102993"
      unitRef="RATIO">0.120</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4316Member"
      decimals="INF"
      id="ixv-102994"
      unitRef="RATIO">0.076</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4315Member"
      decimals="INF"
      id="ixv-102995"
      unitRef="RATIO">0.052</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4317Member"
      decimals="INF"
      id="ixv-102996"
      unitRef="RATIO">0.037</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4314Member"
      decimals="INF"
      id="ixv-102997"
      unitRef="RATIO">0.025</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_3986Member"
      decimals="INF"
      id="ixv-102998"
      unitRef="RATIO">0.025</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4922Member"
      decimals="INF"
      id="ixv-102999"
      unitRef="RATIO">0.022</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4924Member"
      decimals="INF"
      id="ixv-103000"
      unitRef="RATIO">0.008</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4923Member"
      decimals="INF"
      id="ixv-103001"
      unitRef="RATIO">0.001</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_3989Member"
      decimals="INF"
      id="ixv-103002"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4925Member"
      decimals="INF"
      id="ixv-103003"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_4975Member"
      decimals="INF"
      id="ixv-103004"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7431_instant_FranklinCorePlusBondFund_AdvisorClass_2026-04-30_3991Member"
      decimals="INF"
      id="ixv-103005"
      unitRef="RATIO">0.070</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-5052"
      xml:lang="en-US">Franklin Growth Opportunities Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-5061"
      xml:lang="en-US">Class A</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-5064"
      xml:lang="en-US">FGRAX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-5071"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-5078"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Growth Opportunities Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-5080"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-5087"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-5089"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-5093"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:ExpensesTextBlock
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="foot-7485_811083-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class A&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$97&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.88%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103006"
      unitRef="USD">97</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7485_811083-1021"
      unitRef="RATIO">0.0088</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-5156"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class A shares of Franklin Growth Opportunities Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;20.74%. The Fund &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;compares its performance to the Russell 3000 Growth Index and the S&amp;amp;P 500 Index, which returned 30.98% and 31.05%, respectively, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the communications services sector, Google parent company Alphabet was a leading relative contributor. The company saw a &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;favorable resolution to its antitrust trial and benefited from the positive impacts of artificial intelligence (AI) on its business.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund benefited most from stock selection in the information technology (IT) sector. Within IT, Monolithic Power Systems was &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the leading contributor to relative returns. Shares of the analog semiconductor manufacturer advanced sharply amid growing &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;confidence around AI infrastructure-related demand, capped by sharp earnings beat and guidance raise.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the industrials sector, an off index holding in private company Space Exploration Technologies (SpaceX) was a leading &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;contributor to relative returns. The merger with xAI boosted the private market share price of the company, and expectations &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;increased around a 2026 initial public offering for the aerospace and technology company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;By sector, stock selection in communication services sector was the largest detractor from relative returns. Among individual &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;detractors, in the IT sector, underweight in AI chip designer NVIDIA held back relative returns. The company continued to benefit &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;from increased AI infrastructure spending, and demand for its advanced chips remained strong across cloud computing, data &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;centers and enterprise AI applications. NVIDIA was the largest position in the Fund on an absolute basis, but the Fund was &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;underweighted on a relative basis due to position size constraints.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the consumer staples sector, an off-benchmark holding in BellRing Brands was a leading detractor. The nutrition products &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;company reported shrinking profit margins and saw increased competition in the protein shake category. Retailer inventory &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;adjustments and reduced full year 2025 guidance were also headwinds for the company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the industrials sector, Axon shares fell as investors expressed concerns about near-term margin pressure from higher &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;investment spending, even though the company continued to report strong revenue growth and solid demand from public safety &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;agencies.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-5279"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-5282"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-5303"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7485img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-5307"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class A&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;20.74&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;6.62&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.94&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class A (with sales charge)&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.10&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;5.43&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.30&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Growth Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;30.98&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.23&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;17.82&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30_1400Member"
      id="ixv-5343"
      xml:lang="en-US">Class A</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103008"
      unitRef="RATIO">0.2074</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2021-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103009"
      unitRef="RATIO">0.0662</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2016-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103010"
      unitRef="RATIO">0.1394</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-5358"
      xml:lang="en-US">Class A (with sales charge)</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103011"
      unitRef="RATIO">0.1410</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103012"
      unitRef="RATIO">0.0543</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103013"
      unitRef="RATIO">0.1330</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-5373"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103014"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103015"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103016"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member"
      id="ixv-5388"
      xml:lang="en-US">Russell 3000 Growth Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103017"
      unitRef="RATIO">0.3098</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103018"
      unitRef="RATIO">0.1323</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103019"
      unitRef="RATIO">0.1782</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-5403"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103020"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103021"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103022"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-5423"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-5439"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$4,394,400,813&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;92&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$24,181,309&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;39.14%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30Member"
      decimals="INF"
      id="ixv-103023"
      unitRef="USD">4394400813</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30Member"
      decimals="INF"
      id="ixv-103024"
      unitRef="UNIT">92</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103025"
      unitRef="USD">24181309</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103026"
      unitRef="RATIO">0.3914</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="foot-7485_811104-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9pt;color:#161616;;"&gt;&lt;sup&gt;,&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;&#x2020;&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7485img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:UpdProspectusWebAddress
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-5562"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-103027"
      unitRef="USD">9450</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-103028"
      unitRef="USD">11045</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-103029"
      unitRef="USD">13301</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-103030"
      unitRef="USD">15417</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-103031"
      unitRef="USD">16789</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-103032"
      unitRef="USD">25291</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-103033"
      unitRef="USD">21099</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-103034"
      unitRef="USD">20049</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-103035"
      unitRef="USD">26764</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-103036"
      unitRef="USD">28866</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103037"
      unitRef="USD">34853</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-103038"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-103039"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-103040"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-103041"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-103042"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-103043"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-103044"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-103045"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-103046"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-103047"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103048"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_5438Member"
      decimals="INF"
      id="ixv-103049"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_5438Member"
      decimals="INF"
      id="ixv-103050"
      unitRef="USD">11983</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_5438Member"
      decimals="INF"
      id="ixv-103051"
      unitRef="USD">14233</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_5438Member"
      decimals="INF"
      id="ixv-103052"
      unitRef="USD">16598</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_5438Member"
      decimals="INF"
      id="ixv-103053"
      unitRef="USD">18169</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_5438Member"
      decimals="INF"
      id="ixv-103054"
      unitRef="USD">27693</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_5438Member"
      decimals="INF"
      id="ixv-103055"
      unitRef="USD">25802</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_5438Member"
      decimals="INF"
      id="ixv-103056"
      unitRef="USD">26382</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_5438Member"
      decimals="INF"
      id="ixv-103057"
      unitRef="USD">34493</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_5438Member"
      decimals="INF"
      id="ixv-103058"
      unitRef="USD">39346</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103059"
      unitRef="USD">51536</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-103060"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-103061"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-103062"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-103063"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-103064"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-103065"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-103066"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-103067"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-103068"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-103069"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7485_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103070"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-103071"
      unitRef="RATIO">0.477</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-103072"
      unitRef="RATIO">0.134</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_3995Member"
      decimals="INF"
      id="ixv-103073"
      unitRef="RATIO">0.131</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_3996Member"
      decimals="INF"
      id="ixv-103074"
      unitRef="RATIO">0.092</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-103075"
      unitRef="RATIO">0.078</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-103076"
      unitRef="RATIO">0.027</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-103077"
      unitRef="RATIO">0.022</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_4001Member"
      decimals="INF"
      id="ixv-103078"
      unitRef="RATIO">0.017</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_4002Member"
      decimals="INF"
      id="ixv-103079"
      unitRef="RATIO">0.007</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_4943Member"
      decimals="INF"
      id="ixv-103080"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7485_instant_FranklinGrowthOpportunitiesFund_ClassA_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-103081"
      unitRef="RATIO">0.015</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-5608"
      xml:lang="en-US">Franklin Growth Opportunities Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-5617"
      xml:lang="en-US">Class C</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-5620"
      xml:lang="en-US">FKACX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-5627"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-5634"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Growth Opportunities Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-5636"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-5643"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-5645"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-5649"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:ExpensesTextBlock
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="foot-7484_810961-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class C&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$180&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.64%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103082"
      unitRef="USD">180</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7484_810961-1021"
      unitRef="RATIO">0.0164</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-5712"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class C shares of Franklin Growth Opportunities Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;19.82%. The Fund &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;compares its performance to the Russell 3000 Growth Index and the S&amp;amp;P 500 Index, which returned 30.98% and 31.05%, respectively, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the communications services sector, Google parent company Alphabet was a leading relative contributor. The company saw a &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;favorable resolution to its antitrust trial and benefited from the positive impacts of artificial intelligence (AI) on its business.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund benefited most from stock selection in the information technology (IT) sector. Within IT, Monolithic Power Systems was &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the leading contributor to relative returns. Shares of the analog semiconductor manufacturer advanced sharply amid growing &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;confidence around AI infrastructure-related demand, capped by sharp earnings beat and guidance raise.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the industrials sector, an off index holding in private company Space Exploration Technologies (SpaceX) was a leading &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;contributor to relative returns. The merger with xAI boosted the private market share price of the company, and expectations &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;increased around a 2026 initial public offering for the aerospace and technology company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;By sector, stock selection in communication services sector was the largest detractor from relative returns. Among individual &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;detractors, in the IT sector, underweight in AI chip designer NVIDIA held back relative returns. The company continued to benefit &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;from increased AI infrastructure spending, and demand for its advanced chips remained strong across cloud computing, data &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;centers and enterprise AI applications. NVIDIA was the largest position in the Fund on an absolute basis, but the Fund was &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;underweighted on a relative basis due to position size constraints.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the consumer staples sector, an off-benchmark holding in BellRing Brands was a leading detractor. The nutrition products &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;company reported shrinking profit margins and saw increased competition in the protein shake category. Retailer inventory &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;adjustments and reduced full year 2025 guidance were also headwinds for the company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the industrials sector, Axon shares fell as investors expressed concerns about near-term margin pressure from higher &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;investment spending, even though the company continued to report strong revenue growth and solid demand from public safety &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;agencies.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-5835"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-5838"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-5855"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7484img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-5859"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class C&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;19.82&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;5.83&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.09&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class C (with sales charge)&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;18.92&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;5.83&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.09&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Growth Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;30.98&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.23&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;17.82&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30_1400Member"
      id="ixv-5895"
      xml:lang="en-US">Class C</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103084"
      unitRef="RATIO">0.1982</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2021-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103085"
      unitRef="RATIO">0.0583</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2016-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103086"
      unitRef="RATIO">0.1309</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-5910"
      xml:lang="en-US">Class C (with sales charge)</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103087"
      unitRef="RATIO">0.1892</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103088"
      unitRef="RATIO">0.0583</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103089"
      unitRef="RATIO">0.1309</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-5925"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103090"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103091"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103092"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member"
      id="ixv-5940"
      xml:lang="en-US">Russell 3000 Growth Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103093"
      unitRef="RATIO">0.3098</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103094"
      unitRef="RATIO">0.1323</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103095"
      unitRef="RATIO">0.1782</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-5955"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103096"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103097"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103098"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-5971"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-5987"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$4,394,400,813&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;92&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$24,181,309&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;39.14%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30Member"
      decimals="INF"
      id="ixv-103099"
      unitRef="USD">4394400813</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30Member"
      decimals="INF"
      id="ixv-103100"
      unitRef="UNIT">92</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103101"
      unitRef="USD">24181309</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103102"
      unitRef="RATIO">0.3914</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="foot-7484_810981-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9pt;color:#161616;;"&gt;&lt;sup&gt;,&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;&#x2020;&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7484img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:UpdProspectusWebAddress
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-6110"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-103103"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-103104"
      unitRef="USD">11598</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-103105"
      unitRef="USD">13863</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-103106"
      unitRef="USD">15956</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-103107"
      unitRef="USD">17249</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-103108"
      unitRef="USD">25783</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-103109"
      unitRef="USD">21349</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-103110"
      unitRef="USD">20135</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-103111"
      unitRef="USD">26683</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-103112"
      unitRef="USD">28560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103113"
      unitRef="USD">34219</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-103114"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-103115"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-103116"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-103117"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-103118"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-103119"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-103120"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-103121"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-103122"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-103123"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103124"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_5438Member"
      decimals="INF"
      id="ixv-103125"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_5438Member"
      decimals="INF"
      id="ixv-103126"
      unitRef="USD">11983</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_5438Member"
      decimals="INF"
      id="ixv-103127"
      unitRef="USD">14233</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_5438Member"
      decimals="INF"
      id="ixv-103128"
      unitRef="USD">16598</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_5438Member"
      decimals="INF"
      id="ixv-103129"
      unitRef="USD">18169</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_5438Member"
      decimals="INF"
      id="ixv-103130"
      unitRef="USD">27693</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_5438Member"
      decimals="INF"
      id="ixv-103131"
      unitRef="USD">25802</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_5438Member"
      decimals="INF"
      id="ixv-103132"
      unitRef="USD">26382</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_5438Member"
      decimals="INF"
      id="ixv-103133"
      unitRef="USD">34493</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_5438Member"
      decimals="INF"
      id="ixv-103134"
      unitRef="USD">39346</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103135"
      unitRef="USD">51536</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-103136"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-103137"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-103138"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-103139"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-103140"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-103141"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-103142"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-103143"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-103144"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-103145"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7484_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103146"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-103147"
      unitRef="RATIO">0.477</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-103148"
      unitRef="RATIO">0.134</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_3995Member"
      decimals="INF"
      id="ixv-103149"
      unitRef="RATIO">0.131</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_3996Member"
      decimals="INF"
      id="ixv-103150"
      unitRef="RATIO">0.092</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-103151"
      unitRef="RATIO">0.078</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-103152"
      unitRef="RATIO">0.027</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-103153"
      unitRef="RATIO">0.022</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_4001Member"
      decimals="INF"
      id="ixv-103154"
      unitRef="RATIO">0.017</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_4002Member"
      decimals="INF"
      id="ixv-103155"
      unitRef="RATIO">0.007</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_4943Member"
      decimals="INF"
      id="ixv-103156"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7484_instant_FranklinGrowthOpportunitiesFund_ClassC_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-103157"
      unitRef="RATIO">0.015</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-6156"
      xml:lang="en-US">Franklin Growth Opportunities Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-6165"
      xml:lang="en-US">Class R</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-6168"
      xml:lang="en-US">FKARX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-6175"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-6182"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Growth Opportunities Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-6184"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-6191"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-6193"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-6197"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:ExpensesTextBlock
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="foot-7482_810717-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class R&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$126&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.14%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103158"
      unitRef="USD">126</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7482_810717-1021"
      unitRef="RATIO">0.0114</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-6260"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R shares of Franklin Growth Opportunities Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;20.42%. The Fund &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;compares its performance to the Russell 3000 Growth Index and the S&amp;amp;P 500 Index, which returned 30.98% and 31.05%, respectively, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the communications services sector, Google parent company Alphabet was a leading relative contributor. The company saw a &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;favorable resolution to its antitrust trial and benefited from the positive impacts of artificial intelligence (AI) on its business.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund benefited most from stock selection in the information technology (IT) sector. Within IT, Monolithic Power Systems was &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the leading contributor to relative returns. Shares of the analog semiconductor manufacturer advanced sharply amid growing &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;confidence around AI infrastructure-related demand, capped by sharp earnings beat and guidance raise.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the industrials sector, an off index holding in private company Space Exploration Technologies (SpaceX) was a leading &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;contributor to relative returns. The merger with xAI boosted the private market share price of the company, and expectations &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;increased around a 2026 initial public offering for the aerospace and technology company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;By sector, stock selection in communication services sector was the largest detractor from relative returns. Among individual &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;detractors, in the IT sector, underweight in AI chip designer NVIDIA held back relative returns. The company continued to benefit &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;from increased AI infrastructure spending, and demand for its advanced chips remained strong across cloud computing, data &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;centers and enterprise AI applications. NVIDIA was the largest position in the Fund on an absolute basis, but the Fund was &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;underweighted on a relative basis due to position size constraints.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the consumer staples sector, an off-benchmark holding in BellRing Brands was a leading detractor. The nutrition products &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;company reported shrinking profit margins and saw increased competition in the protein shake category. Retailer inventory &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;adjustments and reduced full year 2025 guidance were also headwinds for the company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the industrials sector, Axon shares fell as investors expressed concerns about near-term margin pressure from higher &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;investment spending, even though the company continued to report strong revenue growth and solid demand from public safety &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;agencies.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-6383"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-6386"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-6403"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7482img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-6407"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class R&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;20.42&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;6.35&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.66&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Growth Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;30.98&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.23&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;17.82&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-6443"
      xml:lang="en-US">Class R</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103160"
      unitRef="RATIO">0.2042</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103161"
      unitRef="RATIO">0.0635</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103162"
      unitRef="RATIO">0.1366</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-6458"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103163"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103164"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103165"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member"
      id="ixv-6473"
      xml:lang="en-US">Russell 3000 Growth Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103166"
      unitRef="RATIO">0.3098</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103167"
      unitRef="RATIO">0.1323</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103168"
      unitRef="RATIO">0.1782</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-6488"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103169"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103170"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103171"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-6504"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-6520"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$4,394,400,813&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;92&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$24,181,309&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;39.14%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30Member"
      decimals="INF"
      id="ixv-103172"
      unitRef="USD">4394400813</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30Member"
      decimals="INF"
      id="ixv-103173"
      unitRef="UNIT">92</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103174"
      unitRef="USD">24181309</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103175"
      unitRef="RATIO">0.3914</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="foot-7482_810737-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9pt;color:#161616;;"&gt;&lt;sup&gt;,&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;&#x2020;&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7482img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:UpdProspectusWebAddress
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-6643"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-103176"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-103177"
      unitRef="USD">11662</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-103178"
      unitRef="USD">14010</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-103179"
      unitRef="USD">16204</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-103180"
      unitRef="USD">17604</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-103181"
      unitRef="USD">26451</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-103182"
      unitRef="USD">22010</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-103183"
      unitRef="USD">20863</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-103184"
      unitRef="USD">27785</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-103185"
      unitRef="USD">29888</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103186"
      unitRef="USD">35992</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-103187"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-103188"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-103189"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-103190"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-103191"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-103192"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-103193"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-103194"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-103195"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-103196"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103197"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_5438Member"
      decimals="INF"
      id="ixv-103198"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_5438Member"
      decimals="INF"
      id="ixv-103199"
      unitRef="USD">11983</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_5438Member"
      decimals="INF"
      id="ixv-103200"
      unitRef="USD">14233</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_5438Member"
      decimals="INF"
      id="ixv-103201"
      unitRef="USD">16598</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_5438Member"
      decimals="INF"
      id="ixv-103202"
      unitRef="USD">18169</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_5438Member"
      decimals="INF"
      id="ixv-103203"
      unitRef="USD">27693</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_5438Member"
      decimals="INF"
      id="ixv-103204"
      unitRef="USD">25802</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_5438Member"
      decimals="INF"
      id="ixv-103205"
      unitRef="USD">26382</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_5438Member"
      decimals="INF"
      id="ixv-103206"
      unitRef="USD">34493</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_5438Member"
      decimals="INF"
      id="ixv-103207"
      unitRef="USD">39346</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103208"
      unitRef="USD">51536</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-103209"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-103210"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-103211"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-103212"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-103213"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-103214"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-103215"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-103216"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-103217"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-103218"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7482_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103219"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-103220"
      unitRef="RATIO">0.477</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-103221"
      unitRef="RATIO">0.134</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_3995Member"
      decimals="INF"
      id="ixv-103222"
      unitRef="RATIO">0.131</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_3996Member"
      decimals="INF"
      id="ixv-103223"
      unitRef="RATIO">0.092</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-103224"
      unitRef="RATIO">0.078</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-103225"
      unitRef="RATIO">0.027</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-103226"
      unitRef="RATIO">0.022</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_4001Member"
      decimals="INF"
      id="ixv-103227"
      unitRef="RATIO">0.017</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_4002Member"
      decimals="INF"
      id="ixv-103228"
      unitRef="RATIO">0.007</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_4943Member"
      decimals="INF"
      id="ixv-103229"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7482_instant_FranklinGrowthOpportunitiesFund_ClassR_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-103230"
      unitRef="RATIO">0.015</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-6689"
      xml:lang="en-US">Franklin Growth Opportunities Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-6698"
      xml:lang="en-US">Class R6</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-6701"
      xml:lang="en-US">FOPPX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-6708"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-6715"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Growth Opportunities Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-6717"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-6724"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-6726"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-6730"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:ExpensesTextBlock
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="foot-7483_810839-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class R6&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$63&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.57%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103231"
      unitRef="USD">63</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7483_810839-1021"
      unitRef="RATIO">0.0057</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-6793"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R6 shares of Franklin Growth Opportunities Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;21.11%. The Fund &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;compares its performance to the Russell 3000 Growth Index and the S&amp;amp;P 500 Index, which returned 30.98% and 31.05%, respectively, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the communications services sector, Google parent company Alphabet was a leading relative contributor. The company saw a &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;favorable resolution to its antitrust trial and benefited from the positive impacts of artificial intelligence (AI) on its business.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund benefited most from stock selection in the information technology (IT) sector. Within IT, Monolithic Power Systems was &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the leading contributor to relative returns. Shares of the analog semiconductor manufacturer advanced sharply amid growing &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;confidence around AI infrastructure-related demand, capped by sharp earnings beat and guidance raise.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the industrials sector, an off index holding in private company Space Exploration Technologies (SpaceX) was a leading &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;contributor to relative returns. The merger with xAI boosted the private market share price of the company, and expectations &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;increased around a 2026 initial public offering for the aerospace and technology company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;By sector, stock selection in communication services sector was the largest detractor from relative returns. Among individual &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;detractors, in the IT sector, underweight in AI chip designer NVIDIA held back relative returns. The company continued to benefit &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;from increased AI infrastructure spending, and demand for its advanced chips remained strong across cloud computing, data &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;centers and enterprise AI applications. NVIDIA was the largest position in the Fund on an absolute basis, but the Fund was &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;underweighted on a relative basis due to position size constraints.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the consumer staples sector, an off-benchmark holding in BellRing Brands was a leading detractor. The nutrition products &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;company reported shrinking profit margins and saw increased competition in the protein shake category. Retailer inventory &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;adjustments and reduced full year 2025 guidance were also headwinds for the company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the industrials sector, Axon shares fell as investors expressed concerns about near-term margin pressure from higher &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;investment spending, even though the company continued to report strong revenue growth and solid demand from public safety &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;agencies.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-6916"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-6919"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-6936"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7483img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-6940"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class R6&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;21.11&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;6.97&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.35&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Growth Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;30.98&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.23&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;17.82&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-6976"
      xml:lang="en-US">Class R6</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103233"
      unitRef="RATIO">0.2111</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103234"
      unitRef="RATIO">0.0697</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103235"
      unitRef="RATIO">0.1435</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-6991"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103236"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103237"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103238"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member"
      id="ixv-7006"
      xml:lang="en-US">Russell 3000 Growth Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103239"
      unitRef="RATIO">0.3098</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103240"
      unitRef="RATIO">0.1323</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103241"
      unitRef="RATIO">0.1782</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-7021"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103242"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103243"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103244"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-7037"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-7053"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$4,394,400,813&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;92&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$24,181,309&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;39.14%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30Member"
      decimals="INF"
      id="ixv-103245"
      unitRef="USD">4394400813</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30Member"
      decimals="INF"
      id="ixv-103246"
      unitRef="UNIT">92</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103247"
      unitRef="USD">24181309</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103248"
      unitRef="RATIO">0.3914</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="foot-7483_810859-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9pt;color:#161616;;"&gt;&lt;sup&gt;,&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;&#x2020;&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7483img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:UpdProspectusWebAddress
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-7176"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-103249"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-103250"
      unitRef="USD">11742</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-103251"
      unitRef="USD">14206</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-103252"
      unitRef="USD">16516</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-103253"
      unitRef="USD">18058</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-103254"
      unitRef="USD">27292</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-103255"
      unitRef="USD">22839</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-103256"
      unitRef="USD">21784</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-103257"
      unitRef="USD">29178</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-103258"
      unitRef="USD">31568</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103259"
      unitRef="USD">38233</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-103260"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-103261"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-103262"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-103263"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-103264"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-103265"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-103266"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-103267"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-103268"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-103269"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103270"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_5438Member"
      decimals="INF"
      id="ixv-103271"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_5438Member"
      decimals="INF"
      id="ixv-103272"
      unitRef="USD">11983</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_5438Member"
      decimals="INF"
      id="ixv-103273"
      unitRef="USD">14233</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_5438Member"
      decimals="INF"
      id="ixv-103274"
      unitRef="USD">16598</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_5438Member"
      decimals="INF"
      id="ixv-103275"
      unitRef="USD">18169</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_5438Member"
      decimals="INF"
      id="ixv-103276"
      unitRef="USD">27693</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_5438Member"
      decimals="INF"
      id="ixv-103277"
      unitRef="USD">25802</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_5438Member"
      decimals="INF"
      id="ixv-103278"
      unitRef="USD">26382</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_5438Member"
      decimals="INF"
      id="ixv-103279"
      unitRef="USD">34493</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_5438Member"
      decimals="INF"
      id="ixv-103280"
      unitRef="USD">39346</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103281"
      unitRef="USD">51536</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-103282"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-103283"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-103284"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-103285"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-103286"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-103287"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-103288"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-103289"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-103290"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-103291"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7483_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103292"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-103293"
      unitRef="RATIO">0.477</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-103294"
      unitRef="RATIO">0.134</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_3995Member"
      decimals="INF"
      id="ixv-103295"
      unitRef="RATIO">0.131</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_3996Member"
      decimals="INF"
      id="ixv-103296"
      unitRef="RATIO">0.092</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-103297"
      unitRef="RATIO">0.078</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-103298"
      unitRef="RATIO">0.027</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-103299"
      unitRef="RATIO">0.022</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_4001Member"
      decimals="INF"
      id="ixv-103300"
      unitRef="RATIO">0.017</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_4002Member"
      decimals="INF"
      id="ixv-103301"
      unitRef="RATIO">0.007</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_4943Member"
      decimals="INF"
      id="ixv-103302"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7483_instant_FranklinGrowthOpportunitiesFund_ClassR6_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-103303"
      unitRef="RATIO">0.015</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-7222"
      xml:lang="en-US">Franklin Growth Opportunities Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-7231"
      xml:lang="en-US">Advisor Class</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-7234"
      xml:lang="en-US">FRAAX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-7241"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-7248"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Growth Opportunities Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-7250"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-7257"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-7259"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-7263"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:ExpensesTextBlock
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="foot-7486_811206-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Advisor Class&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$70&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.63%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103304"
      unitRef="USD">70</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7486_811206-1021"
      unitRef="RATIO">0.0063</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-7326"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Advisor Class shares of Franklin Growth Opportunities Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;21.04%. The Fund &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;compares its performance to the Russell 3000 Growth Index and the S&amp;amp;P 500 Index, which returned 30.98% and 31.05%, respectively, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the communications services sector, Google parent company Alphabet was a leading relative contributor. The company saw a &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;favorable resolution to its antitrust trial and benefited from the positive impacts of artificial intelligence (AI) on its business.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund benefited most from stock selection in the information technology (IT) sector. Within IT, Monolithic Power Systems was &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the leading contributor to relative returns. Shares of the analog semiconductor manufacturer advanced sharply amid growing &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;confidence around AI infrastructure-related demand, capped by sharp earnings beat and guidance raise.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the industrials sector, an off index holding in private company Space Exploration Technologies (SpaceX) was a leading &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;contributor to relative returns. The merger with xAI boosted the private market share price of the company, and expectations &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;increased around a 2026 initial public offering for the aerospace and technology company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;By sector, stock selection in communication services sector was the largest detractor from relative returns. Among individual &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;detractors, in the IT sector, underweight in AI chip designer NVIDIA held back relative returns. The company continued to benefit &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;from increased AI infrastructure spending, and demand for its advanced chips remained strong across cloud computing, data &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;centers and enterprise AI applications. NVIDIA was the largest position in the Fund on an absolute basis, but the Fund was &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;underweighted on a relative basis due to position size constraints.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the consumer staples sector, an off-benchmark holding in BellRing Brands was a leading detractor. The nutrition products &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;company reported shrinking profit margins and saw increased competition in the protein shake category. Retailer inventory &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;adjustments and reduced full year 2025 guidance were also headwinds for the company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the industrials sector, Axon shares fell as investors expressed concerns about near-term margin pressure from higher &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;investment spending, even though the company continued to report strong revenue growth and solid demand from public safety &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;agencies.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-7449"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-7452"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-7469"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7486img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-7473"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Advisor Class&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;21.04&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;6.89&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.23&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Growth Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;30.98&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.23&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;17.82&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-7509"
      xml:lang="en-US">Advisor Class</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103306"
      unitRef="RATIO">0.2104</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103307"
      unitRef="RATIO">0.0689</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103308"
      unitRef="RATIO">0.1423</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-7524"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103309"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103310"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103311"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member"
      id="ixv-7539"
      xml:lang="en-US">Russell 3000 Growth Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103312"
      unitRef="RATIO">0.3098</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103313"
      unitRef="RATIO">0.1323</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103314"
      unitRef="RATIO">0.1782</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-7554"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103315"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103316"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103317"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-7570"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-7586"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$4,394,400,813&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;92&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$24,181,309&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;39.14%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30Member"
      decimals="INF"
      id="ixv-103318"
      unitRef="USD">4394400813</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30Member"
      decimals="INF"
      id="ixv-103319"
      unitRef="UNIT">92</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103320"
      unitRef="USD">24181309</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103321"
      unitRef="RATIO">0.3914</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="foot-7486_811226-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9pt;color:#161616;;"&gt;&lt;sup&gt;,&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;&#x2020;&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7486img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:UpdProspectusWebAddress
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-7709"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-103322"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-103323"
      unitRef="USD">11721</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-103324"
      unitRef="USD">14148</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-103325"
      unitRef="USD">16434</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-103326"
      unitRef="USD">17945</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-103327"
      unitRef="USD">27099</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-103328"
      unitRef="USD">22664</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-103329"
      unitRef="USD">21596</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-103330"
      unitRef="USD">28896</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-103331"
      unitRef="USD">31242</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103332"
      unitRef="USD">37814</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-103333"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-103334"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-103335"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-103336"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-103337"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-103338"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-103339"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-103340"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-103341"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-103342"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103343"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_5438Member"
      decimals="INF"
      id="ixv-103344"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_5438Member"
      decimals="INF"
      id="ixv-103345"
      unitRef="USD">11983</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_5438Member"
      decimals="INF"
      id="ixv-103346"
      unitRef="USD">14233</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_5438Member"
      decimals="INF"
      id="ixv-103347"
      unitRef="USD">16598</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_5438Member"
      decimals="INF"
      id="ixv-103348"
      unitRef="USD">18169</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_5438Member"
      decimals="INF"
      id="ixv-103349"
      unitRef="USD">27693</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_5438Member"
      decimals="INF"
      id="ixv-103350"
      unitRef="USD">25802</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_5438Member"
      decimals="INF"
      id="ixv-103351"
      unitRef="USD">26382</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_5438Member"
      decimals="INF"
      id="ixv-103352"
      unitRef="USD">34493</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_5438Member"
      decimals="INF"
      id="ixv-103353"
      unitRef="USD">39346</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_5438Member"
      decimals="INF"
      id="ixv-103354"
      unitRef="USD">51536</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-103355"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-103356"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-103357"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-103358"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-103359"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-103360"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-103361"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-103362"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-103363"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-103364"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7486_duration_FranklinGrowthOpportunitiesFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103365"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-103366"
      unitRef="RATIO">0.477</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-103367"
      unitRef="RATIO">0.134</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_3995Member"
      decimals="INF"
      id="ixv-103368"
      unitRef="RATIO">0.131</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_3996Member"
      decimals="INF"
      id="ixv-103369"
      unitRef="RATIO">0.092</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-103370"
      unitRef="RATIO">0.078</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-103371"
      unitRef="RATIO">0.027</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-103372"
      unitRef="RATIO">0.022</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_4001Member"
      decimals="INF"
      id="ixv-103373"
      unitRef="RATIO">0.017</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_4002Member"
      decimals="INF"
      id="ixv-103374"
      unitRef="RATIO">0.007</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_4943Member"
      decimals="INF"
      id="ixv-103375"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7486_instant_FranklinGrowthOpportunitiesFund_AdvisorClass_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-103376"
      unitRef="RATIO">0.015</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-7755"
      xml:lang="en-US">Franklin Natural Resources Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-7764"
      xml:lang="en-US">Class A</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-7767"
      xml:lang="en-US">FRNRX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-7774"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-7781"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Natural Resources Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-7783"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-7791"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-7793"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-7797"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:ExpensesTextBlock
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="foot-7444_806683-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class A&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$127&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.96%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103377"
      unitRef="USD">127</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7444_806683-1021"
      unitRef="RATIO">0.0096</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-7860"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class A shares of Franklin Natural Resources Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;64.73%. The Fund compares &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;its performance to the S&amp;amp;P North American Natural Resources Sector Index and the S&amp;amp;P Global Natural Resources Index, which &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;returned 53.73% and 49.88%, respectively, for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Among metals producers, exceptionally strong gains for overweighted or off-benchmark positions in the diversified metals and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;mining industry, including rare earth development and production companies like Aclara Resources, MP Materials and Lindian &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Resources (purchased during the period); Copper-focused producers like Lundin Mining, ERO Copper and Antofagasta; and gold &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;miners such as Barrick Mining and Newmont. Many of these stocks more than doubled in value as prices for copper, gold, silver, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and other metals rose to all-time or multiyear highs.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the energy sector, beneficial underweighting and stock selection in the oil and gas storage and transportation industry (led by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;a much lighter-than-index exposure to Enbridge); overweighting and stock selection in oilfield services, where the Fund&#x2019;s &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;holdings collectively increased more than 100%; and effective stock selection in integrated oil and gas, as well as oil and gas &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;exploration and production.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Triple-digit percentage gains for select off-benchmark industry allocations, including specialty chemicals (led by key contributor &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Albemarle); electrical components and equipment (led by T1 Energy); and heavy electrical equipment (led by GE Vernova).&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Benchmark-lagging gains for off-index positions in Linde, as well as Air Products and Chemicals, in the industrial gases industry &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and, to a lesser extent, Corteva and Nutrien in fertilizers and agricultural chemicals.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Underweighted exposures to select oil and gas refining and marketing companies that rallied well beyond the benchmark &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;averages, including key detractor Valero Energy. Relative returns were further pressured by underweighting&#x2019;s in other &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;energy-related outliers to the upside, including uranium fuel producer Cameco and drilling contractor Baker Hughes.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Negative returns in some of the Fund&#x2019;s single-asset, off-benchmark industry allocations, with the detractors focused on water &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;infrastructure plays such as Badger Meter (electronic equipment and instruments industry) and Xylem (industrial machinery, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;supplies and components).&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-7983"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-7986"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-8007"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7444img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-8011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class A&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;64.73&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;20.21&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;8.15&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class A (with sales charge)&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;55.67&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;18.86&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;7.54&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P North American Natural Resources Sector Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;53.73&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;20.81&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.34&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P Global Natural Resources Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;49.88&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;12.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.96&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30_1400Member"
      id="ixv-8047"
      xml:lang="en-US">Class A</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103379"
      unitRef="RATIO">0.6473</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2021-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103380"
      unitRef="RATIO">0.2021</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2016-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103381"
      unitRef="RATIO">0.0815</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-8062"
      xml:lang="en-US">Class A (with sales charge)</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103382"
      unitRef="RATIO">0.5567</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103383"
      unitRef="RATIO">0.1886</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103384"
      unitRef="RATIO">0.0754</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-8077"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103385"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103386"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103387"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5440Member"
      id="ixv-8092"
      xml:lang="en-US">S&amp;P North American Natural Resources Sector Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5440Member"
      decimals="INF"
      id="ixv-103388"
      unitRef="RATIO">0.5373</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_5440Member"
      decimals="INF"
      id="ixv-103389"
      unitRef="RATIO">0.2081</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_5440Member"
      decimals="INF"
      id="ixv-103390"
      unitRef="RATIO">0.1034</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5441Member"
      id="ixv-8107"
      xml:lang="en-US">S&amp;P Global Natural Resources Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5441Member"
      decimals="INF"
      id="ixv-103391"
      unitRef="RATIO">0.4988</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_5441Member"
      decimals="INF"
      id="ixv-103392"
      unitRef="RATIO">0.1201</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_5441Member"
      decimals="INF"
      id="ixv-103393"
      unitRef="RATIO">0.1096</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-8127"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-8143"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$538,915,982&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;100&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$1,953,759&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;27.09%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7444_instant_FranklinNaturalResourcesFund_ClassA_2026-04-30Member"
      decimals="INF"
      id="ixv-103394"
      unitRef="USD">538915982</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7444_instant_FranklinNaturalResourcesFund_ClassA_2026-04-30Member"
      decimals="INF"
      id="ixv-103395"
      unitRef="UNIT">100</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103396"
      unitRef="USD">1953759</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103397"
      unitRef="RATIO">0.2709</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="foot-7444_806726-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7444img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:UpdProspectusWebAddress
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-8255"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-103398"
      unitRef="USD">9450</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-103399"
      unitRef="USD">9580</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-103400"
      unitRef="USD">10801</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-103401"
      unitRef="USD">9322</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-103402"
      unitRef="USD">5472</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-103403"
      unitRef="USD">8239</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-103404"
      unitRef="USD">11256</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-103405"
      unitRef="USD">11994</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-103406"
      unitRef="USD">13483</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-103407"
      unitRef="USD">12556</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103408"
      unitRef="USD">20684</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-103409"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-103410"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-103411"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-103412"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-103413"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-103414"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-103415"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-103416"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-103417"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-103418"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103419"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_5440Member"
      decimals="INF"
      id="ixv-103420"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_5440Member"
      decimals="INF"
      id="ixv-103421"
      unitRef="USD">10259</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_5440Member"
      decimals="INF"
      id="ixv-103422"
      unitRef="USD">11334</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_5440Member"
      decimals="INF"
      id="ixv-103423"
      unitRef="USD">10301</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_5440Member"
      decimals="INF"
      id="ixv-103424"
      unitRef="USD">7397</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_5440Member"
      decimals="INF"
      id="ixv-103425"
      unitRef="USD">10399</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_5440Member"
      decimals="INF"
      id="ixv-103426"
      unitRef="USD">14748</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_5440Member"
      decimals="INF"
      id="ixv-103427"
      unitRef="USD">15613</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_5440Member"
      decimals="INF"
      id="ixv-103428"
      unitRef="USD">18055</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_5440Member"
      decimals="INF"
      id="ixv-103429"
      unitRef="USD">17404</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5440Member"
      decimals="INF"
      id="ixv-103430"
      unitRef="USD">26756</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_5441Member"
      decimals="INF"
      id="ixv-103431"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_5441Member"
      decimals="INF"
      id="ixv-103432"
      unitRef="USD">11147</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_5441Member"
      decimals="INF"
      id="ixv-103433"
      unitRef="USD">13791</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_5441Member"
      decimals="INF"
      id="ixv-103434"
      unitRef="USD">13126</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_5441Member"
      decimals="INF"
      id="ixv-103435"
      unitRef="USD">10454</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_5441Member"
      decimals="INF"
      id="ixv-103436"
      unitRef="USD">16042</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_5441Member"
      decimals="INF"
      id="ixv-103437"
      unitRef="USD">19271</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_5441Member"
      decimals="INF"
      id="ixv-103438"
      unitRef="USD">19099</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_5441Member"
      decimals="INF"
      id="ixv-103439"
      unitRef="USD">20227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_5441Member"
      decimals="INF"
      id="ixv-103440"
      unitRef="USD">18866</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7444_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5441Member"
      decimals="INF"
      id="ixv-103441"
      unitRef="USD">28277</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7444_instant_FranklinNaturalResourcesFund_ClassA_2026-04-30_3999Member"
      decimals="INF"
      id="ixv-103442"
      unitRef="RATIO">0.539</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7444_instant_FranklinNaturalResourcesFund_ClassA_2026-04-30_4001Member"
      decimals="INF"
      id="ixv-103443"
      unitRef="RATIO">0.378</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7444_instant_FranklinNaturalResourcesFund_ClassA_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-103444"
      unitRef="RATIO">0.033</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7444_instant_FranklinNaturalResourcesFund_ClassA_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-103445"
      unitRef="RATIO">0.008</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7444_instant_FranklinNaturalResourcesFund_ClassA_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-103446"
      unitRef="RATIO">0.005</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7444_instant_FranklinNaturalResourcesFund_ClassA_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-103447"
      unitRef="RATIO">0.037</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-8301"
      xml:lang="en-US">Franklin Natural Resources Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-8310"
      xml:lang="en-US">Class C</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-8313"
      xml:lang="en-US">FNCRX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-8320"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-8327"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Natural Resources Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-8329"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-8337"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-8339"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-8343"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:ExpensesTextBlock
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="foot-7445_806851-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class C&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$225&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.71%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103448"
      unitRef="USD">225</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7445_806851-1021"
      unitRef="RATIO">0.0171</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-8406"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class C shares of Franklin Natural Resources Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;63.49%. The Fund compares &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;its performance to the S&amp;amp;P North American Natural Resources Sector Index and the S&amp;amp;P Global Natural Resources Index, which &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;returned 53.73% and 49.88%, respectively, for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Among metals producers, exceptionally strong gains for overweighted or off-benchmark positions in the diversified metals and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;mining industry, including rare earth development and production companies like Aclara Resources, MP Materials and Lindian &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Resources (purchased during the period); Copper-focused producers like Lundin Mining, ERO Copper and Antofagasta; and gold &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;miners such as Barrick Mining and Newmont. Many of these stocks more than doubled in value as prices for copper, gold, silver, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and other metals rose to all-time or multiyear highs.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the energy sector, beneficial underweighting and stock selection in the oil and gas storage and transportation industry (led by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;a much lighter-than-index exposure to Enbridge); overweighting and stock selection in oilfield services, where the Fund&#x2019;s &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;holdings collectively increased more than 100%; and effective stock selection in integrated oil and gas, as well as oil and gas &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;exploration and production.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Triple-digit percentage gains for select off-benchmark industry allocations, including specialty chemicals (led by key contributor &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Albemarle); electrical components and equipment (led by T1 Energy); and heavy electrical equipment (led by GE Vernova).&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Benchmark-lagging gains for off-index positions in Linde, as well as Air Products and Chemicals, in the industrial gases industry &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and, to a lesser extent, Corteva and Nutrien in fertilizers and agricultural chemicals.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Underweighted exposures to select oil and gas refining and marketing companies that rallied well beyond the benchmark &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;averages, including key detractor Valero Energy. Relative returns were further pressured by underweighting&#x2019;s in other &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;energy-related outliers to the upside, including uranium fuel producer Cameco and drilling contractor Baker Hughes.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Negative returns in some of the Fund&#x2019;s single-asset, off-benchmark industry allocations, with the detractors focused on water &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;infrastructure plays such as Badger Meter (electronic equipment and instruments industry) and Xylem (industrial machinery, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;supplies and components).&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-8529"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-8532"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-8549"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7445img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-8553"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class C&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;63.49&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;19.31&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;7.34&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class C (with sales charge)&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;62.49&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;19.31&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;7.34&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P North American Natural Resources Sector Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;53.73&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;20.81&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.34&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P Global Natural Resources Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;49.88&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;12.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.96&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30_1400Member"
      id="ixv-8589"
      xml:lang="en-US">Class C</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103450"
      unitRef="RATIO">0.6349</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2021-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103451"
      unitRef="RATIO">0.1931</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2016-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103452"
      unitRef="RATIO">0.0734</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-8604"
      xml:lang="en-US">Class C (with sales charge)</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103453"
      unitRef="RATIO">0.6249</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103454"
      unitRef="RATIO">0.1931</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103455"
      unitRef="RATIO">0.0734</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-8619"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103456"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103457"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103458"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5440Member"
      id="ixv-8634"
      xml:lang="en-US">S&amp;P North American Natural Resources Sector Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5440Member"
      decimals="INF"
      id="ixv-103459"
      unitRef="RATIO">0.5373</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_5440Member"
      decimals="INF"
      id="ixv-103460"
      unitRef="RATIO">0.2081</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_5440Member"
      decimals="INF"
      id="ixv-103461"
      unitRef="RATIO">0.1034</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5441Member"
      id="ixv-8649"
      xml:lang="en-US">S&amp;P Global Natural Resources Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5441Member"
      decimals="INF"
      id="ixv-103462"
      unitRef="RATIO">0.4988</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_5441Member"
      decimals="INF"
      id="ixv-103463"
      unitRef="RATIO">0.1201</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_5441Member"
      decimals="INF"
      id="ixv-103464"
      unitRef="RATIO">0.1096</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-8665"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-8681"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$538,915,982&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;100&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$1,953,759&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;27.09%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7445_instant_FranklinNaturalResourcesFund_ClassC_2026-04-30Member"
      decimals="INF"
      id="ixv-103465"
      unitRef="USD">538915982</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7445_instant_FranklinNaturalResourcesFund_ClassC_2026-04-30Member"
      decimals="INF"
      id="ixv-103466"
      unitRef="UNIT">100</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103467"
      unitRef="USD">1953759</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103468"
      unitRef="RATIO">0.2709</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="foot-7445_806871-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7445img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:UpdProspectusWebAddress
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-8793"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-103469"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-103470"
      unitRef="USD">10063</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-103471"
      unitRef="USD">11261</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-103472"
      unitRef="USD">9642</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-103473"
      unitRef="USD">5620</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-103474"
      unitRef="USD">8397</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-103475"
      unitRef="USD">11386</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-103476"
      unitRef="USD">12040</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-103477"
      unitRef="USD">13438</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-103478"
      unitRef="USD">12419</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103479"
      unitRef="USD">20305</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-103480"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-103481"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-103482"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-103483"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-103484"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-103485"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-103486"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-103487"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-103488"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-103489"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103490"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_5440Member"
      decimals="INF"
      id="ixv-103491"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_5440Member"
      decimals="INF"
      id="ixv-103492"
      unitRef="USD">10259</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_5440Member"
      decimals="INF"
      id="ixv-103493"
      unitRef="USD">11334</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_5440Member"
      decimals="INF"
      id="ixv-103494"
      unitRef="USD">10301</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_5440Member"
      decimals="INF"
      id="ixv-103495"
      unitRef="USD">7397</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_5440Member"
      decimals="INF"
      id="ixv-103496"
      unitRef="USD">10399</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_5440Member"
      decimals="INF"
      id="ixv-103497"
      unitRef="USD">14748</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_5440Member"
      decimals="INF"
      id="ixv-103498"
      unitRef="USD">15613</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_5440Member"
      decimals="INF"
      id="ixv-103499"
      unitRef="USD">18055</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_5440Member"
      decimals="INF"
      id="ixv-103500"
      unitRef="USD">17404</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5440Member"
      decimals="INF"
      id="ixv-103501"
      unitRef="USD">26756</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_5441Member"
      decimals="INF"
      id="ixv-103502"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_5441Member"
      decimals="INF"
      id="ixv-103503"
      unitRef="USD">11147</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_5441Member"
      decimals="INF"
      id="ixv-103504"
      unitRef="USD">13791</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_5441Member"
      decimals="INF"
      id="ixv-103505"
      unitRef="USD">13126</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_5441Member"
      decimals="INF"
      id="ixv-103506"
      unitRef="USD">10454</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_5441Member"
      decimals="INF"
      id="ixv-103507"
      unitRef="USD">16042</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_5441Member"
      decimals="INF"
      id="ixv-103508"
      unitRef="USD">19271</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_5441Member"
      decimals="INF"
      id="ixv-103509"
      unitRef="USD">19099</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_5441Member"
      decimals="INF"
      id="ixv-103510"
      unitRef="USD">20227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_5441Member"
      decimals="INF"
      id="ixv-103511"
      unitRef="USD">18866</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7445_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5441Member"
      decimals="INF"
      id="ixv-103512"
      unitRef="USD">28277</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7445_instant_FranklinNaturalResourcesFund_ClassC_2026-04-30_3999Member"
      decimals="INF"
      id="ixv-103513"
      unitRef="RATIO">0.539</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7445_instant_FranklinNaturalResourcesFund_ClassC_2026-04-30_4001Member"
      decimals="INF"
      id="ixv-103514"
      unitRef="RATIO">0.378</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7445_instant_FranklinNaturalResourcesFund_ClassC_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-103515"
      unitRef="RATIO">0.033</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7445_instant_FranklinNaturalResourcesFund_ClassC_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-103516"
      unitRef="RATIO">0.008</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7445_instant_FranklinNaturalResourcesFund_ClassC_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-103517"
      unitRef="RATIO">0.005</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7445_instant_FranklinNaturalResourcesFund_ClassC_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-103518"
      unitRef="RATIO">0.037</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-8839"
      xml:lang="en-US">Franklin Natural Resources Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-8848"
      xml:lang="en-US">Class R6</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-8851"
      xml:lang="en-US">FNCSX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-8858"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-8865"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Natural Resources Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-8867"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-8875"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-8877"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-8881"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:ExpensesTextBlock
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="foot-7446_806969-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class R6&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$78&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.59%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103519"
      unitRef="USD">78</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7446_806969-1021"
      unitRef="RATIO">0.0059</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-8944"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R6 shares of Franklin Natural Resources Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;65.36%. The Fund &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;compares its performance to the S&amp;amp;P North American Natural Resources Sector Index and the S&amp;amp;P Global Natural Resources Index, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;which returned 53.73% and 49.88%, respectively, for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Among metals producers, exceptionally strong gains for overweighted or off-benchmark positions in the diversified metals and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;mining industry, including rare earth development and production companies like Aclara Resources, MP Materials and Lindian &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Resources (purchased during the period); Copper-focused producers like Lundin Mining, ERO Copper and Antofagasta; and gold &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;miners such as Barrick Mining and Newmont. Many of these stocks more than doubled in value as prices for copper, gold, silver, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and other metals rose to all-time or multiyear highs.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the energy sector, beneficial underweighting and stock selection in the oil and gas storage and transportation industry (led by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;a much lighter-than-index exposure to Enbridge); overweighting and stock selection in oilfield services, where the Fund&#x2019;s &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;holdings collectively increased more than 100%; and effective stock selection in integrated oil and gas, as well as oil and gas &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;exploration and production.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Triple-digit percentage gains for select off-benchmark industry allocations, including specialty chemicals (led by key contributor &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Albemarle); electrical components and equipment (led by T1 Energy); and heavy electrical equipment (led by GE Vernova).&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Benchmark-lagging gains for off-index positions in Linde, as well as Air Products and Chemicals, in the industrial gases industry &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and, to a lesser extent, Corteva and Nutrien in fertilizers and agricultural chemicals.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Underweighted exposures to select oil and gas refining and marketing companies that rallied well beyond the benchmark &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;averages, including key detractor Valero Energy. Relative returns were further pressured by underweighting&#x2019;s in other &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;energy-related outliers to the upside, including uranium fuel producer Cameco and drilling contractor Baker Hughes.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Negative returns in some of the Fund&#x2019;s single-asset, off-benchmark industry allocations, with the detractors focused on water &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;infrastructure plays such as Badger Meter (electronic equipment and instruments industry) and Xylem (industrial machinery, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;supplies and components).&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-9067"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-9070"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-9087"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7446img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-9091"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class R6&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;65.36&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;20.70&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;8.64&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P North American Natural Resources Sector Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;53.73&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;20.81&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.34&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P Global Natural Resources Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;49.88&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;12.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.96&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-9127"
      xml:lang="en-US">Class R6</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103521"
      unitRef="RATIO">0.6536</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103522"
      unitRef="RATIO">0.2070</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103523"
      unitRef="RATIO">0.0864</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-9142"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103524"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103525"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103526"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5440Member"
      id="ixv-9157"
      xml:lang="en-US">S&amp;P North American Natural Resources Sector Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5440Member"
      decimals="INF"
      id="ixv-103527"
      unitRef="RATIO">0.5373</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_5440Member"
      decimals="INF"
      id="ixv-103528"
      unitRef="RATIO">0.2081</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_5440Member"
      decimals="INF"
      id="ixv-103529"
      unitRef="RATIO">0.1034</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5441Member"
      id="ixv-9172"
      xml:lang="en-US">S&amp;P Global Natural Resources Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5441Member"
      decimals="INF"
      id="ixv-103530"
      unitRef="RATIO">0.4988</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_5441Member"
      decimals="INF"
      id="ixv-103531"
      unitRef="RATIO">0.1201</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_5441Member"
      decimals="INF"
      id="ixv-103532"
      unitRef="RATIO">0.1096</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-9188"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-9204"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$538,915,982&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;100&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$1,953,759&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;27.09%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7446_instant_FranklinNaturalResourcesFund_ClassR6_2026-04-30Member"
      decimals="INF"
      id="ixv-103533"
      unitRef="USD">538915982</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7446_instant_FranklinNaturalResourcesFund_ClassR6_2026-04-30Member"
      decimals="INF"
      id="ixv-103534"
      unitRef="UNIT">100</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103535"
      unitRef="USD">1953759</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103536"
      unitRef="RATIO">0.2709</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="foot-7446_806989-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7446img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:UpdProspectusWebAddress
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-9316"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-103537"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-103538"
      unitRef="USD">10189</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-103539"
      unitRef="USD">11551</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-103540"
      unitRef="USD">10014</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-103541"
      unitRef="USD">5906</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-103542"
      unitRef="USD">8944</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-103543"
      unitRef="USD">12275</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-103544"
      unitRef="USD">13132</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-103545"
      unitRef="USD">14826</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-103546"
      unitRef="USD">13854</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103547"
      unitRef="USD">22908</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-103548"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-103549"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-103550"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-103551"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-103552"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-103553"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-103554"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-103555"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-103556"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-103557"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103558"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_5440Member"
      decimals="INF"
      id="ixv-103559"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_5440Member"
      decimals="INF"
      id="ixv-103560"
      unitRef="USD">10259</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_5440Member"
      decimals="INF"
      id="ixv-103561"
      unitRef="USD">11334</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_5440Member"
      decimals="INF"
      id="ixv-103562"
      unitRef="USD">10301</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_5440Member"
      decimals="INF"
      id="ixv-103563"
      unitRef="USD">7397</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_5440Member"
      decimals="INF"
      id="ixv-103564"
      unitRef="USD">10399</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_5440Member"
      decimals="INF"
      id="ixv-103565"
      unitRef="USD">14748</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_5440Member"
      decimals="INF"
      id="ixv-103566"
      unitRef="USD">15613</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_5440Member"
      decimals="INF"
      id="ixv-103567"
      unitRef="USD">18055</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_5440Member"
      decimals="INF"
      id="ixv-103568"
      unitRef="USD">17404</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5440Member"
      decimals="INF"
      id="ixv-103569"
      unitRef="USD">26756</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_5441Member"
      decimals="INF"
      id="ixv-103570"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_5441Member"
      decimals="INF"
      id="ixv-103571"
      unitRef="USD">11147</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_5441Member"
      decimals="INF"
      id="ixv-103572"
      unitRef="USD">13791</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_5441Member"
      decimals="INF"
      id="ixv-103573"
      unitRef="USD">13126</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_5441Member"
      decimals="INF"
      id="ixv-103574"
      unitRef="USD">10454</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_5441Member"
      decimals="INF"
      id="ixv-103575"
      unitRef="USD">16042</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_5441Member"
      decimals="INF"
      id="ixv-103576"
      unitRef="USD">19271</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_5441Member"
      decimals="INF"
      id="ixv-103577"
      unitRef="USD">19099</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_5441Member"
      decimals="INF"
      id="ixv-103578"
      unitRef="USD">20227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_5441Member"
      decimals="INF"
      id="ixv-103579"
      unitRef="USD">18866</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7446_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5441Member"
      decimals="INF"
      id="ixv-103580"
      unitRef="USD">28277</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7446_instant_FranklinNaturalResourcesFund_ClassR6_2026-04-30_3999Member"
      decimals="INF"
      id="ixv-103581"
      unitRef="RATIO">0.539</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7446_instant_FranklinNaturalResourcesFund_ClassR6_2026-04-30_4001Member"
      decimals="INF"
      id="ixv-103582"
      unitRef="RATIO">0.378</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7446_instant_FranklinNaturalResourcesFund_ClassR6_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-103583"
      unitRef="RATIO">0.033</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7446_instant_FranklinNaturalResourcesFund_ClassR6_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-103584"
      unitRef="RATIO">0.008</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7446_instant_FranklinNaturalResourcesFund_ClassR6_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-103585"
      unitRef="RATIO">0.005</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7446_instant_FranklinNaturalResourcesFund_ClassR6_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-103586"
      unitRef="RATIO">0.037</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-9362"
      xml:lang="en-US">Franklin Natural Resources Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-9371"
      xml:lang="en-US">Advisor Class</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-9374"
      xml:lang="en-US">FNRAX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-9381"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-9388"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Natural Resources Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-9390"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-9398"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-9400"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-9404"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:ExpensesTextBlock
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="foot-7442_806485-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Advisor Class&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$93&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.70%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103587"
      unitRef="USD">93</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7442_806485-1021"
      unitRef="RATIO">0.0070</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-9467"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Advisor Class shares of Franklin Natural Resources Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;65.18%. The Fund &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;compares its performance to the S&amp;amp;P North American Natural Resources Sector Index and the S&amp;amp;P Global Natural Resources Index, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;which returned 53.73% and 49.88%, respectively, for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Among metals producers, exceptionally strong gains for overweighted or off-benchmark positions in the diversified metals and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;mining industry, including rare earth development and production companies like Aclara Resources, MP Materials and Lindian &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Resources (purchased during the period); Copper-focused producers like Lundin Mining, ERO Copper and Antofagasta; and gold &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;miners such as Barrick Mining and Newmont. Many of these stocks more than doubled in value as prices for copper, gold, silver, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and other metals rose to all-time or multiyear highs.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the energy sector, beneficial underweighting and stock selection in the oil and gas storage and transportation industry (led by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;a much lighter-than-index exposure to Enbridge); overweighting and stock selection in oilfield services, where the Fund&#x2019;s &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;holdings collectively increased more than 100%; and effective stock selection in integrated oil and gas, as well as oil and gas &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;exploration and production.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Triple-digit percentage gains for select off-benchmark industry allocations, including specialty chemicals (led by key contributor &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Albemarle); electrical components and equipment (led by T1 Energy); and heavy electrical equipment (led by GE Vernova).&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Benchmark-lagging gains for off-index positions in Linde, as well as Air Products and Chemicals, in the industrial gases industry &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;and, to a lesser extent, Corteva and Nutrien in fertilizers and agricultural chemicals.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Underweighted exposures to select oil and gas refining and marketing companies that rallied well beyond the benchmark &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;averages, including key detractor Valero Energy. Relative returns were further pressured by underweighting&#x2019;s in other &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;energy-related outliers to the upside, including uranium fuel producer Cameco and drilling contractor Baker Hughes.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Negative returns in some of the Fund&#x2019;s single-asset, off-benchmark industry allocations, with the detractors focused on water &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;infrastructure plays such as Badger Meter (electronic equipment and instruments industry) and Xylem (industrial machinery, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;supplies and components).&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-9590"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-9593"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-9610"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7442img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-9614"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Advisor Class&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;65.18&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;20.52&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;8.42&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P North American Natural Resources Sector Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;53.73&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;20.81&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.34&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P Global Natural Resources Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;49.88&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;12.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.96&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-9650"
      xml:lang="en-US">Advisor Class</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103589"
      unitRef="RATIO">0.6518</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103590"
      unitRef="RATIO">0.2052</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103591"
      unitRef="RATIO">0.0842</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-9665"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103592"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103593"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103594"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5440Member"
      id="ixv-9680"
      xml:lang="en-US">S&amp;P North American Natural Resources Sector Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5440Member"
      decimals="INF"
      id="ixv-103595"
      unitRef="RATIO">0.5373</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_5440Member"
      decimals="INF"
      id="ixv-103596"
      unitRef="RATIO">0.2081</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_5440Member"
      decimals="INF"
      id="ixv-103597"
      unitRef="RATIO">0.1034</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5441Member"
      id="ixv-9695"
      xml:lang="en-US">S&amp;P Global Natural Resources Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5441Member"
      decimals="INF"
      id="ixv-103598"
      unitRef="RATIO">0.4988</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2021-05-01_2026-04-30_5441Member"
      decimals="INF"
      id="ixv-103599"
      unitRef="RATIO">0.1201</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2016-05-01_2026-04-30_5441Member"
      decimals="INF"
      id="ixv-103600"
      unitRef="RATIO">0.1096</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-9711"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-9727"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$538,915,982&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;100&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$1,953,759&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;27.09%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7442_instant_FranklinNaturalResourcesFund_AdvisorClass_2026-04-30Member"
      decimals="INF"
      id="ixv-103601"
      unitRef="USD">538915982</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7442_instant_FranklinNaturalResourcesFund_AdvisorClass_2026-04-30Member"
      decimals="INF"
      id="ixv-103602"
      unitRef="UNIT">100</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103603"
      unitRef="USD">1953759</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103604"
      unitRef="RATIO">0.2709</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="foot-7442_806505-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7442img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:UpdProspectusWebAddress
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-9839"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-103605"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-103606"
      unitRef="USD">10164</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-103607"
      unitRef="USD">11489</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-103608"
      unitRef="USD">9939</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-103609"
      unitRef="USD">5849</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-103610"
      unitRef="USD">8829</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-103611"
      unitRef="USD">12089</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-103612"
      unitRef="USD">12918</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-103613"
      unitRef="USD">14562</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-103614"
      unitRef="USD">13590</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103615"
      unitRef="USD">22447</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-103616"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-103617"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-103618"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-103619"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-103620"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-103621"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-103622"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-103623"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-103624"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-103625"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103626"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_5440Member"
      decimals="INF"
      id="ixv-103627"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_5440Member"
      decimals="INF"
      id="ixv-103628"
      unitRef="USD">10259</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_5440Member"
      decimals="INF"
      id="ixv-103629"
      unitRef="USD">11334</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_5440Member"
      decimals="INF"
      id="ixv-103630"
      unitRef="USD">10301</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_5440Member"
      decimals="INF"
      id="ixv-103631"
      unitRef="USD">7397</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_5440Member"
      decimals="INF"
      id="ixv-103632"
      unitRef="USD">10399</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_5440Member"
      decimals="INF"
      id="ixv-103633"
      unitRef="USD">14748</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_5440Member"
      decimals="INF"
      id="ixv-103634"
      unitRef="USD">15613</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_5440Member"
      decimals="INF"
      id="ixv-103635"
      unitRef="USD">18055</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_5440Member"
      decimals="INF"
      id="ixv-103636"
      unitRef="USD">17404</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5440Member"
      decimals="INF"
      id="ixv-103637"
      unitRef="USD">26756</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2016-04-30_2016-04-30_5441Member"
      decimals="INF"
      id="ixv-103638"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2017-04-30_2017-04-30_5441Member"
      decimals="INF"
      id="ixv-103639"
      unitRef="USD">11147</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2018-04-30_2018-04-30_5441Member"
      decimals="INF"
      id="ixv-103640"
      unitRef="USD">13791</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2019-04-30_2019-04-30_5441Member"
      decimals="INF"
      id="ixv-103641"
      unitRef="USD">13126</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2020-04-30_2020-04-30_5441Member"
      decimals="INF"
      id="ixv-103642"
      unitRef="USD">10454</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2021-04-30_2021-04-30_5441Member"
      decimals="INF"
      id="ixv-103643"
      unitRef="USD">16042</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2022-04-30_2022-04-30_5441Member"
      decimals="INF"
      id="ixv-103644"
      unitRef="USD">19271</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2023-04-30_2023-04-30_5441Member"
      decimals="INF"
      id="ixv-103645"
      unitRef="USD">19099</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2024-04-30_2024-04-30_5441Member"
      decimals="INF"
      id="ixv-103646"
      unitRef="USD">20227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2025-04-30_2025-04-30_5441Member"
      decimals="INF"
      id="ixv-103647"
      unitRef="USD">18866</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7442_duration_FranklinNaturalResourcesFund_2025-05-01_2026-04-30_5441Member"
      decimals="INF"
      id="ixv-103648"
      unitRef="USD">28277</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7442_instant_FranklinNaturalResourcesFund_AdvisorClass_2026-04-30_3999Member"
      decimals="INF"
      id="ixv-103649"
      unitRef="RATIO">0.539</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7442_instant_FranklinNaturalResourcesFund_AdvisorClass_2026-04-30_4001Member"
      decimals="INF"
      id="ixv-103650"
      unitRef="RATIO">0.378</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7442_instant_FranklinNaturalResourcesFund_AdvisorClass_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-103651"
      unitRef="RATIO">0.033</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7442_instant_FranklinNaturalResourcesFund_AdvisorClass_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-103652"
      unitRef="RATIO">0.008</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7442_instant_FranklinNaturalResourcesFund_AdvisorClass_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-103653"
      unitRef="RATIO">0.005</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7442_instant_FranklinNaturalResourcesFund_AdvisorClass_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-103654"
      unitRef="RATIO">0.037</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-9885"
      xml:lang="en-US">Franklin Small Cap Growth Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-9894"
      xml:lang="en-US">Class A</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-9897"
      xml:lang="en-US">FSGRX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-9904"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-9911"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Small Cap Growth Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-9913"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-9921"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-9923"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-9927"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:MaterialFundChngNoticeTextBlock
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-9932"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;"&gt;&lt;b&gt;&lt;i&gt;This report describes changes to the Fund that occurred during the reporting period.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngNoticeTextBlock>
    <oef:ExpensesTextBlock
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="foot-7463_808803-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class A&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$123&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.07%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103655"
      unitRef="USD">123</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7463_808803-1021"
      unitRef="RATIO">0.0107</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-9996"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class A shares of Franklin Small Cap Growth Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;30.13%. The Fund compares &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;its performance to the Russell 2000 Growth Index and the S&amp;amp;P 500 Index, which returned 42.64% and 31.05%, respectively, for the &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;same period.&#160;&#x2009;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;By sector, the largest contributor to relative returns was stock selection in the health care sector. However, the largest individual &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;contributors all came from the information technology (IT) sector. An off-benchmark position in phototonics specialist Lumentum &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Holdings led relative contributors after the company reported strong fiscal second quarter 2026 financial results and upbeat &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;forward guidance, driven by surging demand for artificial intelligence (AI) data center optics.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Semiconductor manufacturer SiTime also advanced relative returns. Shares in the company, which makes precision timing chips, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;soared late in the period after the company posted strong revenue growth amid increased demand from AI data centers.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Onto Innovation supported relative returns. The process control solutions company benefited from surging demand for advanced &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;semiconductor packaging and metrology tools driven by AI chip growth.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Stock selection and an overweight in the consumer staples sector held back relative returns. Within the sector, an off-benchmark &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;holding in BellRing Brands was the leading detractor. The nutrition products company reported shrinking profit margins and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;decreasing demand for its protein shakes. Retailer inventory adjustments and reduced full year 2025 guidance were also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;headwinds for the company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Within IT, a broader market pivot away from software stocks had a negative impact on shares of software development platform &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;GitLab, despite the company&#x2019;s positive earnings reports.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the health care sector, relative performance was hurt by a position in health care software company Phreesia. The company &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;reduced guidance for 2027, reporting that it is losing visibility into spending commitments from some of its clients.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-10116"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-10119"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-10140"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7463img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-10144"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class A&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;30.13&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.99&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.19&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class A (with sales charge)&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;22.96&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;-0.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.57&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 2000 Growth Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;42.64&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;4.00&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.19&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30_1400Member"
      id="ixv-10180"
      xml:lang="en-US">Class A</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103657"
      unitRef="RATIO">0.3013</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2021-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103658"
      unitRef="RATIO">0.0099</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2016-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103659"
      unitRef="RATIO">0.1119</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-10195"
      xml:lang="en-US">Class A (with sales charge)</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103660"
      unitRef="RATIO">0.2296</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103661"
      unitRef="RATIO">-0.0014</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103662"
      unitRef="RATIO">0.1057</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-10210"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103663"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103664"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103665"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member"
      id="ixv-10225"
      xml:lang="en-US">Russell 2000 Growth Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103666"
      unitRef="RATIO">0.4264</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103667"
      unitRef="RATIO">0.0400</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103668"
      unitRef="RATIO">0.1119</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-10240"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103669"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103670"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103671"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-10260"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-10276"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$2,435,287,399&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;129&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$15,084,958&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;48.01%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30Member"
      decimals="INF"
      id="ixv-103672"
      unitRef="USD">2435287399</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30Member"
      decimals="INF"
      id="ixv-103673"
      unitRef="UNIT">129</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103674"
      unitRef="USD">15084958</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103675"
      unitRef="RATIO">0.4801</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="foot-7463_808824-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9pt;color:#161616;;"&gt;&lt;sup&gt;,&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;&#x2020;&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7463img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:MaterialFundChngTextBlock
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-10383"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW HAS THE FUND CHANGED?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund and Jacob Swartz was added as a &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;portfolio manager of the Fund.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngTextBlock>
    <oef:SummaryOfChngLegendTextBlock
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-10396"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;</oef:SummaryOfChngLegendTextBlock>
    <oef:MaterialChngDate
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-10398"
      xml:lang="en-US">2025-05-01</oef:MaterialChngDate>
    <oef:UpdProspectusWebAddress
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-10403"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:UpdProspectusPhoneNumber
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-10406"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:UpdProspectusPhoneNumber>
    <oef:UpdProspectusEmailAddress
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-10411"
      xml:lang="en-US">prospectus.us.franklintempleton@fisglobal.com</oef:UpdProspectusEmailAddress>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-103676"
      unitRef="USD">9450</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-103677"
      unitRef="USD">11309</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-103678"
      unitRef="USD">13537</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-103679"
      unitRef="USD">15712</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-103680"
      unitRef="USD">14729</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-103681"
      unitRef="USD">25986</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-103682"
      unitRef="USD">18311</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-103683"
      unitRef="USD">17811</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-103684"
      unitRef="USD">21686</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-103685"
      unitRef="USD">20982</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103686"
      unitRef="USD">27303</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-103687"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-103688"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-103689"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-103690"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-103691"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-103692"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-103693"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-103694"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-103695"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-103696"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103697"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_5442Member"
      decimals="INF"
      id="ixv-103698"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_5442Member"
      decimals="INF"
      id="ixv-103699"
      unitRef="USD">12406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_5442Member"
      decimals="INF"
      id="ixv-103700"
      unitRef="USD">14466</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_5442Member"
      decimals="INF"
      id="ixv-103701"
      unitRef="USD">15465</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_5442Member"
      decimals="INF"
      id="ixv-103702"
      unitRef="USD">14040</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_5442Member"
      decimals="INF"
      id="ixv-103703"
      unitRef="USD">23749</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_5442Member"
      decimals="INF"
      id="ixv-103704"
      unitRef="USD">17469</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_5442Member"
      decimals="INF"
      id="ixv-103705"
      unitRef="USD">17596</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_5442Member"
      decimals="INF"
      id="ixv-103706"
      unitRef="USD">19775</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_5442Member"
      decimals="INF"
      id="ixv-103707"
      unitRef="USD">20253</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103708"
      unitRef="USD">28889</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-103709"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-103710"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-103711"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-103712"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-103713"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-103714"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-103715"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-103716"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-103717"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-103718"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7463_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103719"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-103720"
      unitRef="RATIO">0.246</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-103721"
      unitRef="RATIO">0.240</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-103722"
      unitRef="RATIO">0.231</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_3996Member"
      decimals="INF"
      id="ixv-103723"
      unitRef="RATIO">0.080</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-103724"
      unitRef="RATIO">0.075</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_3999Member"
      decimals="INF"
      id="ixv-103725"
      unitRef="RATIO">0.049</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-103726"
      unitRef="RATIO">0.028</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_3995Member"
      decimals="INF"
      id="ixv-103727"
      unitRef="RATIO">0.016</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_4000Member"
      decimals="INF"
      id="ixv-103728"
      unitRef="RATIO">0.007</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_4001Member"
      decimals="INF"
      id="ixv-103729"
      unitRef="RATIO">0.003</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_4943Member"
      decimals="INF"
      id="ixv-103730"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7463_instant_FranklinSmallCapGrowthFund_ClassA_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-103731"
      unitRef="RATIO">0.025</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10477"
      xml:lang="en-US">Franklin Small Cap Growth Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10486"
      xml:lang="en-US">Class C</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10489"
      xml:lang="en-US">FCSGX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-10496"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10503"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Small Cap Growth Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-10505"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10513"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10515"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10519"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:MaterialFundChngNoticeTextBlock
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10524"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;"&gt;&lt;b&gt;&lt;i&gt;This report describes changes to the Fund that occurred during the reporting period.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngNoticeTextBlock>
    <oef:ExpensesTextBlock
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="foot-7464_808922-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class C&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$209&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.82%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103732"
      unitRef="USD">209</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7464_808922-1021"
      unitRef="RATIO">0.0182</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10588"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class C shares of Franklin Small Cap Growth Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;29.21%. The Fund compares &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;its performance to the Russell 2000 Growth Index and the S&amp;amp;P 500 Index, which returned 42.64% and 31.05%, respectively, for the &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;same period.&#160;&#x2009;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;By sector, the largest contributor to relative returns was stock selection in the health care sector. However, the largest individual &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;contributors all came from the information technology (IT) sector. An off-benchmark position in phototonics specialist Lumentum &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Holdings led relative contributors after the company reported strong fiscal second quarter 2026 financial results and upbeat &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;forward guidance, driven by surging demand for artificial intelligence (AI) data center optics.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Semiconductor manufacturer SiTime also advanced relative returns. Shares in the company, which makes precision timing chips, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;soared late in the period after the company posted strong revenue growth amid increased demand from AI data centers.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Onto Innovation supported relative returns. The process control solutions company benefited from surging demand for advanced &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;semiconductor packaging and metrology tools driven by AI chip growth.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Stock selection and an overweight in the consumer staples sector held back relative returns. Within the sector, an off-benchmark &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;holding in BellRing Brands was the leading detractor. The nutrition products company reported shrinking profit margins and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;decreasing demand for its protein shakes. Retailer inventory adjustments and reduced full year 2025 guidance were also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;headwinds for the company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Within IT, a broader market pivot away from software stocks had a negative impact on shares of software development platform &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;GitLab, despite the company&#x2019;s positive earnings reports.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the health care sector, relative performance was hurt by a position in health care software company Phreesia. The company &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;reduced guidance for 2027, reporting that it is losing visibility into spending commitments from some of its clients.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10708"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10711"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10728"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7464img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10732"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class C&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;29.21&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.38&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class C (with sales charge)&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;28.21&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.38&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 2000 Growth Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;42.64&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;4.00&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.19&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30_1400Member"
      id="ixv-10768"
      xml:lang="en-US">Class C</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103734"
      unitRef="RATIO">0.2921</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2021-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103735"
      unitRef="RATIO">0.0026</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2016-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-103736"
      unitRef="RATIO">0.1038</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10783"
      xml:lang="en-US">Class C (with sales charge)</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103737"
      unitRef="RATIO">0.2821</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103738"
      unitRef="RATIO">0.0026</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103739"
      unitRef="RATIO">0.1038</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-10798"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103740"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103741"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103742"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member"
      id="ixv-10813"
      xml:lang="en-US">Russell 2000 Growth Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103743"
      unitRef="RATIO">0.4264</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103744"
      unitRef="RATIO">0.0400</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103745"
      unitRef="RATIO">0.1119</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-10828"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103746"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103747"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103748"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10844"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10860"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$2,435,287,399&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;129&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$15,084,958&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;48.01%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30Member"
      decimals="INF"
      id="ixv-103749"
      unitRef="USD">2435287399</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30Member"
      decimals="INF"
      id="ixv-103750"
      unitRef="UNIT">129</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103751"
      unitRef="USD">15084958</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103752"
      unitRef="RATIO">0.4801</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="foot-7464_808942-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9pt;color:#161616;;"&gt;&lt;sup&gt;,&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;&#x2020;&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7464img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:MaterialFundChngTextBlock
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10967"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW HAS THE FUND CHANGED?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund and Jacob Swartz was added as a &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;portfolio manager of the Fund.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngTextBlock>
    <oef:SummaryOfChngLegendTextBlock
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10980"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;</oef:SummaryOfChngLegendTextBlock>
    <oef:MaterialChngDate
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10982"
      xml:lang="en-US">2025-05-01</oef:MaterialChngDate>
    <oef:UpdProspectusWebAddress
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10987"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:UpdProspectusPhoneNumber
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10990"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:UpdProspectusPhoneNumber>
    <oef:UpdProspectusEmailAddress
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-10995"
      xml:lang="en-US">prospectus.us.franklintempleton@fisglobal.com</oef:UpdProspectusEmailAddress>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-103753"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-103754"
      unitRef="USD">11876</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-103755"
      unitRef="USD">14107</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-103756"
      unitRef="USD">16267</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-103757"
      unitRef="USD">15133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-103758"
      unitRef="USD">26503</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-103759"
      unitRef="USD">18534</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-103760"
      unitRef="USD">17896</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-103761"
      unitRef="USD">21644</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-103762"
      unitRef="USD">20783</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103763"
      unitRef="USD">26853</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-103764"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-103765"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-103766"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-103767"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-103768"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-103769"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-103770"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-103771"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-103772"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-103773"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103774"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_5442Member"
      decimals="INF"
      id="ixv-103775"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_5442Member"
      decimals="INF"
      id="ixv-103776"
      unitRef="USD">12406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_5442Member"
      decimals="INF"
      id="ixv-103777"
      unitRef="USD">14466</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_5442Member"
      decimals="INF"
      id="ixv-103778"
      unitRef="USD">15465</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_5442Member"
      decimals="INF"
      id="ixv-103779"
      unitRef="USD">14040</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_5442Member"
      decimals="INF"
      id="ixv-103780"
      unitRef="USD">23749</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_5442Member"
      decimals="INF"
      id="ixv-103781"
      unitRef="USD">17469</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_5442Member"
      decimals="INF"
      id="ixv-103782"
      unitRef="USD">17596</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_5442Member"
      decimals="INF"
      id="ixv-103783"
      unitRef="USD">19775</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_5442Member"
      decimals="INF"
      id="ixv-103784"
      unitRef="USD">20253</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103785"
      unitRef="USD">28889</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-103786"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-103787"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-103788"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-103789"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-103790"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-103791"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-103792"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-103793"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-103794"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-103795"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7464_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103796"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-103797"
      unitRef="RATIO">0.246</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-103798"
      unitRef="RATIO">0.240</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-103799"
      unitRef="RATIO">0.231</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_3996Member"
      decimals="INF"
      id="ixv-103800"
      unitRef="RATIO">0.080</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-103801"
      unitRef="RATIO">0.075</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_3999Member"
      decimals="INF"
      id="ixv-103802"
      unitRef="RATIO">0.049</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-103803"
      unitRef="RATIO">0.028</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_3995Member"
      decimals="INF"
      id="ixv-103804"
      unitRef="RATIO">0.016</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_4000Member"
      decimals="INF"
      id="ixv-103805"
      unitRef="RATIO">0.007</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_4001Member"
      decimals="INF"
      id="ixv-103806"
      unitRef="RATIO">0.003</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_4943Member"
      decimals="INF"
      id="ixv-103807"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7464_instant_FranklinSmallCapGrowthFund_ClassC_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-103808"
      unitRef="RATIO">0.025</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11061"
      xml:lang="en-US">Franklin Small Cap Growth Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11070"
      xml:lang="en-US">Class R</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11073"
      xml:lang="en-US">FSSRX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-11080"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11087"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Small Cap Growth Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-11089"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11097"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11099"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11103"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:MaterialFundChngNoticeTextBlock
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11108"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;"&gt;&lt;b&gt;&lt;i&gt;This report describes changes to the Fund that occurred during the reporting period.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngNoticeTextBlock>
    <oef:ExpensesTextBlock
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="foot-7466_809158-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class R&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$152&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.32%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103809"
      unitRef="USD">152</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7466_809158-1021"
      unitRef="RATIO">0.0132</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11172"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R shares of Franklin Small Cap Growth Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;29.79%. The Fund compares &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;its performance to the Russell 2000 Growth Index and the S&amp;amp;P 500 Index, which returned 42.64% and 31.05%, respectively, for the &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;same period.&#160;&#x2009;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;By sector, the largest contributor to relative returns was stock selection in the health care sector. However, the largest individual &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;contributors all came from the information technology (IT) sector. An off-benchmark position in phototonics specialist Lumentum &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Holdings led relative contributors after the company reported strong fiscal second quarter 2026 financial results and upbeat &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;forward guidance, driven by surging demand for artificial intelligence (AI) data center optics.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Semiconductor manufacturer SiTime also advanced relative returns. Shares in the company, which makes precision timing chips, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;soared late in the period after the company posted strong revenue growth amid increased demand from AI data centers.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Onto Innovation supported relative returns. The process control solutions company benefited from surging demand for advanced &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;semiconductor packaging and metrology tools driven by AI chip growth.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Stock selection and an overweight in the consumer staples sector held back relative returns. Within the sector, an off-benchmark &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;holding in BellRing Brands was the leading detractor. The nutrition products company reported shrinking profit margins and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;decreasing demand for its protein shakes. Retailer inventory adjustments and reduced full year 2025 guidance were also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;headwinds for the company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Within IT, a broader market pivot away from software stocks had a negative impact on shares of software development platform &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;GitLab, despite the company&#x2019;s positive earnings reports.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the health care sector, relative performance was hurt by a position in health care software company Phreesia. The company &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;reduced guidance for 2027, reporting that it is losing visibility into spending commitments from some of its clients.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11292"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11295"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11312"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7466img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11316"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class R&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;29.79&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.74&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 2000 Growth Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;42.64&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;4.00&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.19&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11352"
      xml:lang="en-US">Class R</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103811"
      unitRef="RATIO">0.2979</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103812"
      unitRef="RATIO">0.0074</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103813"
      unitRef="RATIO">0.1091</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-11367"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103814"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103815"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103816"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member"
      id="ixv-11382"
      xml:lang="en-US">Russell 2000 Growth Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103817"
      unitRef="RATIO">0.4264</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103818"
      unitRef="RATIO">0.0400</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103819"
      unitRef="RATIO">0.1119</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-11397"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103820"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103821"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103822"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11413"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11429"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$2,435,287,399&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;129&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$15,084,958&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;48.01%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30Member"
      decimals="INF"
      id="ixv-103823"
      unitRef="USD">2435287399</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30Member"
      decimals="INF"
      id="ixv-103824"
      unitRef="UNIT">129</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103825"
      unitRef="USD">15084958</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103826"
      unitRef="RATIO">0.4801</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="foot-7466_809178-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9pt;color:#161616;;"&gt;&lt;sup&gt;,&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;&#x2020;&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7466img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:MaterialFundChngTextBlock
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11536"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW HAS THE FUND CHANGED?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund and Jacob Swartz was added as a &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;portfolio manager of the Fund.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngTextBlock>
    <oef:SummaryOfChngLegendTextBlock
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11549"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;</oef:SummaryOfChngLegendTextBlock>
    <oef:MaterialChngDate
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11551"
      xml:lang="en-US">2025-05-01</oef:MaterialChngDate>
    <oef:UpdProspectusWebAddress
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11556"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:UpdProspectusPhoneNumber
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11559"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:UpdProspectusPhoneNumber>
    <oef:UpdProspectusEmailAddress
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-11564"
      xml:lang="en-US">prospectus.us.franklintempleton@fisglobal.com</oef:UpdProspectusEmailAddress>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-103827"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-103828"
      unitRef="USD">11936</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-103829"
      unitRef="USD">14248</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-103830"
      unitRef="USD">16497</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-103831"
      unitRef="USD">15431</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-103832"
      unitRef="USD">27152</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-103833"
      unitRef="USD">19086</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-103834"
      unitRef="USD">18522</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-103835"
      unitRef="USD">22496</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-103836"
      unitRef="USD">21709</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103837"
      unitRef="USD">28176</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-103838"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-103839"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-103840"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-103841"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-103842"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-103843"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-103844"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-103845"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-103846"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-103847"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103848"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_5442Member"
      decimals="INF"
      id="ixv-103849"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_5442Member"
      decimals="INF"
      id="ixv-103850"
      unitRef="USD">12406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_5442Member"
      decimals="INF"
      id="ixv-103851"
      unitRef="USD">14466</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_5442Member"
      decimals="INF"
      id="ixv-103852"
      unitRef="USD">15465</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_5442Member"
      decimals="INF"
      id="ixv-103853"
      unitRef="USD">14040</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_5442Member"
      decimals="INF"
      id="ixv-103854"
      unitRef="USD">23749</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_5442Member"
      decimals="INF"
      id="ixv-103855"
      unitRef="USD">17469</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_5442Member"
      decimals="INF"
      id="ixv-103856"
      unitRef="USD">17596</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_5442Member"
      decimals="INF"
      id="ixv-103857"
      unitRef="USD">19775</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_5442Member"
      decimals="INF"
      id="ixv-103858"
      unitRef="USD">20253</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103859"
      unitRef="USD">28889</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-103860"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-103861"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-103862"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-103863"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-103864"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-103865"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-103866"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-103867"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-103868"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-103869"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7466_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103870"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-103871"
      unitRef="RATIO">0.246</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-103872"
      unitRef="RATIO">0.240</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-103873"
      unitRef="RATIO">0.231</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_3996Member"
      decimals="INF"
      id="ixv-103874"
      unitRef="RATIO">0.080</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-103875"
      unitRef="RATIO">0.075</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_3999Member"
      decimals="INF"
      id="ixv-103876"
      unitRef="RATIO">0.049</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-103877"
      unitRef="RATIO">0.028</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_3995Member"
      decimals="INF"
      id="ixv-103878"
      unitRef="RATIO">0.016</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_4000Member"
      decimals="INF"
      id="ixv-103879"
      unitRef="RATIO">0.007</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_4001Member"
      decimals="INF"
      id="ixv-103880"
      unitRef="RATIO">0.003</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_4943Member"
      decimals="INF"
      id="ixv-103881"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7466_instant_FranklinSmallCapGrowthFund_ClassR_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-103882"
      unitRef="RATIO">0.025</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-11630"
      xml:lang="en-US">Franklin Small Cap Growth Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-11639"
      xml:lang="en-US">Class R6</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-11642"
      xml:lang="en-US">FSMLX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-11649"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-11656"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Small Cap Growth Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-11658"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-11666"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-11668"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-11672"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:MaterialFundChngNoticeTextBlock
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-11677"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;"&gt;&lt;b&gt;&lt;i&gt;This report describes changes to the Fund that occurred during the reporting period.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngNoticeTextBlock>
    <oef:ExpensesTextBlock
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="foot-7462_808685-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class R6&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.66%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103883"
      unitRef="USD">76</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7462_808685-1021"
      unitRef="RATIO">0.0066</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-11741"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R6 shares of Franklin Small Cap Growth Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;30.66%. The Fund compares &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;its performance to the Russell 2000 Growth Index and the S&amp;amp;P 500 Index, which returned 42.64% and 31.05%, respectively, for the &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;same period.&#160;&#x2009;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;By sector, the largest contributor to relative returns was stock selection in the health care sector. However, the largest individual &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;contributors all came from the information technology (IT) sector. An off-benchmark position in phototonics specialist Lumentum &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Holdings led relative contributors after the company reported strong fiscal second quarter 2026 financial results and upbeat &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;forward guidance, driven by surging demand for artificial intelligence (AI) data center optics.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Semiconductor manufacturer SiTime also advanced relative returns. Shares in the company, which makes precision timing chips, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;soared late in the period after the company posted strong revenue growth amid increased demand from AI data centers.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Onto Innovation supported relative returns. The process control solutions company benefited from surging demand for advanced &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;semiconductor packaging and metrology tools driven by AI chip growth.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Stock selection and an overweight in the consumer staples sector held back relative returns. Within the sector, an off-benchmark &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;holding in BellRing Brands was the leading detractor. The nutrition products company reported shrinking profit margins and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;decreasing demand for its protein shakes. Retailer inventory adjustments and reduced full year 2025 guidance were also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;headwinds for the company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Within IT, a broader market pivot away from software stocks had a negative impact on shares of software development platform &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;GitLab, despite the company&#x2019;s positive earnings reports.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the health care sector, relative performance was hurt by a position in health care software company Phreesia. The company &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;reduced guidance for 2027, reporting that it is losing visibility into spending commitments from some of its clients.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-11861"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-11864"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-11881"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7462img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-11885"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class R6&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;30.66&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.40&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.65&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 2000 Growth Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;42.64&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;4.00&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.19&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-11921"
      xml:lang="en-US">Class R6</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103885"
      unitRef="RATIO">0.3066</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103886"
      unitRef="RATIO">0.0140</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103887"
      unitRef="RATIO">0.1165</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-11936"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103888"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103889"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103890"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member"
      id="ixv-11951"
      xml:lang="en-US">Russell 2000 Growth Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103891"
      unitRef="RATIO">0.4264</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103892"
      unitRef="RATIO">0.0400</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103893"
      unitRef="RATIO">0.1119</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-11966"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103894"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103895"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103896"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-11982"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-11998"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$2,435,287,399&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;129&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$15,084,958&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;48.01%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30Member"
      decimals="INF"
      id="ixv-103897"
      unitRef="USD">2435287399</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30Member"
      decimals="INF"
      id="ixv-103898"
      unitRef="UNIT">129</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103899"
      unitRef="USD">15084958</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103900"
      unitRef="RATIO">0.4801</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="foot-7462_808705-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9pt;color:#161616;;"&gt;&lt;sup&gt;,&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;&#x2020;&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7462img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:MaterialFundChngTextBlock
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-12105"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW HAS THE FUND CHANGED?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund and Jacob Swartz was added as a &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;portfolio manager of the Fund.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngTextBlock>
    <oef:SummaryOfChngLegendTextBlock
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-12118"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;</oef:SummaryOfChngLegendTextBlock>
    <oef:MaterialChngDate
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-12120"
      xml:lang="en-US">2025-05-01</oef:MaterialChngDate>
    <oef:UpdProspectusWebAddress
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-12125"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:UpdProspectusPhoneNumber
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-12128"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:UpdProspectusPhoneNumber>
    <oef:UpdProspectusEmailAddress
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-12133"
      xml:lang="en-US">prospectus.us.franklintempleton@fisglobal.com</oef:UpdProspectusEmailAddress>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-103901"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-103902"
      unitRef="USD">12021</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-103903"
      unitRef="USD">14453</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-103904"
      unitRef="USD">16837</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-103905"
      unitRef="USD">15850</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-103906"
      unitRef="USD">28076</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-103907"
      unitRef="USD">19862</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-103908"
      unitRef="USD">19407</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-103909"
      unitRef="USD">23721</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-103910"
      unitRef="USD">23038</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103911"
      unitRef="USD">30101</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-103912"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-103913"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-103914"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-103915"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-103916"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-103917"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-103918"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-103919"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-103920"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-103921"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103922"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_5442Member"
      decimals="INF"
      id="ixv-103923"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_5442Member"
      decimals="INF"
      id="ixv-103924"
      unitRef="USD">12406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_5442Member"
      decimals="INF"
      id="ixv-103925"
      unitRef="USD">14466</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_5442Member"
      decimals="INF"
      id="ixv-103926"
      unitRef="USD">15465</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_5442Member"
      decimals="INF"
      id="ixv-103927"
      unitRef="USD">14040</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_5442Member"
      decimals="INF"
      id="ixv-103928"
      unitRef="USD">23749</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_5442Member"
      decimals="INF"
      id="ixv-103929"
      unitRef="USD">17469</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_5442Member"
      decimals="INF"
      id="ixv-103930"
      unitRef="USD">17596</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_5442Member"
      decimals="INF"
      id="ixv-103931"
      unitRef="USD">19775</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_5442Member"
      decimals="INF"
      id="ixv-103932"
      unitRef="USD">20253</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103933"
      unitRef="USD">28889</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-103934"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-103935"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-103936"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-103937"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-103938"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-103939"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-103940"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-103941"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-103942"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-103943"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7462_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103944"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-103945"
      unitRef="RATIO">0.246</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-103946"
      unitRef="RATIO">0.240</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-103947"
      unitRef="RATIO">0.231</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_3996Member"
      decimals="INF"
      id="ixv-103948"
      unitRef="RATIO">0.080</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-103949"
      unitRef="RATIO">0.075</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_3999Member"
      decimals="INF"
      id="ixv-103950"
      unitRef="RATIO">0.049</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-103951"
      unitRef="RATIO">0.028</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_3995Member"
      decimals="INF"
      id="ixv-103952"
      unitRef="RATIO">0.016</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_4000Member"
      decimals="INF"
      id="ixv-103953"
      unitRef="RATIO">0.007</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_4001Member"
      decimals="INF"
      id="ixv-103954"
      unitRef="RATIO">0.003</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_4943Member"
      decimals="INF"
      id="ixv-103955"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7462_instant_FranklinSmallCapGrowthFund_ClassR6_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-103956"
      unitRef="RATIO">0.025</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12199"
      xml:lang="en-US">Franklin Small Cap Growth Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12208"
      xml:lang="en-US">Advisor Class</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12211"
      xml:lang="en-US">FSSAX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-12218"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12225"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Small Cap Growth Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-12227"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12235"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12237"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12241"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:MaterialFundChngNoticeTextBlock
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12246"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;"&gt;&lt;b&gt;&lt;i&gt;This report describes changes to the Fund that occurred during the reporting period.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngNoticeTextBlock>
    <oef:ExpensesTextBlock
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="foot-7465_809040-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Advisor Class&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$95&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.82%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103957"
      unitRef="USD">95</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7465_809040-1021"
      unitRef="RATIO">0.0082</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12310"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Advisor Class shares of Franklin Small Cap Growth Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;30.50%. The Fund &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;compares its performance to the Russell 2000 Growth Index and the S&amp;amp;P 500 Index, which returned 42.64% and 31.05%, respectively, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;for the same period.&#160;&#x2009;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;By sector, the largest contributor to relative returns was stock selection in the health care sector. However, the largest individual &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;contributors all came from the information technology (IT) sector. An off-benchmark position in phototonics specialist Lumentum &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Holdings led relative contributors after the company reported strong fiscal second quarter 2026 financial results and upbeat &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;forward guidance, driven by surging demand for artificial intelligence (AI) data center optics.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Semiconductor manufacturer SiTime also advanced relative returns. Shares in the company, which makes precision timing chips, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;soared late in the period after the company posted strong revenue growth amid increased demand from AI data centers.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Onto Innovation supported relative returns. The process control solutions company benefited from surging demand for advanced &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;semiconductor packaging and metrology tools driven by AI chip growth.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Stock selection and an overweight in the consumer staples sector held back relative returns. Within the sector, an off-benchmark &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;holding in BellRing Brands was the leading detractor. The nutrition products company reported shrinking profit margins and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;decreasing demand for its protein shakes. Retailer inventory adjustments and reduced full year 2025 guidance were also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;headwinds for the company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Within IT, a broader market pivot away from software stocks had a negative impact on shares of software development platform &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;GitLab, despite the company&#x2019;s positive earnings reports.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the health care sector, relative performance was hurt by a position in health care software company Phreesia. The company &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;reduced guidance for 2027, reporting that it is losing visibility into spending commitments from some of its clients.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12430"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12433"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12450"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7465img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12454"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Advisor Class&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;30.50&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.25&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.47&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 2000 Growth Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;42.64&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;4.00&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.19&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12490"
      xml:lang="en-US">Advisor Class</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103959"
      unitRef="RATIO">0.3050</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103960"
      unitRef="RATIO">0.0125</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103961"
      unitRef="RATIO">0.1147</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-12505"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103962"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103963"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103964"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member"
      id="ixv-12520"
      xml:lang="en-US">Russell 2000 Growth Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103965"
      unitRef="RATIO">0.4264</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103966"
      unitRef="RATIO">0.0400</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-103967"
      unitRef="RATIO">0.1119</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-12535"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103968"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103969"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-103970"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12551"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12567"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$2,435,287,399&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;129&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$15,084,958&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;48.01%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30Member"
      decimals="INF"
      id="ixv-103971"
      unitRef="USD">2435287399</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30Member"
      decimals="INF"
      id="ixv-103972"
      unitRef="UNIT">129</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103973"
      unitRef="USD">15084958</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103974"
      unitRef="RATIO">0.4801</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="foot-7465_809060-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9pt;color:#161616;;"&gt;&lt;sup&gt;,&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;&#x2020;&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7465img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:MaterialFundChngTextBlock
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12674"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW HAS THE FUND CHANGED?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund and Jacob Swartz was added as a &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;portfolio manager of the Fund.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngTextBlock>
    <oef:SummaryOfChngLegendTextBlock
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12687"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;</oef:SummaryOfChngLegendTextBlock>
    <oef:MaterialChngDate
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12689"
      xml:lang="en-US">2025-05-01</oef:MaterialChngDate>
    <oef:UpdProspectusWebAddress
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12694"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:UpdProspectusPhoneNumber
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12697"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:UpdProspectusPhoneNumber>
    <oef:UpdProspectusEmailAddress
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-12702"
      xml:lang="en-US">prospectus.us.franklintempleton@fisglobal.com</oef:UpdProspectusEmailAddress>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-103975"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-103976"
      unitRef="USD">12000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-103977"
      unitRef="USD">14397</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-103978"
      unitRef="USD">16743</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-103979"
      unitRef="USD">15740</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-103980"
      unitRef="USD">27838</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-103981"
      unitRef="USD">19669</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-103982"
      unitRef="USD">19177</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-103983"
      unitRef="USD">23416</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-103984"
      unitRef="USD">22701</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-103985"
      unitRef="USD">29625</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-103986"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-103987"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-103988"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-103989"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-103990"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-103991"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-103992"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-103993"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-103994"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-103995"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-103996"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_5442Member"
      decimals="INF"
      id="ixv-103997"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_5442Member"
      decimals="INF"
      id="ixv-103998"
      unitRef="USD">12406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_5442Member"
      decimals="INF"
      id="ixv-103999"
      unitRef="USD">14466</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_5442Member"
      decimals="INF"
      id="ixv-104000"
      unitRef="USD">15465</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_5442Member"
      decimals="INF"
      id="ixv-104001"
      unitRef="USD">14040</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_5442Member"
      decimals="INF"
      id="ixv-104002"
      unitRef="USD">23749</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_5442Member"
      decimals="INF"
      id="ixv-104003"
      unitRef="USD">17469</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_5442Member"
      decimals="INF"
      id="ixv-104004"
      unitRef="USD">17596</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_5442Member"
      decimals="INF"
      id="ixv-104005"
      unitRef="USD">19775</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_5442Member"
      decimals="INF"
      id="ixv-104006"
      unitRef="USD">20253</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_5442Member"
      decimals="INF"
      id="ixv-104007"
      unitRef="USD">28889</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-104008"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-104009"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-104010"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-104011"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-104012"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-104013"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-104014"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-104015"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-104016"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-104017"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7465_duration_FranklinSmallCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104018"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-104019"
      unitRef="RATIO">0.246</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-104020"
      unitRef="RATIO">0.240</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-104021"
      unitRef="RATIO">0.231</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_3996Member"
      decimals="INF"
      id="ixv-104022"
      unitRef="RATIO">0.080</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-104023"
      unitRef="RATIO">0.075</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_3999Member"
      decimals="INF"
      id="ixv-104024"
      unitRef="RATIO">0.049</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-104025"
      unitRef="RATIO">0.028</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_3995Member"
      decimals="INF"
      id="ixv-104026"
      unitRef="RATIO">0.016</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_4000Member"
      decimals="INF"
      id="ixv-104027"
      unitRef="RATIO">0.007</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_4001Member"
      decimals="INF"
      id="ixv-104028"
      unitRef="RATIO">0.003</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_4943Member"
      decimals="INF"
      id="ixv-104029"
      unitRef="RATIO">0.000</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7465_instant_FranklinSmallCapGrowthFund_AdvisorClass_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-104030"
      unitRef="RATIO">0.025</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-12768"
      xml:lang="en-US">Franklin Small-Mid Cap Growth Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-12777"
      xml:lang="en-US">Class A</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-12780"
      xml:lang="en-US">FRSGX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-12787"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-12794"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Small-Mid Cap Growth Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-12796"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-12803"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-12805"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-12809"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:MaterialFundChngNoticeTextBlock
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-12814"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;"&gt;&lt;b&gt;&lt;i&gt;This report describes changes to the Fund that occurred during the reporting period.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngNoticeTextBlock>
    <oef:ExpensesTextBlock
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="foot-7453_807586-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class A&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$90&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.84%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104031"
      unitRef="USD">90</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7453_807586-1021"
      unitRef="RATIO">0.0084</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-12878"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class A shares of Franklin Small-Mid Cap Growth Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;14.38%. The Fund &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;compares its performance to the Russell&#160;&#x2009;Midcap Growth Index and the S&amp;amp;P 500 Index, which returned 12.86% and 31.05%, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;respectively, for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund was helped most by stock selection in the information technology (IT) sector, where an off-benchmark holding in Arteris &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;was a leading relative contributor. The company, which develops network-on-chip (NoC) technology, has been a beneficiary of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the artificial intelligence (AI) chip boom, and has seen strong adoption of its Smart NoC product.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Also in IT, Lattice Semiconductor lifted relative returns. The chipmaker reported solid fourth-quarter 2025 financial results and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;issued strong forward guidance, highlighting accelerating growth in AI and data-center applications.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the industrials sector, nuclear power components supplier BWX Technologies was a contributor. Shares in the company traded &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;higher on the back of strong operational momentum and major national security contracts.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Stock selection in the industrials sector weighed on relative returns over the period. Within the sector, data analytics and risk &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;assessment firm, Verisk, was a leading detractor as investors worried that generative AI tools could weaken traditional data and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;analytics businesses.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In financials, alternative asset manager Blue Owl Capital hampered relative returns. The company put a cap on withdrawals after &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;investors tried to pull over $5 billion from two key funds, amid concerns about unregulated private lending markets.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the consumer staples sector, an off-benchmark holding in BellRing Brands was the leading detractor. The nutrition products &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;company reported shrinking profit margins and decreasing demand for its protein shakes. Retailer inventory adjustments and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;reduced full year 2025 guidance were also headwinds for the company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-12997"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-13000"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-13021"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7453img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-13025"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class A&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.38&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.50&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.62&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class A (with sales charge)&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;8.08&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;-0.63&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;9.99&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell Midcap Growth Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;12.86&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;5.54&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;12.40&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30_1400Member"
      id="ixv-13061"
      xml:lang="en-US">Class A</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-104033"
      unitRef="RATIO">0.1438</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2021-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-104034"
      unitRef="RATIO">0.0050</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2016-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-104035"
      unitRef="RATIO">0.1062</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-13076"
      xml:lang="en-US">Class A (with sales charge)</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104036"
      unitRef="RATIO">0.0808</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104037"
      unitRef="RATIO">-0.0063</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104038"
      unitRef="RATIO">0.0999</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-13091"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104039"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104040"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104041"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member"
      id="ixv-13106"
      xml:lang="en-US">Russell Midcap Growth Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104042"
      unitRef="RATIO">0.1286</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104043"
      unitRef="RATIO">0.0554</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104044"
      unitRef="RATIO">0.1240</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-13121"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104045"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104046"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104047"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-13141"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-13157"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$3,532,752,879&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;87&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$16,900,774&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;32.96%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30Member"
      decimals="INF"
      id="ixv-104048"
      unitRef="USD">3532752879</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30Member"
      decimals="INF"
      id="ixv-104049"
      unitRef="UNIT">87</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104050"
      unitRef="USD">16900774</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104051"
      unitRef="RATIO">0.3296</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="foot-7453_807607-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7453img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:MaterialFundChngTextBlock
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-13253"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW HAS THE FUND CHANGED?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngTextBlock>
    <oef:SummaryOfChngLegendTextBlock
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-13265"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;</oef:SummaryOfChngLegendTextBlock>
    <oef:MaterialChngDate
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-13267"
      xml:lang="en-US">2025-05-01</oef:MaterialChngDate>
    <oef:UpdProspectusWebAddress
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-13272"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:UpdProspectusPhoneNumber
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-13275"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:UpdProspectusPhoneNumber>
    <oef:UpdProspectusEmailAddress
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      id="ixv-13278"
      xml:lang="en-US">prospectus.us.franklintempleton@fisglobal.com</oef:UpdProspectusEmailAddress>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-104052"
      unitRef="USD">9450</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-104053"
      unitRef="USD">10868</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-104054"
      unitRef="USD">12420</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-104055"
      unitRef="USD">14585</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-104056"
      unitRef="USD">15018</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-104057"
      unitRef="USD">25284</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-104058"
      unitRef="USD">19511</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-104059"
      unitRef="USD">18717</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-104060"
      unitRef="USD">22158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-104061"
      unitRef="USD">22662</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_ClassA_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104062"
      unitRef="USD">25921</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-104063"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-104064"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-104065"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-104066"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-104067"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-104068"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-104069"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-104070"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-104071"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-104072"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104073"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_5108Member"
      decimals="INF"
      id="ixv-104074"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_5108Member"
      decimals="INF"
      id="ixv-104075"
      unitRef="USD">11583</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_5108Member"
      decimals="INF"
      id="ixv-104076"
      unitRef="USD">13537</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_5108Member"
      decimals="INF"
      id="ixv-104077"
      unitRef="USD">15925</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_5108Member"
      decimals="INF"
      id="ixv-104078"
      unitRef="USD">15961</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_5108Member"
      decimals="INF"
      id="ixv-104079"
      unitRef="USD">24576</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_5108Member"
      decimals="INF"
      id="ixv-104080"
      unitRef="USD">20464</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_5108Member"
      decimals="INF"
      id="ixv-104081"
      unitRef="USD">20791</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_5108Member"
      decimals="INF"
      id="ixv-104082"
      unitRef="USD">25094</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_5108Member"
      decimals="INF"
      id="ixv-104083"
      unitRef="USD">28520</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104084"
      unitRef="USD">32187</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-104085"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-104086"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-104087"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-104088"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-104089"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-104090"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-104091"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-104092"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-104093"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-104094"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7453_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104095"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-104096"
      unitRef="RATIO">0.261</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_3996Member"
      decimals="INF"
      id="ixv-104097"
      unitRef="RATIO">0.197</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-104098"
      unitRef="RATIO">0.188</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-104099"
      unitRef="RATIO">0.122</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-104100"
      unitRef="RATIO">0.092</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_3995Member"
      decimals="INF"
      id="ixv-104101"
      unitRef="RATIO">0.037</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_3999Member"
      decimals="INF"
      id="ixv-104102"
      unitRef="RATIO">0.034</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_4002Member"
      decimals="INF"
      id="ixv-104103"
      unitRef="RATIO">0.021</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-104104"
      unitRef="RATIO">0.018</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_4000Member"
      decimals="INF"
      id="ixv-104105"
      unitRef="RATIO">0.009</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7453_instant_FranklinSmall-MidCapGrowthFund_ClassA_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-104106"
      unitRef="RATIO">0.021</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13344"
      xml:lang="en-US">Franklin Small-Mid Cap Growth Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13353"
      xml:lang="en-US">Class C</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13356"
      xml:lang="en-US">FRSIX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-13363"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13370"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Small-Mid Cap Growth Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-13372"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13379"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13381"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13385"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:MaterialFundChngNoticeTextBlock
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13390"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;"&gt;&lt;b&gt;&lt;i&gt;This report describes changes to the Fund that occurred during the reporting period.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngNoticeTextBlock>
    <oef:ExpensesTextBlock
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="foot-7454_807709-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class C&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$170&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.59%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104107"
      unitRef="USD">170</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7454_807709-1021"
      unitRef="RATIO">0.0159</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13454"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class C shares of Franklin Small-Mid Cap Growth Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;13.55%. The Fund &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;compares its performance to the Russell&#160;&#x2009;Midcap Growth Index and the S&amp;amp;P 500 Index, which returned 12.86% and 31.05%, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;respectively, for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund was helped most by stock selection in the information technology (IT) sector, where an off-benchmark holding in Arteris &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;was a leading relative contributor. The company, which develops network-on-chip (NoC) technology, has been a beneficiary of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the artificial intelligence (AI) chip boom, and has seen strong adoption of its Smart NoC product.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Also in IT, Lattice Semiconductor lifted relative returns. The chipmaker reported solid fourth-quarter 2025 financial results and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;issued strong forward guidance, highlighting accelerating growth in AI and data-center applications.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the industrials sector, nuclear power components supplier BWX Technologies was a contributor. Shares in the company traded &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;higher on the back of strong operational momentum and major national security contracts.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Stock selection in the industrials sector weighed on relative returns over the period. Within the sector, data analytics and risk &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;assessment firm, Verisk, was a leading detractor as investors worried that generative AI tools could weaken traditional data and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;analytics businesses.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In financials, alternative asset manager Blue Owl Capital hampered relative returns. The company put a cap on withdrawals after &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;investors tried to pull over $5 billion from two key funds, amid concerns about unregulated private lending markets.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the consumer staples sector, an off-benchmark holding in BellRing Brands was the leading detractor. The nutrition products &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;company reported shrinking profit margins and decreasing demand for its protein shakes. Retailer inventory adjustments and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;reduced full year 2025 guidance were also headwinds for the company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13573"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13576"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13593"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7454img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13597"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class C&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.55&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;-0.25&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;9.79&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class C (with sales charge)&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;12.60&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;-0.25&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;9.79&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell Midcap Growth Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;12.86&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;5.54&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;12.40&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30_1400Member"
      id="ixv-13633"
      xml:lang="en-US">Class C</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-104109"
      unitRef="RATIO">0.1355</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2021-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-104110"
      unitRef="RATIO">-0.0025</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2016-05-01_2026-04-30_1400Member"
      decimals="INF"
      id="ixv-104111"
      unitRef="RATIO">0.0979</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13648"
      xml:lang="en-US">Class C (with sales charge)</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104112"
      unitRef="RATIO">0.1260</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104113"
      unitRef="RATIO">-0.0025</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104114"
      unitRef="RATIO">0.0979</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-13663"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104115"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104116"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104117"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member"
      id="ixv-13678"
      xml:lang="en-US">Russell Midcap Growth Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104118"
      unitRef="RATIO">0.1286</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104119"
      unitRef="RATIO">0.0554</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104120"
      unitRef="RATIO">0.1240</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-13693"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104121"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104122"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104123"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13709"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13725"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$3,532,752,879&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;87&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$16,900,774&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;32.96%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30Member"
      decimals="INF"
      id="ixv-104124"
      unitRef="USD">3532752879</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30Member"
      decimals="INF"
      id="ixv-104125"
      unitRef="UNIT">87</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104126"
      unitRef="USD">16900774</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104127"
      unitRef="RATIO">0.3296</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="foot-7454_807729-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7454img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:MaterialFundChngTextBlock
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13821"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW HAS THE FUND CHANGED?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngTextBlock>
    <oef:SummaryOfChngLegendTextBlock
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13833"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;</oef:SummaryOfChngLegendTextBlock>
    <oef:MaterialChngDate
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13835"
      xml:lang="en-US">2025-05-01</oef:MaterialChngDate>
    <oef:UpdProspectusWebAddress
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13840"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:UpdProspectusPhoneNumber
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13843"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:UpdProspectusPhoneNumber>
    <oef:UpdProspectusEmailAddress
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      id="ixv-13846"
      xml:lang="en-US">prospectus.us.franklintempleton@fisglobal.com</oef:UpdProspectusEmailAddress>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-104128"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-104129"
      unitRef="USD">11415</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-104130"
      unitRef="USD">12944</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-104131"
      unitRef="USD">15103</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-104132"
      unitRef="USD">15426</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-104133"
      unitRef="USD">25778</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-104134"
      unitRef="USD">19738</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-104135"
      unitRef="USD">18798</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-104136"
      unitRef="USD">22083</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-104137"
      unitRef="USD">22418</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_ClassC_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104138"
      unitRef="USD">25455</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-104139"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-104140"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-104141"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-104142"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-104143"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-104144"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-104145"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-104146"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-104147"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-104148"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104149"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_5108Member"
      decimals="INF"
      id="ixv-104150"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_5108Member"
      decimals="INF"
      id="ixv-104151"
      unitRef="USD">11583</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_5108Member"
      decimals="INF"
      id="ixv-104152"
      unitRef="USD">13537</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_5108Member"
      decimals="INF"
      id="ixv-104153"
      unitRef="USD">15925</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_5108Member"
      decimals="INF"
      id="ixv-104154"
      unitRef="USD">15961</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_5108Member"
      decimals="INF"
      id="ixv-104155"
      unitRef="USD">24576</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_5108Member"
      decimals="INF"
      id="ixv-104156"
      unitRef="USD">20464</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_5108Member"
      decimals="INF"
      id="ixv-104157"
      unitRef="USD">20791</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_5108Member"
      decimals="INF"
      id="ixv-104158"
      unitRef="USD">25094</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_5108Member"
      decimals="INF"
      id="ixv-104159"
      unitRef="USD">28520</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104160"
      unitRef="USD">32187</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-104161"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-104162"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-104163"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-104164"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-104165"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-104166"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-104167"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-104168"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-104169"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-104170"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7454_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104171"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-104172"
      unitRef="RATIO">0.261</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_3996Member"
      decimals="INF"
      id="ixv-104173"
      unitRef="RATIO">0.197</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-104174"
      unitRef="RATIO">0.188</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-104175"
      unitRef="RATIO">0.122</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-104176"
      unitRef="RATIO">0.092</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_3995Member"
      decimals="INF"
      id="ixv-104177"
      unitRef="RATIO">0.037</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_3999Member"
      decimals="INF"
      id="ixv-104178"
      unitRef="RATIO">0.034</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_4002Member"
      decimals="INF"
      id="ixv-104179"
      unitRef="RATIO">0.021</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-104180"
      unitRef="RATIO">0.018</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_4000Member"
      decimals="INF"
      id="ixv-104181"
      unitRef="RATIO">0.009</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7454_instant_FranklinSmall-MidCapGrowthFund_ClassC_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-104182"
      unitRef="RATIO">0.021</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-13912"
      xml:lang="en-US">Franklin Small-Mid Cap Growth Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-13921"
      xml:lang="en-US">Class R</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-13924"
      xml:lang="en-US">FSMRX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-13931"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-13938"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Small-Mid Cap Growth Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-13940"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-13947"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-13949"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-13953"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:MaterialFundChngNoticeTextBlock
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-13958"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;"&gt;&lt;b&gt;&lt;i&gt;This report describes changes to the Fund that occurred during the reporting period.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngNoticeTextBlock>
    <oef:ExpensesTextBlock
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="foot-7461_808564-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class R&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$117&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;1.09%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104183"
      unitRef="USD">117</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7461_808564-1021"
      unitRef="RATIO">0.0109</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-14022"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R shares of Franklin Small-Mid Cap Growth Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;14.07%. The Fund &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;compares its performance to the Russell&#160;&#x2009;Midcap Growth Index and the S&amp;amp;P 500 Index, which returned 12.86% and 31.05%, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;respectively, for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund was helped most by stock selection in the information technology (IT) sector, where an off-benchmark holding in Arteris &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;was a leading relative contributor. The company, which develops network-on-chip (NoC) technology, has been a beneficiary of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the artificial intelligence (AI) chip boom, and has seen strong adoption of its Smart NoC product.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Also in IT, Lattice Semiconductor lifted relative returns. The chipmaker reported solid fourth-quarter 2025 financial results and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;issued strong forward guidance, highlighting accelerating growth in AI and data-center applications.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the industrials sector, nuclear power components supplier BWX Technologies was a contributor. Shares in the company traded &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;higher on the back of strong operational momentum and major national security contracts.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Stock selection in the industrials sector weighed on relative returns over the period. Within the sector, data analytics and risk &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;assessment firm, Verisk, was a leading detractor as investors worried that generative AI tools could weaken traditional data and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;analytics businesses.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In financials, alternative asset manager Blue Owl Capital hampered relative returns. The company put a cap on withdrawals after &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;investors tried to pull over $5 billion from two key funds, amid concerns about unregulated private lending markets.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the consumer staples sector, an off-benchmark holding in BellRing Brands was the leading detractor. The nutrition products &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;company reported shrinking profit margins and decreasing demand for its protein shakes. Retailer inventory adjustments and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;reduced full year 2025 guidance were also headwinds for the company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-14141"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-14144"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-14161"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7461img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-14165"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class R&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.07&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.35&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell Midcap Growth Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;12.86&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;5.54&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;12.40&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-14201"
      xml:lang="en-US">Class R</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104185"
      unitRef="RATIO">0.1407</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104186"
      unitRef="RATIO">0.0026</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104187"
      unitRef="RATIO">0.1035</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-14216"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104188"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104189"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104190"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member"
      id="ixv-14231"
      xml:lang="en-US">Russell Midcap Growth Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104191"
      unitRef="RATIO">0.1286</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104192"
      unitRef="RATIO">0.0554</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104193"
      unitRef="RATIO">0.1240</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-14246"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104194"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104195"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104196"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-14262"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-14278"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$3,532,752,879&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;87&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$16,900,774&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;32.96%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30Member"
      decimals="INF"
      id="ixv-104197"
      unitRef="USD">3532752879</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30Member"
      decimals="INF"
      id="ixv-104198"
      unitRef="UNIT">87</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104199"
      unitRef="USD">16900774</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104200"
      unitRef="RATIO">0.3296</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="foot-7461_808584-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7461img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:MaterialFundChngTextBlock
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-14374"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW HAS THE FUND CHANGED?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngTextBlock>
    <oef:SummaryOfChngLegendTextBlock
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-14386"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;</oef:SummaryOfChngLegendTextBlock>
    <oef:MaterialChngDate
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-14388"
      xml:lang="en-US">2025-05-01</oef:MaterialChngDate>
    <oef:UpdProspectusWebAddress
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-14393"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:UpdProspectusPhoneNumber
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-14396"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:UpdProspectusPhoneNumber>
    <oef:UpdProspectusEmailAddress
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      id="ixv-14399"
      xml:lang="en-US">prospectus.us.franklintempleton@fisglobal.com</oef:UpdProspectusEmailAddress>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-104201"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-104202"
      unitRef="USD">11470</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-104203"
      unitRef="USD">13077</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-104204"
      unitRef="USD">15322</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-104205"
      unitRef="USD">15734</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-104206"
      unitRef="USD">26428</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-104207"
      unitRef="USD">20350</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-104208"
      unitRef="USD">19475</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-104209"
      unitRef="USD">22999</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-104210"
      unitRef="USD">23467</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_ClassR_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104211"
      unitRef="USD">26770</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-104212"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-104213"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-104214"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-104215"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-104216"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-104217"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-104218"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-104219"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-104220"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-104221"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104222"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_5108Member"
      decimals="INF"
      id="ixv-104223"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_5108Member"
      decimals="INF"
      id="ixv-104224"
      unitRef="USD">11583</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_5108Member"
      decimals="INF"
      id="ixv-104225"
      unitRef="USD">13537</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_5108Member"
      decimals="INF"
      id="ixv-104226"
      unitRef="USD">15925</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_5108Member"
      decimals="INF"
      id="ixv-104227"
      unitRef="USD">15961</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_5108Member"
      decimals="INF"
      id="ixv-104228"
      unitRef="USD">24576</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_5108Member"
      decimals="INF"
      id="ixv-104229"
      unitRef="USD">20464</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_5108Member"
      decimals="INF"
      id="ixv-104230"
      unitRef="USD">20791</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_5108Member"
      decimals="INF"
      id="ixv-104231"
      unitRef="USD">25094</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_5108Member"
      decimals="INF"
      id="ixv-104232"
      unitRef="USD">28520</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104233"
      unitRef="USD">32187</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-104234"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-104235"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-104236"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-104237"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-104238"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-104239"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-104240"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-104241"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-104242"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-104243"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7461_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104244"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-104245"
      unitRef="RATIO">0.261</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_3996Member"
      decimals="INF"
      id="ixv-104246"
      unitRef="RATIO">0.197</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-104247"
      unitRef="RATIO">0.188</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-104248"
      unitRef="RATIO">0.122</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-104249"
      unitRef="RATIO">0.092</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_3995Member"
      decimals="INF"
      id="ixv-104250"
      unitRef="RATIO">0.037</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_3999Member"
      decimals="INF"
      id="ixv-104251"
      unitRef="RATIO">0.034</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_4002Member"
      decimals="INF"
      id="ixv-104252"
      unitRef="RATIO">0.021</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-104253"
      unitRef="RATIO">0.018</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_4000Member"
      decimals="INF"
      id="ixv-104254"
      unitRef="RATIO">0.009</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7461_instant_FranklinSmall-MidCapGrowthFund_ClassR_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-104255"
      unitRef="RATIO">0.021</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14465"
      xml:lang="en-US">Franklin Small-Mid Cap Growth Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14474"
      xml:lang="en-US">Class R6</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14477"
      xml:lang="en-US">FMGGX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-14484"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14491"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Small-Mid Cap Growth Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-14493"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14500"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14502"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14506"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:MaterialFundChngNoticeTextBlock
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14511"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;"&gt;&lt;b&gt;&lt;i&gt;This report describes changes to the Fund that occurred during the reporting period.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngNoticeTextBlock>
    <oef:ExpensesTextBlock
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="foot-7455_807831-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Class R6&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$54&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.50%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104256"
      unitRef="USD">54</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7455_807831-1021"
      unitRef="RATIO">0.0050</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14575"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Class R6 shares of Franklin Small-Mid Cap Growth Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;14.79%. The Fund &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;compares its performance to the Russell&#160;&#x2009;Midcap Growth Index and the S&amp;amp;P 500 Index, which returned 12.86% and 31.05%, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;respectively, for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund was helped most by stock selection in the information technology (IT) sector, where an off-benchmark holding in Arteris &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;was a leading relative contributor. The company, which develops network-on-chip (NoC) technology, has been a beneficiary of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the artificial intelligence (AI) chip boom, and has seen strong adoption of its Smart NoC product.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Also in IT, Lattice Semiconductor lifted relative returns. The chipmaker reported solid fourth-quarter 2025 financial results and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;issued strong forward guidance, highlighting accelerating growth in AI and data-center applications.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the industrials sector, nuclear power components supplier BWX Technologies was a contributor. Shares in the company traded &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;higher on the back of strong operational momentum and major national security contracts.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Stock selection in the industrials sector weighed on relative returns over the period. Within the sector, data analytics and risk &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;assessment firm, Verisk, was a leading detractor as investors worried that generative AI tools could weaken traditional data and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;analytics businesses.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In financials, alternative asset manager Blue Owl Capital hampered relative returns. The company put a cap on withdrawals after &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;investors tried to pull over $5 billion from two key funds, amid concerns about unregulated private lending markets.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the consumer staples sector, an off-benchmark holding in BellRing Brands was the leading detractor. The nutrition products &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;company reported shrinking profit margins and decreasing demand for its protein shakes. Retailer inventory adjustments and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;reduced full year 2025 guidance were also headwinds for the company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14694"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14697"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14714"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7455img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14718"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Class R6&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.79&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.86&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell Midcap Growth Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;12.86&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;5.54&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;12.40&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14754"
      xml:lang="en-US">Class R6</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104258"
      unitRef="RATIO">0.1479</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104259"
      unitRef="RATIO">0.0086</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104260"
      unitRef="RATIO">0.1105</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-14769"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104261"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104262"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104263"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member"
      id="ixv-14784"
      xml:lang="en-US">Russell Midcap Growth Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104264"
      unitRef="RATIO">0.1286</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104265"
      unitRef="RATIO">0.0554</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104266"
      unitRef="RATIO">0.1240</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-14799"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104267"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104268"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104269"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14815"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14831"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$3,532,752,879&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;87&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$16,900,774&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;32.96%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30Member"
      decimals="INF"
      id="ixv-104270"
      unitRef="USD">3532752879</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30Member"
      decimals="INF"
      id="ixv-104271"
      unitRef="UNIT">87</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104272"
      unitRef="USD">16900774</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104273"
      unitRef="RATIO">0.3296</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="foot-7455_807883-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7455img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:MaterialFundChngTextBlock
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14927"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW HAS THE FUND CHANGED?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngTextBlock>
    <oef:SummaryOfChngLegendTextBlock
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14939"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;</oef:SummaryOfChngLegendTextBlock>
    <oef:MaterialChngDate
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14941"
      xml:lang="en-US">2025-05-01</oef:MaterialChngDate>
    <oef:UpdProspectusWebAddress
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14946"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:UpdProspectusPhoneNumber
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14949"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:UpdProspectusPhoneNumber>
    <oef:UpdProspectusEmailAddress
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      id="ixv-14952"
      xml:lang="en-US">prospectus.us.franklintempleton@fisglobal.com</oef:UpdProspectusEmailAddress>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-104274"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-104275"
      unitRef="USD">11551</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-104276"
      unitRef="USD">13273</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-104277"
      unitRef="USD">15638</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-104278"
      unitRef="USD">16170</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-104279"
      unitRef="USD">27320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-104280"
      unitRef="USD">21155</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-104281"
      unitRef="USD">20373</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-104282"
      unitRef="USD">24208</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-104283"
      unitRef="USD">24840</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_ClassR6_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104284"
      unitRef="USD">28513</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-104285"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-104286"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-104287"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-104288"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-104289"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-104290"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-104291"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-104292"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-104293"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-104294"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104295"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_5108Member"
      decimals="INF"
      id="ixv-104296"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_5108Member"
      decimals="INF"
      id="ixv-104297"
      unitRef="USD">11583</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_5108Member"
      decimals="INF"
      id="ixv-104298"
      unitRef="USD">13537</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_5108Member"
      decimals="INF"
      id="ixv-104299"
      unitRef="USD">15925</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_5108Member"
      decimals="INF"
      id="ixv-104300"
      unitRef="USD">15961</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_5108Member"
      decimals="INF"
      id="ixv-104301"
      unitRef="USD">24576</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_5108Member"
      decimals="INF"
      id="ixv-104302"
      unitRef="USD">20464</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_5108Member"
      decimals="INF"
      id="ixv-104303"
      unitRef="USD">20791</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_5108Member"
      decimals="INF"
      id="ixv-104304"
      unitRef="USD">25094</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_5108Member"
      decimals="INF"
      id="ixv-104305"
      unitRef="USD">28520</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104306"
      unitRef="USD">32187</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-104307"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-104308"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-104309"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-104310"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-104311"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-104312"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-104313"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-104314"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-104315"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-104316"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7455_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104317"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-104318"
      unitRef="RATIO">0.261</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_3996Member"
      decimals="INF"
      id="ixv-104319"
      unitRef="RATIO">0.197</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-104320"
      unitRef="RATIO">0.188</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-104321"
      unitRef="RATIO">0.122</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-104322"
      unitRef="RATIO">0.092</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_3995Member"
      decimals="INF"
      id="ixv-104323"
      unitRef="RATIO">0.037</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_3999Member"
      decimals="INF"
      id="ixv-104324"
      unitRef="RATIO">0.034</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_4002Member"
      decimals="INF"
      id="ixv-104325"
      unitRef="RATIO">0.021</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-104326"
      unitRef="RATIO">0.018</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_4000Member"
      decimals="INF"
      id="ixv-104327"
      unitRef="RATIO">0.009</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7455_instant_FranklinSmall-MidCapGrowthFund_ClassR6_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-104328"
      unitRef="RATIO">0.021</oef:PctOfTotalInv>
    <oef:FundName
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15018"
      xml:lang="en-US">Franklin Small-Mid Cap Growth Fund</oef:FundName>
    <oef:ClassName
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15027"
      xml:lang="en-US">Advisor Class</oef:ClassName>
    <dei:TradingSymbol
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15030"
      xml:lang="en-US">FSGAX</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-15037"
      xml:lang="en-US">2026-04-30</dei:DocumentPeriodEndDate>
    <oef:AnnlOrSemiAnnlStatementTextBlock
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15044"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;This &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;annual shareholder report&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt; contains important information about &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;Franklin Small-Mid Cap Growth Fund for the period &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;May 1, 2025, to &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;April 30, 2026.&lt;/span&gt;</oef:AnnlOrSemiAnnlStatementTextBlock>
    <oef:ShareholderReportAnnualOrSemiAnnual
      contextRef="c_7358_duration_FranklinBiotechnologyDiscoveryFund_2025-05-01_2026-04-30Member"
      id="ixv-15046"
      xml:lang="en-US">annual shareholder report</oef:ShareholderReportAnnualOrSemiAnnual>
    <oef:AddlInfoTextBlock
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15053"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;You can find additional information about the Fund at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;. You can also &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;request this information by contacting us at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;;"&gt;.&lt;/span&gt;</oef:AddlInfoTextBlock>
    <oef:AddlInfoWebsite
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15055"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:AddlInfoWebsite>
    <oef:AddlInfoPhoneNumber
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15059"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:AddlInfoPhoneNumber>
    <oef:MaterialFundChngNoticeTextBlock
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15064"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#161616;"&gt;&lt;b&gt;&lt;i&gt;This report describes changes to the Fund that occurred during the reporting period.&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngNoticeTextBlock>
    <oef:ExpensesTextBlock
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="foot-7460_808442-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT WERE THE FUND COSTS FOR THE LAST YEAR? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(based on a hypothetical $10,000 investment)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #E6FAFF;border-left:1.5pt solid #E6FAFF;  border-right:1.5pt solid #E6FAFF;  border-bottom:1.5pt solid #E6FAFF; margin-left:7.9pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:50%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:22.33812949640288%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:27.661870503597125%;background-color:#E6FAFF;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Class Name&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs of a $10,000 &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;investment&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;Costs paid as a percentage of a &lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;b&gt;$10,000 investment&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;Advisor Class&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$63&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="background-color:#E6FAFF;;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#E6FAFF;padding-left:2pt;padding-top:1.5pt;padding-bottom:0;align:center;text-align:center;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.59%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:ExpensesTextBlock>
    <oef:ExpensesPaidAmt
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104329"
      unitRef="USD">63</oef:ExpensesPaidAmt>
    <oef:ExpenseRatioPct
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="foot-7460_808442-1021"
      unitRef="RATIO">0.0059</oef:ExpenseRatioPct>
    <oef:FactorsAffectingPerfTextBlock
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15128"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For the twelve months ended April 30, 2026, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Advisor Class shares of Franklin Small-Mid Cap Growth Fund returned &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;14.69%. The Fund &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;compares its performance to the Russell&#160;&#x2009;Midcap Growth Index and the S&amp;amp;P 500 Index, which returned 12.86% and 31.05%, &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;respectively, for the same period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;PERFORMANCE HIGHLIGHTS&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top contributors to performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The Fund was helped most by stock selection in the information technology (IT) sector, where an off-benchmark holding in Arteris &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;was a leading relative contributor. The company, which develops network-on-chip (NoC) technology, has been a beneficiary of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;the artificial intelligence (AI) chip boom, and has seen strong adoption of its Smart NoC product.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Also in IT, Lattice Semiconductor lifted relative returns. The chipmaker reported solid fourth-quarter 2025 financial results and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;issued strong forward guidance, highlighting accelerating growth in AI and data-center applications.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#30DB87;;"&gt;&#x2191;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the industrials sector, nuclear power components supplier BWX Technologies was a contributor. Shares in the company traded &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;higher on the back of strong operational momentum and major national security contracts.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;padding-bottom:2pt;padding-top:0pt;margin-left:7.75pt;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:1.8507194244604317%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:98.14928057553956%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="2" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Top detractors from performance:&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Stock selection in the industrials sector weighed on relative returns over the period. Within the sector, data analytics and risk &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;assessment firm, Verisk, was a leading detractor as investors worried that generative AI tools could weaken traditional data and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;analytics businesses.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In financials, alternative asset manager Blue Owl Capital hampered relative returns. The company put a cap on withdrawals after &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;investors tried to pull over $5 billion from two key funds, amid concerns about unregulated private lending markets.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#CA0046;;"&gt;&#x2193;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;In the consumer staples sector, an off-benchmark holding in BellRing Brands was the leading detractor. The nutrition products &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;company reported shrinking profit margins and decreasing demand for its protein shakes. Retailer inventory adjustments and &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;reduced full year 2025 guidance were also headwinds for the company.&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:FactorsAffectingPerfTextBlock>
    <oef:PerformancePastDoesNotIndicateFuture
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15247"
      xml:lang="en-US">The Fund&#x2019;s past performance is not necessarily an indication of how the Fund will perform in the future. </oef:PerformancePastDoesNotIndicateFuture>
    <oef:NoDeductionOfTaxesTextBlock
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15250"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;The graph and table &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.&lt;/span&gt;</oef:NoDeductionOfTaxesTextBlock>
    <oef:LineGraphTableTextBlock
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15267"
      xml:lang="en-US">&lt;div&gt;&lt;img alt="image" src="ts7460img003.jpg" style="width:88.88888888888889%"/&gt;&lt;/div&gt;</oef:LineGraphTableTextBlock>
    <oef:AvgAnnlRtrTableTextBlock
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15271"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#161616;;"&gt;&lt;b&gt;AVERAGE ANNUAL TOTAL RETURNS (%) &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;Period Ended &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;margin-left:7.75pt;border-bottom:1.5pt solid #778B8B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:47.530575539568346%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.489208633093526%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.140287769784173%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:17.83992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:0pt;margin-bottom:0;"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;5 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:1.5pt solid #1447FF;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;10 Year&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Advisor Class&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.69&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;0.75&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:0.5pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;10.89&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell 3000 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.01&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;11.91&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;14.76&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Russell Midcap Growth Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;12.86&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;5.54&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #778B8B;white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;12.40&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;S&amp;amp;P 500 Index&lt;/b&gt;&lt;/span&gt;
               &lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;31.05&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;13.14&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;15.26&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AvgAnnlRtrTableTextBlock>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15307"
      xml:lang="en-US">Advisor Class</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104331"
      unitRef="RATIO">0.1469</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2021-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104332"
      unitRef="RATIO">0.0075</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2016-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104333"
      unitRef="RATIO">0.1089</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      id="ixv-15322"
      xml:lang="en-US">Russell 3000 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104334"
      unitRef="RATIO">0.3101</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104335"
      unitRef="RATIO">0.1191</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104336"
      unitRef="RATIO">0.1476</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member"
      id="ixv-15337"
      xml:lang="en-US">Russell Midcap Growth Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104337"
      unitRef="RATIO">0.1286</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104338"
      unitRef="RATIO">0.0554</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104339"
      unitRef="RATIO">0.1240</oef:AvgAnnlRtrPct>
    <oef:LineGraphAndTableMeasureName
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      id="ixv-15352"
      xml:lang="en-US">S&amp;P 500 Index</oef:LineGraphAndTableMeasureName>
    <oef:AvgAnnlRtrPct
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104340"
      unitRef="RATIO">0.3105</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2021-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104341"
      unitRef="RATIO">0.1314</oef:AvgAnnlRtrPct>
    <oef:AvgAnnlRtrPct
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2016-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104342"
      unitRef="RATIO">0.1526</oef:AvgAnnlRtrPct>
    <oef:UpdPerfInfoLocationTextBlock
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15368"
      xml:lang="en-US">&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;For current month-end performance, please call Franklin Templeton at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236 or visit&lt;/span&gt;&lt;br/&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/investments/options/mutual-funds&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Important data provider notices and terms available at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;www.franklintempletondatasources.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. &lt;/span&gt;&lt;/div&gt;</oef:UpdPerfInfoLocationTextBlock>
    <oef:AddlFundStatisticsTextBlock
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15384"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;KEY FUND STATISTICS &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;
      &lt;table cellspacing="0" style="width:98%;cellspacing:0;border-top:1.5pt solid #6B6B6B;margin-left:7.75pt;border-bottom:1.5pt solid #6B6B6B;margin-top:10px;"&gt;
         &lt;tr style="height:1px;"&gt;
            &lt;td style="height:1px;width:74.41007194244604%;"&gt;&lt;/td&gt;
            &lt;td style="height:1px;width:25.58992805755396%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Net Assets&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$3,532,752,879&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Number of Portfolio Holdings&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;87&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Total Management Fee Paid&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="border-bottom:0.75pt solid #6B6B6B;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;$16,900,774&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
            &lt;td colspan="1" style="vertical-align:top"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:left;text-align:left;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;&lt;b&gt;Portfolio Turnover Rate&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
            &lt;td colspan="1" style="white-space:nowrap;vertical-align:bottom"&gt;
               &lt;div style="background-color:#FFFFFF;padding-left:2pt;padding-top:1pt;padding-bottom:0;align:right;text-align:right;padding-right:2pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;margin-top:1pt;margin-bottom:0;"&gt;&lt;span style="font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;"&gt;32.96%&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
         &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</oef:AddlFundStatisticsTextBlock>
    <us-gaap:AssetsNet
      contextRef="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30Member"
      decimals="INF"
      id="ixv-104343"
      unitRef="USD">3532752879</us-gaap:AssetsNet>
    <oef:HoldingsCount
      contextRef="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30Member"
      decimals="INF"
      id="ixv-104344"
      unitRef="UNIT">87</oef:HoldingsCount>
    <oef:AdvisoryFeesPaidAmt
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104345"
      unitRef="USD">16900774</oef:AdvisoryFeesPaidAmt>
    <us-gaap:InvestmentCompanyPortfolioTurnover
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104346"
      unitRef="RATIO">0.3296</us-gaap:InvestmentCompanyPortfolioTurnover>
    <oef:HoldingsTableTextBlock
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="foot-7460_808462-1011"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;WHAT DID THE FUND INVEST IN? &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;(as of &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.824pt;color:#2D2D2D;;"&gt;April 30, 2026)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt;Portfolio Composition&lt;/b&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;sup&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;color:#161616;;"&gt;&lt;b&gt; (% of Total Investments)&lt;/b&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;img alt="image" src="ts7460img004.jpg" style="width:96.41294838145232%"/&gt;&lt;/div&gt;</oef:HoldingsTableTextBlock>
    <oef:MaterialFundChngTextBlock
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15480"
      xml:lang="en-US">&lt;div&gt;&lt;span style="text-transform:uppercase;"&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:12.024pt;text-transform:uppercase;color:#1447FF;;"&gt;&lt;b&gt;HOW HAS THE FUND CHANGED?&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;&lt;/div&gt;</oef:MaterialFundChngTextBlock>
    <oef:SummaryOfChngLegendTextBlock
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15492"
      xml:lang="en-US">&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;This is a summary of certain changes to the Fund since &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;May 1, 2025&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;. For more complete information, you may review the Fund&#x2019;s current &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus and any applicable supplements and the Fund&#x2019;s next prospectus, which we expect to be available by &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;September 1, 2026, at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;;"&gt;https://www.franklintempleton.com/regulatory-fund-documents&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or upon request at &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;(800) DIAL BEN/342-5236&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt; or &lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;prospectus.us.franklintempleton@fisglobal.com&lt;/span&gt;&lt;span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:10.02pt;color:#2D2D2D;;"&gt;.&lt;/span&gt;</oef:SummaryOfChngLegendTextBlock>
    <oef:MaterialChngDate
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15494"
      xml:lang="en-US">2025-05-01</oef:MaterialChngDate>
    <oef:UpdProspectusWebAddress
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15499"
      xml:lang="en-US">https://www.franklintempleton.com/regulatory-fund-documents</oef:UpdProspectusWebAddress>
    <oef:UpdProspectusPhoneNumber
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15502"
      xml:lang="en-US">(800) DIAL BEN/342-5236</oef:UpdProspectusPhoneNumber>
    <oef:UpdProspectusEmailAddress
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      id="ixv-15505"
      xml:lang="en-US">prospectus.us.franklintempleton@fisglobal.com</oef:UpdProspectusEmailAddress>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2016-04-30_2016-04-30Member"
      decimals="INF"
      id="ixv-104347"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2017-04-30_2017-04-30Member"
      decimals="INF"
      id="ixv-104348"
      unitRef="USD">11528</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2018-04-30_2018-04-30Member"
      decimals="INF"
      id="ixv-104349"
      unitRef="USD">13208</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2019-04-30_2019-04-30Member"
      decimals="INF"
      id="ixv-104350"
      unitRef="USD">15542</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2020-04-30_2020-04-30Member"
      decimals="INF"
      id="ixv-104351"
      unitRef="USD">16049</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2021-04-30_2021-04-30Member"
      decimals="INF"
      id="ixv-104352"
      unitRef="USD">27085</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2022-04-30_2022-04-30Member"
      decimals="INF"
      id="ixv-104353"
      unitRef="USD">20950</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2023-04-30_2023-04-30Member"
      decimals="INF"
      id="ixv-104354"
      unitRef="USD">20151</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2024-04-30_2024-04-30Member"
      decimals="INF"
      id="ixv-104355"
      unitRef="USD">23916</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-04-30_2025-04-30Member"
      decimals="INF"
      id="ixv-104356"
      unitRef="USD">24518</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_AdvisorClass_2025-05-01_2026-04-30Member"
      decimals="INF"
      id="ixv-104357"
      unitRef="USD">28119</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_4435Member"
      decimals="INF"
      id="ixv-104358"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_4435Member"
      decimals="INF"
      id="ixv-104359"
      unitRef="USD">11858</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_4435Member"
      decimals="INF"
      id="ixv-104360"
      unitRef="USD">13406</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_4435Member"
      decimals="INF"
      id="ixv-104361"
      unitRef="USD">15106</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_4435Member"
      decimals="INF"
      id="ixv-104362"
      unitRef="USD">14948</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_4435Member"
      decimals="INF"
      id="ixv-104363"
      unitRef="USD">22560</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_4435Member"
      decimals="INF"
      id="ixv-104364"
      unitRef="USD">21857</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_4435Member"
      decimals="INF"
      id="ixv-104365"
      unitRef="USD">22186</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_4435Member"
      decimals="INF"
      id="ixv-104366"
      unitRef="USD">27133</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_4435Member"
      decimals="INF"
      id="ixv-104367"
      unitRef="USD">30227</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_4435Member"
      decimals="INF"
      id="ixv-104368"
      unitRef="USD">39601</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_5108Member"
      decimals="INF"
      id="ixv-104369"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_5108Member"
      decimals="INF"
      id="ixv-104370"
      unitRef="USD">11583</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_5108Member"
      decimals="INF"
      id="ixv-104371"
      unitRef="USD">13537</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_5108Member"
      decimals="INF"
      id="ixv-104372"
      unitRef="USD">15925</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_5108Member"
      decimals="INF"
      id="ixv-104373"
      unitRef="USD">15961</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_5108Member"
      decimals="INF"
      id="ixv-104374"
      unitRef="USD">24576</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_5108Member"
      decimals="INF"
      id="ixv-104375"
      unitRef="USD">20464</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_5108Member"
      decimals="INF"
      id="ixv-104376"
      unitRef="USD">20791</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_5108Member"
      decimals="INF"
      id="ixv-104377"
      unitRef="USD">25094</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_5108Member"
      decimals="INF"
      id="ixv-104378"
      unitRef="USD">28520</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_5108Member"
      decimals="INF"
      id="ixv-104379"
      unitRef="USD">32187</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2016-04-30_2016-04-30_3882Member"
      decimals="INF"
      id="ixv-104380"
      unitRef="USD">10000</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2017-04-30_2017-04-30_3882Member"
      decimals="INF"
      id="ixv-104381"
      unitRef="USD">11792</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2018-04-30_2018-04-30_3882Member"
      decimals="INF"
      id="ixv-104382"
      unitRef="USD">13356</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2019-04-30_2019-04-30_3882Member"
      decimals="INF"
      id="ixv-104383"
      unitRef="USD">15158</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2020-04-30_2020-04-30_3882Member"
      decimals="INF"
      id="ixv-104384"
      unitRef="USD">15289</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2021-04-30_2021-04-30_3882Member"
      decimals="INF"
      id="ixv-104385"
      unitRef="USD">22320</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2022-04-30_2022-04-30_3882Member"
      decimals="INF"
      id="ixv-104386"
      unitRef="USD">22367</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2023-04-30_2023-04-30_3882Member"
      decimals="INF"
      id="ixv-104387"
      unitRef="USD">22963</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2024-04-30_2024-04-30_3882Member"
      decimals="INF"
      id="ixv-104388"
      unitRef="USD">28167</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-04-30_2025-04-30_3882Member"
      decimals="INF"
      id="ixv-104389"
      unitRef="USD">31574</oef:AccmVal>
    <oef:AccmVal
      contextRef="c_7460_duration_FranklinSmall-MidCapGrowthFund_2025-05-01_2026-04-30_3882Member"
      decimals="INF"
      id="ixv-104390"
      unitRef="USD">41379</oef:AccmVal>
    <oef:PctOfTotalInv
      contextRef="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_3997Member"
      decimals="INF"
      id="ixv-104391"
      unitRef="RATIO">0.261</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_3996Member"
      decimals="INF"
      id="ixv-104392"
      unitRef="RATIO">0.197</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_3992Member"
      decimals="INF"
      id="ixv-104393"
      unitRef="RATIO">0.188</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_3993Member"
      decimals="INF"
      id="ixv-104394"
      unitRef="RATIO">0.122</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_3994Member"
      decimals="INF"
      id="ixv-104395"
      unitRef="RATIO">0.092</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_3995Member"
      decimals="INF"
      id="ixv-104396"
      unitRef="RATIO">0.037</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_3999Member"
      decimals="INF"
      id="ixv-104397"
      unitRef="RATIO">0.034</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_4002Member"
      decimals="INF"
      id="ixv-104398"
      unitRef="RATIO">0.021</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_3998Member"
      decimals="INF"
      id="ixv-104399"
      unitRef="RATIO">0.018</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_4000Member"
      decimals="INF"
      id="ixv-104400"
      unitRef="RATIO">0.009</oef:PctOfTotalInv>
    <oef:PctOfTotalInv
      contextRef="c_7460_instant_FranklinSmall-MidCapGrowthFund_AdvisorClass_2026-04-30_4003Member"
      decimals="INF"
      id="ixv-104401"
      unitRef="RATIO">0.021</oef:PctOfTotalInv>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#foot-7358_798434-1011"
          xlink:label="foot-7358_798434-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7358_798434_11745" xlink:label="WSF_7358_798434_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7358_798434-1011"
          xlink:to="WSF_7358_798434_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7358_798455-1011"
          xlink:label="foot-7358_798455-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7358_798452_2288" xlink:label="WSF_7358_798452_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7358_798455-1011"
          xlink:to="WSF_7358_798452_2288"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7359_798557-1011"
          xlink:label="foot-7359_798557-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7359_798557_11745" xlink:label="WSF_7359_798557_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7359_798557-1011"
          xlink:to="WSF_7359_798557_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7359_798577-1011"
          xlink:label="foot-7359_798577-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7359_798574_2288" xlink:label="WSF_7359_798574_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7359_798577-1011"
          xlink:to="WSF_7359_798574_2288"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7360_798679-1011"
          xlink:label="foot-7360_798679-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7360_798679_11745" xlink:label="WSF_7360_798679_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7360_798679-1011"
          xlink:to="WSF_7360_798679_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7360_798699-1011"
          xlink:label="foot-7360_798699-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7360_798696_2288" xlink:label="WSF_7360_798696_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7360_798699-1011"
          xlink:to="WSF_7360_798696_2288"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7357_798312-1011"
          xlink:label="foot-7357_798312-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7357_798312_11745" xlink:label="WSF_7357_798312_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7357_798312-1011"
          xlink:to="WSF_7357_798312_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7357_798332-1011"
          xlink:label="foot-7357_798332-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7357_798329_2288" xlink:label="WSF_7357_798329_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7357_798332-1011"
          xlink:to="WSF_7357_798329_2288"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7432_805514-1011"
          xlink:label="foot-7432_805514-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7432_805514_11745" xlink:label="WSF_7432_805514_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7432_805514-1011"
          xlink:to="WSF_7432_805514_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7432_805539-1011"
          xlink:label="foot-7432_805539-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7432_805536_2288" xlink:label="WSF_7432_805536_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7432_805539-1011"
          xlink:to="WSF_7432_805536_2288"
          xlink:type="arc"/>
        <link:footnote id="WSF_7432_805537_33921" xlink:label="WSF_7432_805537_33921" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">&#x2020;</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Certain categories may represent less than 0.1%.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7432_805539-1011"
          xlink:to="WSF_7432_805537_33921"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7440_806227-1011"
          xlink:label="foot-7440_806227-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7440_806227_11745" xlink:label="WSF_7440_806227_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7440_806227-1011"
          xlink:to="WSF_7440_806227_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7440_806251-1011"
          xlink:label="foot-7440_806251-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7440_806248_2288" xlink:label="WSF_7440_806248_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7440_806251-1011"
          xlink:to="WSF_7440_806248_2288"
          xlink:type="arc"/>
        <link:footnote id="WSF_7440_806249_33921" xlink:label="WSF_7440_806249_33921" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">&#x2020;</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Certain categories may represent less than 0.1%.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7440_806251-1011"
          xlink:to="WSF_7440_806249_33921"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7443_806629-1011"
          xlink:label="foot-7443_806629-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7443_806629_11745" xlink:label="WSF_7443_806629_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7443_806629-1011"
          xlink:to="WSF_7443_806629_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7443_806705-1011"
          xlink:label="foot-7443_806705-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7443_806702_2288" xlink:label="WSF_7443_806702_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7443_806705-1011"
          xlink:to="WSF_7443_806702_2288"
          xlink:type="arc"/>
        <link:footnote id="WSF_7443_806703_33921" xlink:label="WSF_7443_806703_33921" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">&#x2020;</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Certain categories may represent less than 0.1%.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7443_806705-1011"
          xlink:to="WSF_7443_806703_33921"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7441_806357-1011"
          xlink:label="foot-7441_806357-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7441_806357_11745" xlink:label="WSF_7441_806357_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7441_806357-1011"
          xlink:to="WSF_7441_806357_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7441_806381-1011"
          xlink:label="foot-7441_806381-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7441_806378_2288" xlink:label="WSF_7441_806378_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7441_806381-1011"
          xlink:to="WSF_7441_806378_2288"
          xlink:type="arc"/>
        <link:footnote id="WSF_7441_806379_33921" xlink:label="WSF_7441_806379_33921" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">&#x2020;</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Certain categories may represent less than 0.1%.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7441_806381-1011"
          xlink:to="WSF_7441_806379_33921"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7431_805384-1011"
          xlink:label="foot-7431_805384-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7431_805384_11745" xlink:label="WSF_7431_805384_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7431_805384-1011"
          xlink:to="WSF_7431_805384_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7431_805408-1011"
          xlink:label="foot-7431_805408-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7431_805405_2288" xlink:label="WSF_7431_805405_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7431_805408-1011"
          xlink:to="WSF_7431_805405_2288"
          xlink:type="arc"/>
        <link:footnote id="WSF_7431_805406_33921" xlink:label="WSF_7431_805406_33921" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">&#x2020;</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Certain categories may represent less than 0.1%.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7431_805408-1011"
          xlink:to="WSF_7431_805406_33921"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7485_811083-1011"
          xlink:label="foot-7485_811083-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7485_811083_11745" xlink:label="WSF_7485_811083_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7485_811083-1011"
          xlink:to="WSF_7485_811083_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7485_811104-1011"
          xlink:label="foot-7485_811104-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7485_811101_2288" xlink:label="WSF_7485_811101_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7485_811104-1011"
          xlink:to="WSF_7485_811101_2288"
          xlink:type="arc"/>
        <link:footnote id="WSF_7485_811102_33921" xlink:label="WSF_7485_811102_33921" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">&#x2020;</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Certain categories may represent less than 0.1%.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7485_811104-1011"
          xlink:to="WSF_7485_811102_33921"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7484_810961-1011"
          xlink:label="foot-7484_810961-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7484_810961_11745" xlink:label="WSF_7484_810961_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7484_810961-1011"
          xlink:to="WSF_7484_810961_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7484_810981-1011"
          xlink:label="foot-7484_810981-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7484_810978_2288" xlink:label="WSF_7484_810978_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7484_810981-1011"
          xlink:to="WSF_7484_810978_2288"
          xlink:type="arc"/>
        <link:footnote id="WSF_7484_810979_33921" xlink:label="WSF_7484_810979_33921" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">&#x2020;</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Certain categories may represent less than 0.1%.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7484_810981-1011"
          xlink:to="WSF_7484_810979_33921"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7482_810717-1011"
          xlink:label="foot-7482_810717-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7482_810717_11745" xlink:label="WSF_7482_810717_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7482_810717-1011"
          xlink:to="WSF_7482_810717_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7482_810737-1011"
          xlink:label="foot-7482_810737-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7482_810734_2288" xlink:label="WSF_7482_810734_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7482_810737-1011"
          xlink:to="WSF_7482_810734_2288"
          xlink:type="arc"/>
        <link:footnote id="WSF_7482_810735_33921" xlink:label="WSF_7482_810735_33921" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">&#x2020;</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Certain categories may represent less than 0.1%.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7482_810737-1011"
          xlink:to="WSF_7482_810735_33921"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7483_810839-1011"
          xlink:label="foot-7483_810839-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7483_810839_11745" xlink:label="WSF_7483_810839_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7483_810839-1011"
          xlink:to="WSF_7483_810839_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7483_810859-1011"
          xlink:label="foot-7483_810859-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7483_810856_2288" xlink:label="WSF_7483_810856_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7483_810859-1011"
          xlink:to="WSF_7483_810856_2288"
          xlink:type="arc"/>
        <link:footnote id="WSF_7483_810857_33921" xlink:label="WSF_7483_810857_33921" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">&#x2020;</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Certain categories may represent less than 0.1%.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7483_810859-1011"
          xlink:to="WSF_7483_810857_33921"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7486_811206-1011"
          xlink:label="foot-7486_811206-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7486_811206_11745" xlink:label="WSF_7486_811206_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7486_811206-1011"
          xlink:to="WSF_7486_811206_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7486_811226-1011"
          xlink:label="foot-7486_811226-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7486_811223_2288" xlink:label="WSF_7486_811223_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7486_811226-1011"
          xlink:to="WSF_7486_811223_2288"
          xlink:type="arc"/>
        <link:footnote id="WSF_7486_811224_33921" xlink:label="WSF_7486_811224_33921" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">&#x2020;</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Certain categories may represent less than 0.1%.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7486_811226-1011"
          xlink:to="WSF_7486_811224_33921"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7444_806683-1011"
          xlink:label="foot-7444_806683-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7444_806683_11745" xlink:label="WSF_7444_806683_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7444_806683-1011"
          xlink:to="WSF_7444_806683_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7444_806726-1011"
          xlink:label="foot-7444_806726-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7444_806723_2288" xlink:label="WSF_7444_806723_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7444_806726-1011"
          xlink:to="WSF_7444_806723_2288"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7445_806851-1011"
          xlink:label="foot-7445_806851-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7445_806851_11745" xlink:label="WSF_7445_806851_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7445_806851-1011"
          xlink:to="WSF_7445_806851_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7445_806871-1011"
          xlink:label="foot-7445_806871-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7445_806868_2288" xlink:label="WSF_7445_806868_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7445_806871-1011"
          xlink:to="WSF_7445_806868_2288"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7446_806969-1011"
          xlink:label="foot-7446_806969-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7446_806969_11745" xlink:label="WSF_7446_806969_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7446_806969-1011"
          xlink:to="WSF_7446_806969_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7446_806989-1011"
          xlink:label="foot-7446_806989-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7446_806986_2288" xlink:label="WSF_7446_806986_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7446_806989-1011"
          xlink:to="WSF_7446_806986_2288"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7442_806485-1011"
          xlink:label="foot-7442_806485-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7442_806485_11745" xlink:label="WSF_7442_806485_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7442_806485-1011"
          xlink:to="WSF_7442_806485_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7442_806505-1011"
          xlink:label="foot-7442_806505-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7442_806502_2288" xlink:label="WSF_7442_806502_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7442_806505-1011"
          xlink:to="WSF_7442_806502_2288"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7463_808803-1011"
          xlink:label="foot-7463_808803-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7463_808803_11745" xlink:label="WSF_7463_808803_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7463_808803-1011"
          xlink:to="WSF_7463_808803_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7463_808824-1011"
          xlink:label="foot-7463_808824-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7463_808821_2288" xlink:label="WSF_7463_808821_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7463_808824-1011"
          xlink:to="WSF_7463_808821_2288"
          xlink:type="arc"/>
        <link:footnote id="WSF_7463_808822_33921" xlink:label="WSF_7463_808822_33921" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">&#x2020;</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Certain categories may represent less than 0.1%.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7463_808824-1011"
          xlink:to="WSF_7463_808822_33921"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7464_808922-1011"
          xlink:label="foot-7464_808922-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7464_808922_11745" xlink:label="WSF_7464_808922_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7464_808922-1011"
          xlink:to="WSF_7464_808922_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7464_808942-1011"
          xlink:label="foot-7464_808942-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7464_808939_2288" xlink:label="WSF_7464_808939_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7464_808942-1011"
          xlink:to="WSF_7464_808939_2288"
          xlink:type="arc"/>
        <link:footnote id="WSF_7464_808940_33921" xlink:label="WSF_7464_808940_33921" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">&#x2020;</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Certain categories may represent less than 0.1%.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7464_808942-1011"
          xlink:to="WSF_7464_808940_33921"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7466_809158-1011"
          xlink:label="foot-7466_809158-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7466_809158_11745" xlink:label="WSF_7466_809158_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7466_809158-1011"
          xlink:to="WSF_7466_809158_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7466_809178-1011"
          xlink:label="foot-7466_809178-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7466_809175_2288" xlink:label="WSF_7466_809175_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7466_809178-1011"
          xlink:to="WSF_7466_809175_2288"
          xlink:type="arc"/>
        <link:footnote id="WSF_7466_809176_33921" xlink:label="WSF_7466_809176_33921" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">&#x2020;</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Certain categories may represent less than 0.1%.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7466_809178-1011"
          xlink:to="WSF_7466_809176_33921"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7462_808685-1011"
          xlink:label="foot-7462_808685-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7462_808685_11745" xlink:label="WSF_7462_808685_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7462_808685-1011"
          xlink:to="WSF_7462_808685_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7462_808705-1011"
          xlink:label="foot-7462_808705-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7462_808702_2288" xlink:label="WSF_7462_808702_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7462_808705-1011"
          xlink:to="WSF_7462_808702_2288"
          xlink:type="arc"/>
        <link:footnote id="WSF_7462_808703_33921" xlink:label="WSF_7462_808703_33921" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">&#x2020;</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Certain categories may represent less than 0.1%.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7462_808705-1011"
          xlink:to="WSF_7462_808703_33921"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7465_809040-1011"
          xlink:label="foot-7465_809040-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7465_809040_11745" xlink:label="WSF_7465_809040_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7465_809040-1011"
          xlink:to="WSF_7465_809040_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7465_809060-1011"
          xlink:label="foot-7465_809060-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7465_809057_2288" xlink:label="WSF_7465_809057_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7465_809060-1011"
          xlink:to="WSF_7465_809057_2288"
          xlink:type="arc"/>
        <link:footnote id="WSF_7465_809058_33921" xlink:label="WSF_7465_809058_33921" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">&#x2020;</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Certain categories may represent less than 0.1%.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7465_809060-1011"
          xlink:to="WSF_7465_809058_33921"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7453_807586-1011"
          xlink:label="foot-7453_807586-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7453_807586_11745" xlink:label="WSF_7453_807586_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7453_807586-1011"
          xlink:to="WSF_7453_807586_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7453_807607-1011"
          xlink:label="foot-7453_807607-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7453_807604_2288" xlink:label="WSF_7453_807604_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7453_807607-1011"
          xlink:to="WSF_7453_807604_2288"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7454_807709-1011"
          xlink:label="foot-7454_807709-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7454_807709_11745" xlink:label="WSF_7454_807709_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7454_807709-1011"
          xlink:to="WSF_7454_807709_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7454_807729-1011"
          xlink:label="foot-7454_807729-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7454_807726_2288" xlink:label="WSF_7454_807726_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7454_807729-1011"
          xlink:to="WSF_7454_807726_2288"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7461_808564-1011"
          xlink:label="foot-7461_808564-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7461_808564_11745" xlink:label="WSF_7461_808564_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7461_808564-1011"
          xlink:to="WSF_7461_808564_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7461_808584-1011"
          xlink:label="foot-7461_808584-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7461_808581_2288" xlink:label="WSF_7461_808581_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7461_808584-1011"
          xlink:to="WSF_7461_808581_2288"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7455_807831-1011"
          xlink:label="foot-7455_807831-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7455_807831_11745" xlink:label="WSF_7455_807831_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7455_807831-1011"
          xlink:to="WSF_7455_807831_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7455_807883-1011"
          xlink:label="foot-7455_807883-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7455_807879_2288" xlink:label="WSF_7455_807879_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7455_807883-1011"
          xlink:to="WSF_7455_807879_2288"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7460_808442-1011"
          xlink:label="foot-7460_808442-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7460_808442_11745" xlink:label="WSF_7460_808442_11745" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher.</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7460_808442-1011"
          xlink:to="WSF_7460_808442_11745"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#foot-7460_808462-1011"
          xlink:label="foot-7460_808462-1011"
          xlink:type="locator"/>
        <link:footnote id="WSF_7460_808459_2288" xlink:label="WSF_7460_808459_2288" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en"><xhtml:table style="padding-top:5pt;width:100%;cellspacing:0;margin-left:8pt;"><xhtml:tr><xhtml:td style="vertical-align:top;font-family:Arial, Helvetica, sans-serif;font-size:6pt;text-align:left;align:left;width:2%;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:8.02pt;color:#6B6B6B;;">*</xhtml:span></xhtml:td><xhtml:td style="padding-bottom:0pt;padding-top:-10.02pt;padding-left:2pt;padding-right:0pt;"><xhtml:span style="clear:both;font-family:Arial, Helvetica, sans-serif;font-size:9.02pt;color:#6B6B6B;;">Does not include derivatives, except purchased options, if any.&#160;&#x2009;</xhtml:span></xhtml:td></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="foot-7460_808462-1011"
          xlink:to="WSF_7460_808459_2288"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
